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"iTbrinolysla" is a term used here
to describe the process of aseptic
dissolution of fibrin or whole blood
clot, by means of a lytic agent or of
lytic agents contained in the blood.
INTRODUCTION
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The value of the clotting of "blood, has been
assumed for centuries and has been generally accepted. Yet
if clotting were 'uncontrolled, its mechanism would be of no
value, indeed it would threaten life. It is not surprising,
therefore, that there has been shown to exist, amongst other
controlling mechanisms, a system of clot dissolution which
can counteract the effects of clotting. Its presence,
both in health and in disease, has been demonstrated many
times but its true significance is still a matter for
conjecture.
Aseptic clot dissolution, or fibrinolysis, has
been recognised for well over a hundred years, but it was
not until h&cfarlane and Biggs' review of the subject in
1948 that attention was focussed on the theoretical problem
involved, together with its possible clinical importance.
At first fibrinolysis could be demonstrated only in subjects
under stress. When techniques improved, it could be shown
in vitro that fibrinolysis occurred in healthy people, but
this was not proof of real activity in the body. Finally
the hypothesis was put forward. (Copley, 1957) that fibrinolysis
is not so much a system to be called upon as the need arises,
as one which is constantly at work maintaining equilibrium
with the so-called endo-endothelial fibrin film which is
believed to be the physiological lining of all blood vessels.
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Excessive bleeding has been attributed to over¬
activity of the fibrinolytic system. Nilsson, Sjoerdsma and
Waldenstrom (1960) wrote that they had seen in recent years
43 cases with severe fibrinolysis as the cause of "haeraorrhagic
syrqptoms". Here, therefore, is a field where more knowledge
of the mechanism of fibrinolysis might lead to proof of a
causal relationship and perhaps to better diagnosis and
treatment.
Underactivity of the fibrinolytic system appears to
be well demonstrated by hyaline membrane disease of the lung.
This is usually congenital in origin but may be acquired, and
is discussed independently. With less positive evidence, it
is considered that underactivity or failure in the fibrinolytic
system may well play a part in intravascular thrombosis.
Although unproved, this has a very great clinical implication.
When intravascular thrombosis takes place, premature clotting
is occurring, but it is possible that the clot is allowed to
develop because of a fundamental failure of the normal action
of the fibrinolytic system. This might have been expected to
remove the early fibrin strands, so halting the development
of the thrombus, Lome evidence has been published to support
this theory (faith and Xates, 1955s Hume, 1958: Nestel, 1955:
Czara&ecki, 1960: Merskey, Gordon and Lackner, 1960: McDonald,
1960: Tsitouris, Sandberg, deLeon, Leeks and Bellet, 1960).
The fibrinolytic system has therefore been incriminated
in dangerous bleeding due to an excess of activity; and in
y tm
intravascular clotting and other disorders due to an
insufficiency of activity.
In addition, there is almost certainly a place
in clinical practice for the administration of fibrinolytic
agents as therapeutic substances, to boost or to supersede
inadequate fibrinolysis in dealing with an overwhelming
local deposition of fibrin. The potential role of
/
fibrinolysis is therefore great, and covers both preventive
and therapeutic medicine.
Much work has been done on the problem of fibrinolysis,
particularly in the last ten years, but no great advance in
practical management appears yet to have arisen and many
fundamental points have remained unexplained. Here a short
review of published work on fibrinolysis will be given as a
background to the presentation of new work. The incidence
of active fibrinolysis in carcinoma of the prostate will then
be compered to that of a large control series, and an
explanation offered for the serious and even fatal bleeding
which sometimes occurs in that condition. In addition, a
fundamental point has emerged concerning the effect of age
on fibrinolytic activity.
CHAPTER ONE
SURVEY OF PUBLISHED WORK ON FIBRINOLYSIS
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"In many modes of destroying life the blood is
deprived of its power of coagulation, as
happens in sudden death produced by mary kinds
of fits, by anger, electricity or lightning:
or by a blow in the stomach, otc. In these
cases we find the blood, after death, not only
in as fluid a state as in the living vessels,
but it does not even coagulate when taken out
of them"
The history of observation of fibrinolysis thus goes
back a long time, but the history of the recognition of
fibrinolysis as an important mechanism is modern. L'acfarlane
and Biggs (1943) can be given credit for initiating much of the
present interest in the subject. In their review they made
reference, in relatively short space, to most of the important
discoveries of the last hundred years relating to fibrinolysis.
These early observations were generally made at autopsy or as part
of a laboratory type of investigation, and were not at first
John Hunter, 1794.
recognised as having clinical importance. The name "fibrinolysis"
came from Dastre (1893) who noted the disappearance of fibrin left
in contact with the blood whence it had ccxne and gave the phenomenon
its new name - "C'est cette disparition de la fibrine que je norsme
Fibrinolyse".
Korgagni (1769) described a case where death resulted
from a stab wound in a man of 40 who had previously been healthy.
When he dissected the body next day, his interest being in anatomy,
Forgagni observed that the blood was "more dissolved and more watery
than usual". In the posthumous work of John Hunter (1794) we
find he recognised that the blood after sudden death was often
incapable of clotting, and it can be assumed as a result of later
work that he was observing the results of fibrinolysis. All along
the history of fibrinolysis there has been a close association
between demonstrated fibrinolysis and apparent fibrinogen depletion.
Ilolf (1905-06) reported that surgical removal of the liver in dogs
led to fibrinolysis when this was estimated within half an hour of
the operation. Fibrinogen deficiency followed. When post-mortem
blood failed to clot Morawits (1906) almost always found fibrinogen
deficiency. He felt that the absence of fibrinogen was the result
of fibrinolysis which could be so powerful as to remove all the
fibrinogen and fibrin from the blood stream within ten hours of
death.
An empirical observation was made by Depys and de liarbaix
(1889) that the addition of chloroform, ether, alcohol or thymol
was followed by a demonstrable proteolytic activity in the serum.
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This was dependent on a factor which could be destroyed by
heating.
Almost the first association of fibrinolysis -with a
clinical disorder diagnosed in life was .made by Goodpasture (1914)
who noted rapid dissolution of clots prepared from the blood of
four patients suffering from atrophic hepatic cirrhosis. He also
noticed that the potency of the lytic agent diminished with storage.
The discovery was made by Tillett and Garner (1933) that
certain beta haemolytic streptococci, particularly those of human
origin, create a substance in their culture medium capable of
stimulating very rapid fibrinolysis when added to plasma clot and
they called the substance fibrinolysin. Although this activity
has been confirmed many times, it is still an observation without
certain clinical relevance. Nevertheless great strides in the
understanding of fibrinolysis have developed from the use of the
product of the beta haemolytic streptococcus. The product has
been shown to be inactive against clot prepared from purified
fibrinogen, although the presence of euglobulin from normal human
serum allows lysis to take place (Mlstone, 1941). It was thus
inferred that the agent was acting at an earlier stage of a more
complicated system than had been realised and could no longer
reasonably be called fibrinolysis Christensen and MacLeod (1945)
called the active exotoxin of the streptococcus, streptokinase.
Evidence about the existence of anti-fibrinolysis arose
towards the end of the nineteenth century. Hahn in 1897 talked of
the antifermentative action of the blood and Opie and Barker (1907)
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quoted Landsteiner in 1900 as identifying antitrypsin activity
in the albumin fraction of plasoa. The proteolytic activity of
chloroform-activated serum on gelatin and casein was demonstrated
by Delezenne and Pczerski (1903 a, b). They then showed that
this could be entirely neutralised by the addition of untreated,
serum. Hedin (1904) found that he could neutralize the digestive
effect of his splenic alpha protease upon coagulated serum by
adding albumin or, a little less effective, pseudoglobulin.
The ferment-inhibiting; action of serum was reported by Jobling
and Peterson (1914) to be due to the presence of compounds of
the unsaturated fatty acids, hence its removal by chloroform or
ether, and a similar opinion was expressed by Un-ar (1945) after
using ether, although he felt that a water soluble fraction was
also necessary for antitrypsin activity. Dale and Valpole (1916)
accepted that chloroform destroyed the antiproteolytic potential,
of normal serum, as did Teale and Bach (1920) but they felt that
their evidence favoured antitrypsin being protein in nature and
not lipoidal. Christensen (1954) states that the inhibitor is
not a lipid.
Subsequent work does not seam to have gone much further
concerning the effect of chloroform on antiproteolysis, altliough
it has been felt by some that the chloroform action is more
complicated than can be accounted for by destruction of an
inhibitor alone. -< strup (1956) thought that chloroform had a
denaturing effect on one or more of the fibrinolytic factors to
account for its vigorous activating effect.
Hussey and Northrop (1923) appeared to establish that serum
inhibitor combines with trypsin in a stoicheiometric reversible
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reaction but Shulman (1952) thought that the plasa&n and inhibitor
combination -was irreversible. It is uncertain -whether the difference
between trypsin and plasmin is significant in this respect.
One of the most dramatic stories in the history of
fibrinolysis is that of Yudin (1937) who used blood from the dead
on a large scale for transfusion purposes, but only the blood from
those who had died suddenly was suitably liquid (reliquefied) for
his purpose. Severe trauma, such as operative surgery (Rolf,
1905-06: Macfarlane, 1937s Lnperati, 1937) with cardiac arrest
(Coon and Hodgson, 1952), peptone and anaphylactic shock (Rocha e
£ilva and Texeira, 1946: Kocha e Silva, Andrade and Texeira, 1946),
electrically induced convulsions (fantl and Simon, 1948), severe
haemorrhagic shock and after extensive burns (Tagnon, Levenson,
Davidson and Taylor, 1946) in man and in animals as well as sudden
death, have all been associated with fibrinolysis. Macfarlane
(1937) noted the relationship of fibrinolysis with actual stress on
the body, and then with fear of stress and drew attention to this
with Biggs (1946). Selye's concept of stress appeared appropriate
to fibrinolysis but Truelove (1952) provided evidence against
fibrinolysis being initiated by corticotrqphin or adreno-cortioal
activity. Severe exercise also induced increased fibrinolysis
(Biggs, !«'acfarlane and Pilling, 1947). The common factor in
anxiety and severe exercise seemed to be adrenalin and this was in
fact shown to cause intense fibrinolytic activity when injected
experimentally into normal subjects. The short duration of
adrenalin-induced fibrinolytic activity in the serum does not appear
to be explainable by an increased excretion of such activity in the
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urine (Williams, 1951s laacfarlane and Pilling, 1947). It has
therefore been assumed that serum anti-plasmin neutralises this
effect.
Another observation of Macfarlane (1957), made
incidentally in the first place, Iras proved to have great
investigational value. He found that dilution of plasma -with
saline led to a rate of lysis greater than that shown without
dilution. This principle of rendering lysis apparent by dilution
has been confirmed many times and has been used in many of the
techniques since developed for the demonstration of fibrinolysis.
The explanation of the dilution effect is still unproved. Certain
exceptions to it will be demonstrated later.
acfarlane's dilution technique demonstrated lysis
frequently when it could not be shown in whole plasma, but it was
usually found only in conditions of stress. Fearnley and Tweed
(1953) modified the technique by manipulating the blood at ice
temperature and -were able to demonstrate lysis even in normal people
at rest. Their experiments supplied evidence that there was a
heat-labile fibrinolytic factor in normal plasma. This was not
the first demonstration of fibrinolysis in healthy people at rest.
RatnOff (1949) had shown lysis in a high proportion of clots from
healthy controls and ward patients by using recalcified plasma.
Several recent advances in knowledge about fibrinolysis
have arisen from the use of plasma fractionation. This technique
is not a new one. Hedin (1904) used aiimonium sulphate fractionation,
one third saturation with ammonium sulphate of dilute ox serum
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bringing down euglobulin, one third to one half saturation bringing
down pseudoglobulin, and that appearing between half and full
saturation, albumin. These fractions were tried out for their
respective powers of digestion. Opie and Barker (1907) also used
salt precipitation. Feissly (1942) and Liacfarlane and Pilling
(1946) used acid precipitation. The most important lytic agent
seems to be present in the globulin fraction, and euglobulin
fractionation (. ilstone, 1941: bherry, Id.ndera.eyer, Fletcher and
Alkjaersig, 1959) is one of the most successful of current techniques
for the demonstration of fibrinolysis. Wilder and Parsons (1956)
and Astrup, Piper and Easmussen (i960) have each demonstrated
normal fibrinolysis in a case of agaouaglobulinaernia and the
latter group in a case of raacroglobulinaernia. This appears to
dissociate the euglobulin fibrinolytic activity from the gamma- and
macro-globulin moieties, but at the moment there my be more evidence
against such a dissociation than there is for it. There may well
be more than one fibrinolytic agent in any one fraction, but the
process of fractionation helps to separate the lytic agents from
anti-lytic factors and in particular separates off the anti-
fibrinolytic or antiplasrain agents, these being variously ascribed
to the albumin fraction, the alpha 1 and the alpha 2 globulins.
Antifibrinolytic factors are discussed in the appropriate section.
Important aid to the further analysis of fibrinolytic
mechanisms came from the fibrin plate technique of Permin (1950).
This gave more positive evidence of there being an intermediate
step in fibrinolysis by demonstrating a difference between human
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and "bovine clot. Streptokinase did not lyse purified fibrin from
any source, nor did it lyse untreated bovine fibrin clot; but it
did lyse untreated human clot. If a little human serum was added
to the bovine fibrin, then streptokinase became actively fibrinolytic
there also. It was deduced that human blood contains a substance
not present in bovine blood which acts as an intermediary between
streptokinase and plasminogen. The intermediate factor which
streptokinase converts into activator was called proactivator, and
it appeared that plasminogen and this proaotivator (of plasminogen)
were both adsorbed on to freshly formed fibrin. Comment is made
later concerning this work in its relationship to the nature of
proactivator.
Heating a fibrin plate for about half an hour to
approximately 80 degrees centigrade (°C) was found to inactivate
the plasminogen and proactivator and so the fibrin became
susceptible only to trypsin-like lytic agents such as plasmin
itself (Lassen, 1952). Early fibrinolytic components were incapable
of lysing the fibrin by themselves and retained this power only after
first activating intermediate faotors. These could be added
selectively and their action thus studied. Heated and unheated
fibrin plates used together have contributed greatly to an under¬
standing of some of the mechanisms involved in fibrinolysis.
Tissue substances have been shown to have an influence
on the fibrinolytic system and Astrup and his colleagues have been
responsible for a very large proportion of the work in this field
(Astrup, 1956). A relatively insoluble agent found in the tissues
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acts directly on plasminogen. This agent m called fibrinokinase
at first, but the name was later changed by Astrup to tissue activator.
An interesting group of observations arose from studies
on the fibrinolytic effect of normal urine. Farnsworth, Speer and
Alt (1946) quoted. BrUeke in 1861 as being, perhaps the first to draw
attention to the presence of a proteolytic substance in urine.
They then sketched the subsequent history of this observation but
themselves believed the protease to be pepsin or pepsinogen.
Macfarlane and Pilling (1947) and Williams (1951) referred to the
activity in urine as fibrinolytic. This fibrinolytic factor in
urine can be shown to be a water soluble activator of plasminogen
which is relatively heat stable at neutral and alkaline reaction
(Astrup and kterndorff, 1952). Other body fluids secreted through
narrow channels were then investigated and it was found that human
milk (Astrup and Stera&orff, 1953)» "emotional" tears (Storm, 1955)»
saliva (Albrechtsen and Iiess Thaysen, 1955) and seminal fluid
(von Kaulla and Shettles, 1953: Lundquist, Thorsteinsson and Buus,
1955) all contained large quantities of proactivator, some activator
and usually no plasminogen. Plasma differed in having, plasminogen
in addition. It is assumed that this concentration of early
fibrinolytic factors has the function of keeping the small ducts
clear of obstruction from unwanted clot (which would bring adsorbed
plasminogen with it). Most tissues of the body contain a
fibrinolytic substance or substances which can be demonstrated
after saline extraction but there is some confusion about the
interpretation of the mechanisms involved. Ktlllertz (1955) kept
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many of these observations together by his analysis of the lytic
components, all of -which acted through the common pathway of
plasminogen.
Rwaan, Lai and McPadzean (1960) claimed to be the first
to demonstrate unequivocally the presence in a body fluid of a
lysokinase, having activity at the same level as streptokinase,
but being a naturally occurring agent it was of greater pathological
or physiological significance. They used ascitic fluid from
hepatocarcinoma and believed the active fraction to be in the
gamma globulin while the beta globulin fraction had antilysokinase
activity.
Tissue lysokinase activity, provided it has been
correctly interpreted, appears to have been recognised for some
time. Fantl and KLtzpatrick (1950) showed that brain extract
prepared as for the Quick test is able to act with a serum factor
to form a lysin of unheated but not of heated fibrin. Astrup
and Sterndorff (1956) failed to find any lysokinase activity in
human lung, liver or adrenal and found it only erratically in
kidney and lymph glands.
It has been widely accepted, although often questioned,
that streptokinase, generically a lysokinase, is active only on
the proactivator of plasminogen which it converts stoicheion-etrically
(Millertz, 1955) to the activator. This then changes plasminogen
catalytically to plaamin. The following is the scheme of
fibrinolysis presented by Astrup in 1956.
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Simplified form of fibrinolytic scheme: The Astrup
fibrinolytic scheme of 1956 showing the interrelationship of the
various fibrinolytic factors has been reproduced above. Even now
the presentation seems too detailed for a subject which is still
so full of technical and interpretative pitfalls. A simpler scheme








> ACTIVATOR OP FMSTTROGEN
PLAS '-DI
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This scheme bears a superficial resemblance to the
currently accepted coagulation scheme, where tissue juice can
by-pass the more complicated coagulation mechanism of the blood*
It should be noted that the Astrup scheme is
characterised by the separate existence of proactivator. Further
comment about the existence of proactivator is made later in the
appropriate section, together with a revised scheme of fibrinolysis.
Various successful experiments have been carried out
in vivo to assess the therapeutic effect of fibrinolytic agents.
Cliffton, Grossi and Cannemela (1953) injected human nlasnin into
three species of animal, with rapid lysis of intravascular clots.
Some of the investigations which have been carried out more recently
are described in the section devoted to experimental methods of
increasing fibrinolysis ("thrombolytic activity")*
mAjEKCLA!TURE
The obvious name for the most important lytic agent of
fibrin appears to be "fihrinolysin", but Christensen and MacLeod
(1945)» while using the word themselves, criticised its use because
it did not embrace the accepted ability of the enzyme to lyse proteins
other than fibrin. Macfarlane and Biggs (1948) also objected to
its use. They pointed to the confusion which existed already
from the use of the tern fibrinolysln to describe the bacterial
agent of the beta-haemolytic streptococcus.
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It is proposed to use the nomenclature suggested by
Christensen and MacLeod with additions. This nomenclature is
logically derived, although it is perhaps insufficiently
descriptive for those unfamiliar with the subject. It is based
on the analogy of certain pancreatic proteases. The active agent
is called plasmin, where the prefix indicates the plasma source
of the enzyme, the word as a whole conforming with common usage
for proteases. The inactive precursor of plasmin is called





Nomenclature of Christensen and MacLeod (1945)«
This terminology has been followed very widely since it
was first proposed. New additions to the nomenclature have become
necessary as the fibrinolytic system has been found to be more
complicated. These additions have tended to be based on the names
put forward by Christensen and MacLeod, and have been self-
explanatory, such as "activator" and "proactivator" of plasminogen,
"staphylokinase" (Lewis and Ferguson, 1951) and others. Seme such
names have been superimposed on the original nomenclature below.
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plasmin: syn. fibrinolysin: serum protease
The original nomenclature has been underlined.
Activators of the proactivator have been given the generic
name of lysokinase (a shortened version of fibrinolysokinase) in
order to show their group relationship to streptokinase, the be3t
known end longest recognised constituent member. hen Astrup and
Permin (1947) described the tissue activator substance, they called
it fibrinokinase at first, believing it to be similar to
streptokinase. They expressed their opinion that streptokinase
itself was imperfectly named. They suggested that the whole group
to which streptokinase belonged should teally be called fibrinokinase,
that their tissue activator might be called cyto-fibrinokinase
and that streptokinase itself should be called strepto-fibrinokinase.
Etymologically they seemed correct at the time, but had to drop the
names when it became apparent that the two substances did not in
fact belong to the same group. It is easy to see, therefore, how
the literature on fibrinolysis has become studded with confusing
nomenclature.
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Loomis, George and Ryder (1947) proposed the folio-wing
nomenclature:
streptokinase ^ antistreptokinase as immuno¬
logical response to strepto¬
coccal infection.
profibrinolysin ^ >fibrinolysin (active on fibrin
and fibrinogen)
anti-profibrinolysin fibrxnolysin inhibitor
The classification does not appear in 1960 to justify
the criticism passed on it by liacfarlane and Biggs in 1948,
■when they described the use of the word "fibrinolysin" for plasmin
as fraught with danger because the streptococcal factor had been
so named previously. Astrap (1956) recognised both classifications
but expressed a preference for the one based on "plasrnin" rather
than "fibrinolysin" for the same reasons as Hacfarlane and Biggs.
Although it is tempting to talk of profibrinolysin
instead of plasminogen, there seem to be two good reasons for
not changing to the classification of Loomis, George and Fyder
at this stage. Firstly there is still far too much uncertainty
whether or not more than one lytic agent exists in plasma; and
secondly the more changes there are in nomenclature, the greater
the confusion.
There seems to be a place for the free use of the word
fibrinolysin, or its plural fibrinolysins. These would mean any
fibrin-lysing agent in the blood, whether Identifiable as plasmin
or not.
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There also seems to "be a place in clinical practice
and in related laboratory work for the word thrombolysis to
describe the process of dissolution of a specific clot forming
a thrombus, but the active agent should remain as plasmin or
fibrinolysis There seems no place for the word thrambolysin.
Sherry, Fletcher and Alkjaersig (1939) recommended a
different use of the word thrombolysis. They felt that a
distinction should be drawn between the lysis of a thrombus or
other fibrinous material, for which they would use the word
thrombolysis, and the lysis of purified fibrin which they felt
was only part of the former process and alone justified the word
fibrinolysis. It seems debatable whether it is profitable or
even possible to impose a slightly different meaning on to a
word, already in general use, without increasing the confusion
in nomenclature.
Other names have been suggested for components of the
fibrinolytic system, but have not achieved general acceptance.
Clumsy words like serum proteaseogen and fibrinolysinogen are
as well forgotten.
THE COMPOKSTCTb OF THE PLASivJN OR FIBRINOLYTIC SYSTEM
None of the components of the fibrinolytic system has
been identified chemically. Like the blood coagulation system,
the presence of each component has had to be inferred from the
results of leading a series of reactions through to the end
product which is plasmin itself. Fibrinolytic activity so
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derived is the only indicator of the presence of plastain
precursors and of activity -within the system.
Even although plasitdn itself is the end product towards
■which the whole fibrinolytic system is geared, its presence can
only be deduced from the effect on an appropriate protein which
must be added to the test material if it is not already present.
Such protein, of which fibrin is the most important example, is
not an essential part of the fibrinolytic system, but is necessary
as an indicator of its activity. It adds another variable to
investigational work. In laboratory experiment the plasmin
system is inferior to the coagulation system in respect of its
indicator, for the latter supplies its own.
Some of the components of the fibrinolytic system will
be described individually. They will be taken in reverse order
of their believed action, starting with the protease itself and
working backwards. The various agents are those of a simplified
Astrup classification, but it will become clear that some such
divisions are of doubtful justification. Indeed, two sections
are devoted to two components which may be one and the same.
Plasmin
Plasmin itself behaves as a proteolytic enzyme active
at neutral pH. It is moderately unstable and this has haiipered
its isolation in relatively pure form, although its increased
stability at pH 2 has proved useful in attempts to purify it
(Kline and Pishman, 1957). Recent progress in the purification
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of Its precursor, plasminogen, has allowed the preparation of
pluamin of superior specific activity. Such plasminogen can
he activated spontaneously or by the use of a specific activator
such as streptokinase. Plasrnin is destroyed by heating to 55°C
for twenty minutes. Its molecular weight has been calculated
to be 108,000 (Shulman, Allcjaersig and Oherry, 1958)* Its
action is not restricted to the lysis of fibrin, although it
appears to have a relatively more powerful action against fibrin
than have other proteolytic enzymes. Tests for its presence
may use casein, gelatin or heated fibrin with apparently equal
success and other proteins or synthetic substrates can be used.
The ability of plasmin to split arginirie and lysine esters and
the discovery that the latter act as competitive inhibitors of
plasminogen activation, promise to be of assistance in the
understanding of how plasmin works, although the ability to split
an ester is no proof of fibrinolysis. Plasmin can also digest
all the proteins of normal plasma including early coagulation
factors such as factor V and prothrombin and part of complement.
Plasrain showing such activity has usually been prepared artificially
by adding streptokinase or chloroform.
Plasrain is apparently fibrinogenolytic (Keclcwick,
Mackay, hance and Record, 1955) but here a point of controversy
has arisen. Mole (1948) and Bidwell (1953) ahowed the presence
of normal fibrinogen levels despite active fibrinolysis in cadaver
blood and after exercise. Jacobsson (1955) also found no
fibrinogenolysis in fibrinolytically active plasma following
*■ 2-6 —
exercise. Kman, Mcfadzean and Cook (1956) showed that the
fibrinolysin present in cirrhosis of the liver had no effect
on fibrinogen, prothrombin, gelatin or casein and therefore in
their opinion was not plastnin. Biezenski and Moore (1959)
reported that the fibrinolysin demonstrable after obstetrical
accidental haemorrhage, and before delivery, vac fibrinolytic
but not fibrinogenolytic. Thus, proven fibrinogenolysis has
usually been demonstrated only after artificially stimulated
lysis and not in naturally occurring states.
Such evidence may be interpreted as favouring the
existence of at least two fibrinolysins, one being what is
generally described as plasrain, a fibrinogenolytic enzyme which
is usually artificially produced in plasma by streptokinase or
chloroform, and another, a less well identified enzyme which is
not fibrinogenolytic, but which is more commonly described in
naturally occurring fibrinolysis. Thus plasmin may not be the
only lytic agent which can appear in the blood. Indeed plaamin
itself is not necessarily a single substance, even within its
own definition, despite attempts to purify it and to define it
biologically. Ungar, Damgaard and Hummel (1955) suggested that
the word plasmin designated several different enzymes.
On the other hand and not necessarily in conflict wdth
such ideas, it reaajLns possible that fibrinolysis is always
fibrinogenolytic but that this is not apparent because inhibitors
deny the lysin any access to circulating fibrinogen (Millertz,
1955). hen fibrin is formed, plasminogen and activator are
selectively adsorbed on to the clot. Thus the agent which was
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inhibited in its action on circulating fibrinogen is free to act
upon fibrin. Such an inhibitor may act also on the activator
of plasminogen as -well as on plasmin.
Plasmin appears to act by degrading fibrin and other
proteins into large polypeptides and it releases argirdne and
lysine after digesting fibrinogen (Cohen, 1959)« Proteins which
are split in the process of lysis have been shown to have
electrophoretic mobilities of alpha, beta and gamma globulins
(Kowalski, Budzynski, Kopec and Murawski, 1960).
Less attention has been paid recently to the great
similarity between trypsin and plastnin, but it has been claimed
all along by some and is now accepted generally that they are
not one and the same enzyme. Denys and cle Marbaix (1889) and
later Kaplan (1946) drew attention, to differences between trypsin
and. plasmin. Cliffton and Cannamela (1953) noted that the
fibrinolytic activity of plasrnin and the proteolytic activity
of trypsin were not inhibited by equivalent amounts of soya bean
inhibitor. Sherry, Fletcher and flkjaersig (1959) list the
points of difference between trypsin and plasmin as follows:
1. trypsinogen and plasminogen require different activators;
2. plasmin and trypsin have different ratios of attack
upon synthetic substrates;
3. the inhibition of these enzymes by crystalline soya
hean inhibitor and organaphosphorus cairpoun&s is
different;
4. casein digested by plasrain may be further hydrolysed
by trypsin, but the reverse does not obtain.
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When uninhibited, plasnin activity in the blood stream
is very powerful and is almost certainly greater than is ever
called upon in the maintenance of health, Massive release of
this huge reserve of plasmin has been suggested a.s an
explanation of anaphylactic shock. TJngar and his colleagues
(1953) noted the symptoms and tissue changes associated -with
anaphylaxis when they injected into animals peptone and high
molecular weight carbohydrates which induced proteolytic activity.
There was a high correlation between proteolysis and histamine
release, the proteolysis probably coming first.
Plaaminpgen.
The immediate precursor of plasrain is plasminogen,
which behaves as part of the globulin fraction III (Colon) of
plasma and may be a glycoprotein (Sherry, Fletcher and Alkjaersig,
1959). It is converted to plasmin by the catalytic activity
of plasminogen activator (Mttllertz, 1955)* Plasminogen appears
to have affinities with fibrinogen with which it is brought out
of solution unless special precautions are taken (henaert and
Cohen, 1949: Keckwick, hackay, Nance and Eecord, 1955)* In vivo
exudates and transudates which have a low fibrinogen content tend
to have a low plasminogen content: where fibrinogen is abundant
plasminogen is present in high concentration (Christensen, 1994).
Plasminogen can be brought out of solution by the Milstone (1941)
technique of dilution twenty times with water and 0.32 volumes
of 1 per cent acetic acid, and further purification can be made
by isoelectric precipitation (Reramert and Cohen, 1949): acid
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extraction, making use of the important observation that
plasminogen is soluble in dilute mineral acid (Christensen and
Smith, 1950): or by the method of Kline (1953) "ssho claimed an
increase of purity of 425-fold as compared ■with serum. He
also claimed to obtain crystalline plasminogen. Heat stability
varies with pH, being greatest about pH 2 (Cherry, 1954). The
physical properties of highly purified human plasminogen have
been described by Davies and Englert (i960). They made
observations on the sedimentation constant, diffusion constant,
partial specific volume, intrinsic viscosity and electrophoretic
mobility. They calculated the molecular -weight as 83,800.
Shulman, Alkjaersig and Sherry (1958), in a similar type of
investigation, found the molecular weight of plasminogen to be
143,000. One of the most interesting observations of Davies
and Englert, to be taken with those of Hagan, Ablondi and de Kenso
(i960), is their failure to differentiate plasminogen from
proactivator of plasminogen. The two appeared to be the same
substance, although there is no question as yet of their identity
being proved. They admit to their purified plasminogen having
at least two antigenic actions.
Plasminogen becomes adsorbed to fibrin clots formed
from whole plasma, both in man and in cattle. If clots are to
be freed from plasminogen, the latter can be destroyed by heating
the clots to about o0°C for about half an hour. This appears
to leave fibrin itself unchanged, although some less obvious
alteration seems probable. Considerable latitude is allowed
in time and temperature in the process of deliberately inactivating
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plasminogen without obviously affecting the result. When
plasminogen is activated to plasmin, the same araino-acids are
released as appear when plasrain digests fibrinogen, suggesting
a similar enzymatic process (Cohen, 1959).
If it is wished to draw a very rough parallel between
the fibrinolytic system and the coagulation system, plasminogen
can be likened to fibrinogen? activator of plasminogen to
thrombin? and plasmin to fibrin.
Activators of Plasminogen.
Tissue activator: Astrizp and Perrain (1947) and
Permin (1947) showed the existence of a relatively insoluble
direct activator of plasminogen, present in a great variety of
tissues. At first they called this agent fibrinokinase, but
later changed its name to tissue activator. Tissue activator
is stable and is insoluble except in concentrated potassium
thiocyanide, and has been shown to be present in large amounts
in the uterus, adrenal, lymph nodes, prostate, thyroid, lungs
and ovary. Smaller amounts are present in the pituitary,
kidney, muscles, heart, testes and spleen. Liver tissue is
almost Inactive (Albrechtsen, 1957). Human erythrocyte stroma
has been shown to be a veiy active source of tissue activator
(Permin, 1947). The tissue activator is a particulate component
of these tissues and is probably contained in the microsome
fraction (Lewis and Ferguson, 1950b).
Fischer (1946) may have been the first to demonstrate
tissue activator present in growing tissue cultures. He talked
• 31 *
unequivocally about its species specificity and referred to I'da
orai report of 1927 on the subject. He wrote, "In other words
tumour cells seem to be able by contact to activate the proteolytic
proenzymes in the homologous blood-plaaaa. Our experiments
show that the activation is rather specific." Barnett and Baron
(1959) and Baron and Barnett (1960) siroplied good evidence that
tissue activator is created in some tissue cultures used in the
preparation of poliorryelitis vaccine. They made the interesting
observation that more activator could be demonstrated in the
medium than could ever be demonstrated in the cells at any one
time, suggesting a metabolic production and then a release
of the activator into the medium.
Tissue activator does not appear to have been
successfully freed from impurities to allow of more exact
characterisation, although partial purification was claimed by
Astrup and Sterndorff (1956a) using pig heart and lung, and
further success ought to follow the demonstration of tissue
activator in tissue culture. Tissue activator activates
plasminogen independently of streptokinase end it does not
appear to substitute for streptokinase in an appropriate
experimental system. In these and in other ways the tissue
activator seems quite distinct from the soluble proactivator/
activator which is found so freely in body fluids.
labile activator: A more labile activator of
plasminogen is present in the blood, but it is usually7 only
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demonstrable in such conditions as have been referred to already,
associated with increased fibrinolysis. Miillerts (1956) believes
that there is a constant trace level of the labile activator in
the blood. This labile activator of plasminogen comes out of
solution with the euglobulins of plasma and is adsorbed to fibrin
in the course of clotting and is relatively easily destroyed by
heat; but it has not been successfully isolated and this has
hindered a study of its relationship to the disputed proactivator,
to the tissue activator and to plasiain itself.
The content of labile activator in those secretions
which have to pass through narrow channels - milk, tears, saliva,
seminal fluid - has already been referred to in the section
devoted to the history of fibrinolysis. It has been claimed
that activator is present in these secretions but less abundantly
than proactivator. The activator which can be demonstrated in
urine justifies further comment, if only because of the amount
of work which has been done upon it. It is less certain that
this justifies continuing with the individual name of urokinase
which was initiated by Sobel, Mahler, Jones, howdy and Guest (1952).
Urinary activator: The urinary activator of
plasminogen was probably the first physiological activator of
plasminogen to be isolated in a highly purified, form. It can
be concentrated by adsorption and elution from barium sulphate
and by more complicated but essentially similar methods. By
these means it appears to have been purified to a fairly high
specific activity. Electrophoresis suggests that the urinary
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activator accounts for about 37 per cent of the urinary protein
prepared as "urokinase" (Ploug and Kjeldgaard, 1957)* It is
colourless and stable over a wide pH range unless in acid urine
when it is rapidly destroyed. It appears to transform plasminogen
to plasmin by a first order enzyme reaction (Kjeldgaard and Ploug,
1997) and at great speed (Alkjaersig, Fletcher and Sherry, 1953b).
However, in high concentrations, as have been possible by
purification methods, the agent seems to be proteolytic and
to resemble plasmin itself, particularly in its ability to split
the two amino-acid esters of arginine and lysine, to which reference
has already been made (Kjeldgaard and Ploug, 1957) • It seems
possible to readers of the subject that this urinary activator
could be plaamin itself, bound perhaps to a stabilizing factor
which alone renders it different from plasain as it is at present
recognised.
Kolmen, Guest and Celander (1959) presented good
evidence that red cells can adsorb urokinase, where urokinase
is defined as a saline soluble agent in urine, acting directly
on plasma profibrinolysin (plasminogen) to convert it to fibrino-
lysin (plasmin). They then proposed a rather complicated system
of regulation of fibrinolysis by changes in the amount of lytic
agent and inhibitors adsorbed on to red cells. It scans
unlikely that the red cells can be responsible for such a finely
adjusted control over fibrinolysis by virtue of their passive
powers of adsorption, when one considers the apparently invariable
occurrence of delayed lysis in whole blood, clots as compared with
plasma clots.
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Plasrjiin has been credited -with some activator activity,
which can be demonstrated in a system of purified factors. This
■would be a feed-back mechanism. Thus, plasminogen can be
shown to undergo "spontaneous" activation around pll 7 when 50
per cent glycerol is added to a purified preparation, glycerol
stabilising both plasminogen and plasmirn The yield of plasnsin
however is produced slowly and continues for four to nine days
(Alkjaersig, Fletcher and Sherr , 1958a). This is evidence
in favour of autocatalytic activity, the glycerol acting as a
passive stabilizer. Plaasoin was shown to accelerate this
reaction, behaving in this context as an activator. However,
it remained a slow reaction which was susceptible to plasrain
inhibitors when present and to destruction from the general
instability of its parts. Such evidence draws attention again
to the similarity in effect of plasr.dn and the labile activator
of plasminogen.
Proactivator of nlaaainogen.
While there is no doubt about the existence of activator
of plasminogen, there is much current debate about the existence
of proactivator. Until recently the evidence seemed very-
convincing in support of the existence of a distinct proactivator
of plasminogen. The fibrin plate technique of Perain (1950)
and the heated fibrin plate modification of Lassen (1952) appeared
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to be clear cut research tools which proved the point.
Streptokinase was inactive against heated fibrin from any source.
It was also Inactive against unheated bovine fibrin which was
known to be rich in plasminogen} but was very active against
unheated human fibrin. If a little human serum was added with
the streptokinase, to unheated bovine fibrin, then the latter
was lysed rapidly. Clearly bovine plasma lacked the inter¬
mediate agent which was present in human plasma; this agent
was called proactivator. There is, however, another interpretation
of this which will he discussed below. Proactivator was then
characterised as a globulin Wiich come out of solution with
fibrinogen and by adsorption, with fibrin. In these respects
it was like plasminogen. It was converted to activator by
streptokinase.
Tillett (1938) however' had shown that same bovine
streptococcal exotoxins did in fact lyse bovine clot. Perhaps
proactivator is itself species specific and is present in bovine
plasma. Perhaps the present state of uncertainty Iras arisen
from an almost exclusive use of commercially prepared human-type
streptokinase. At any rate, the experiments quoted above do
not themselves appear to prove the existence of a cofactor with
quite such certainty as at first a-peered. Some cofactor does
appear to be necessary when streptokinase originating from a human-
type streptococcus is required to activate plasminogen of another
species. in the classic experiment above, human-type streptokinase
requires a cofaotor in order to activate bovine plasminogen.
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Reconsideration of the whole situation brings
attention to the fact that -without the streptococcus, pro-
aotivator might hardly be thought to exist. Proof is also
f"
lacking that the exotoxin of the streptococcus, a substance
foreign to the body, is reproducing a physiological reaction
at all. Only the products of certain strains of streptococci
are active plasndn inducers in human plasma. They may be
inactive in others. Tillett (1938) made comment on this
apparent predilection of strains of haemolytic streptococci
for the fibrin of the same species as that in which the organism
may survive. Thus an active human-type streptokinase is not
active against bovine clot: equine streptokinase, active
against horse clot, is not active against human clot: and
as already stated, active bovine streptokinase is sometimes
lytic against bovine clot. It remains possible that strepto¬
kinase is an unphysiological enzyme, specific only for certain
plasminogens, usually those of the same species as the original
host. The plasminogen, being activated, releases plasmin which,
however, nay rot be species specific and may perhaps activate
such plasminogen as bovine plasminogen which is otherwise
insusceptible to that particular streptokinase. The species
specificity of the streptococcal exotoxin weakens greatly the
argument in favour of there being an independent proactivator.
A simplified scheme put forward to explain the action
of streptokinase without incurring the existence of
independent proactivator is presented below.
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Iysokinase e.g. streptokinase (from human-type organisms):
? hepatocarcinoma ascitic fluid
Y
Human plasminogen Bovine plasminogen
Plasmin Plasain
It seems improbable that the simplified, scheme
presented here can be the'whole answer. Hagan, Ablondi and de
Renzo (1960) declare it to be highly unlikely tliat plasmin can
account for all the activator activity and. cite investigations
showing that a mixture of streptokinase and plasminogen
containing a large concentration of plasmin, or trypsin
activated plasmin, is at best a poor activator of bovine
plasminogen.
to prove the need for a proactivator which is present in
human blood but lacking in other species, Kline and fiahman
(1957) interpreted the same experiments differently. They
felt that their own views were in harmony with the experiments
of Sherry (1954). They explained the results from both
laboratories in terns of streptokinase requiring human plasminogen
to convert it into a "universal activating enzyme" which then
activates the plasminogen of any species. It may be observed
at this stage that species specificity still exists according
to this theory* Perhaps bovine-type streptokinase requires
bovine plasminogen and then it too will become an enzyme capable
While Astrup' s experiments with fibrin plates seemed
of acting on the plasminogen of other species. Such an
experiment, important as it is in the theoretical pattern,
does not appear to have "been tackled,
Kline and Fishman (1957) prepared a purified system
involving plasninogen-free human fibrinogen, plasrainogen-free
bovine thrombin and as pure a streptokinase as was available
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and they labelled some of the streptokinase with I and then
tested their preparations for plasminogen content. They supplied
evidence that proactivator and plasminogen were identical
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substances. By using I-labelled streptokinase they showed
quantitative utilisation of the radioiodine in the part which
they subsequently isolated by alcohol fractionation* This
implied incorporation of streptokinase into either activator
or plasmin, both of which come down in the alcohol fraction.
Purification of the plasmin component of the fraction led to loss
of radioactivity by which it was inferred that streptokinase
was incorporated quantitatively into the universal activator
itself (there to lose its specificity).
In the results of Kline and Fishman it was apparent
that proactivator wa3 present in fibrinogen preparations which
were plasainogen-free. How then could proactivator and
plasminogen be one and the same substance? They explained this
apparent obstacle to their theory by regarding the first reaction
with streptokinase as .requiring only minute amounts of
plasminogen for a stoicheiometric reaction, but the second part
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as requiring relatively massive amounts of plasminogen which
are converted catalytically to plasmin. Their theory has much
to commend it. It is unusual in its claim to simplify rather
than complicate previous schemes of fibrinolysis. The following










This and later work has supported the concept that
proactivator and plasminogen activities are not entirely
distinct and in fact reside in the same molecule. Bavies
and Englert (1960) found the same proportion of proactivator
to plasminogen in highly purified plasminogen as they found in
plasma or crude fraction III.
Until recently there was no body substance which
appeared to substitute for streptokinase in the fibrinolytic
system. This gives point to criticism levelled against the
streptokinase effect as being unphysiological and perhaps not
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even pathological. However Kwaan, lad end McFadsean (1960)
published a preliminary report claiming to demonstrate the
presence of lysokinase activity in the ascitic fluid of seven
patients suffering from carcinoma of the liver. It is too
soon to know with what weight to use this finding as an argument
in favour of there being an independent proactivator of
plasminogen.
Kowalski, Kopec, Latallo, RoszowskL and Sendys (19^8)
claimed to show a plasrninogen-like proenzyme in human tissues,
particularly from those organs rich in connective tissue such
as aorta, veins and from fascia. They claimed that this
plas;dnogen-like substance could be activated by streptokinase.
There are certain ambiguities about the descriptions of method
and controls, but it is possible if one follows the scheme of
Astrup (1956) to describe their substance as proactivator of
plasminogen. On the other hand, if an independent proactivator
does not exist, the authors' claim to have demonstrated a
plasroinogen-like proenzyme can be supported - particularly since
they had sane success dissolving their substance in dilute
mineral acid, which is a property of plaaninogen.
Lysokinase
If one accepts the existence of a separate proactivator,
then the formation of soluble activator itself is easily explained.
A lysokinase converts proactivator to activator (llillertz and
Lassen, 1953)• -tost experimental work has used streptokinase,
which is a lysokinase and is the stimulating factor which has set
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the pattern for this early stage of the fibrinolytic system.
Fibrinolytic activation of human plasma by the streptokinase
which is prepared commercially is relatively' violent and is not
obviously inhibited by the anti-plasmins of the blood. Not
all the details of the preparation of commercial streptokinase
are known. Streptokinase appears to be a protein (Christensen,
1954) and was shown by Lassen (1953) to be strongly adsorbed
on to glass surfaces.
There seems to be agreement that streptokinase activates
human plasminogen in a two step process in which the first step
is stoicheiometric and the second step a first order reaction
(bherry, Fletcher and Alkjaersig, 1959)» in other words the
existence of some sort of a proactivator appears to be accepted,
whether proactivator is, or is not, a substance distinct from
plasminogen itself. Nevertheless, it should perhaps be said once
again that streptokinase is not a naturally occurring substance
(unless in the invasive phase of a streptococcal infection) and
caution must be used before assumin." that it mimics & naturally
occurring process.
Streptokinase alone will not hydrolyse lysine and arginine
esters, but Alkjaersig, Fletcher and Sherry (1953b) showed that
these substances act as competitive inhibitors of the activation
of fibrinolysis as stimulated by streptokinase. Without
pressing the point, they do mention that it is possible to argue
from the evidence that the cofactor required for the activation
by streptokinase, is pl&smin.
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In 1950 Fantl and Fitzpatrlck described a property of
human adult brain which can be interpreted as lysokinase activity
of tissue origin. The factor was extracted by salt solution
and was present in the globulin fraction. It was species
specific and not identical with thromboplastin. The enzyme
produced by the combination of plasma with the brain factor
breaks down fibrin made by clotting procedures but shows no
action on plasma fibrinogen or heat inactivated fibrin. It
is possible to interpret their experiments in two ways. They
assumed that the lytic enzyme, resulting from the brain and
plasma combination, failed to act on heated fibrin because
the fibrin was denatured. If, however, one assumes that the
"heat denatured fibrin" is comparable to the heated fibrin
plates of Lassen (1952), then the failure to lyse in that
particular experiment could be attributed to the destruction
by heat of plasminogen adsorbed to the clot. Thus the brain
extract would be acting as a lysokinase, comparable to
streptokinase, and would be activating proactivator in plasma.
The brain extract of Fantl and Pitzpatrick (1950) is not
likely to be the same as the tissue activator found so
widely in the body by Astrup and. Permin (1947) because of
its solubility in salt solution.
Not until recently has it been claimed that a body
fluid has lysokinase activity and in the case of Kwaan, Lai and
L'cPadzean (i960) this was ascitic fluid from hepatocareinoma
arising after cirrhosis.
On the whole it is not felt that there is yet a case
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■Which is unassailable for the existence of a naturally
occurring physiological lysokinase.
Inhibitors of fibrinolysis.
It has often been assumed that anti-plasmin activity
is synonymous -with anti-trypsin activity, but there is "abundant"
evidence that this approach is unsatifactory and that anti-
tryptic and anti-plaamin activities may vary independently in
biological fluids (Sherry, Fletcher and Alkjaersig, 1959).
These authors also supply references to the list of synthetic
inhibitors given later in this section.
There is no clear evidence defining the number of
agents in the blood -which are inhibitory to fibrinolysis, but
it is reasonably certain that at least one inhibitor is an anti-
plasmin. It is not clear, because of technical difficulties,
•whether an anti-activator exists. Epsilon-aininocaproic acid
may be one such (Nilsson, Sjoerdsrna and T?aldenstr8m, 1960),
Ailstone (1941) found anti-plasmin activity in the
pseudoglobulin fraction and Macfarlane and Pilling (1946) used
the supernatant after precipitating euglobulin, calling this
albumin. Others have found plasain inhibitors in relation to
Cohn's fractions. Dausset, Bergerot-Blondel and Colin (1956)
found that dilution of plasma with saline speeded fibrinolysis
more than dilution with fresh sei*um, unless that serum had first
been inactivated by heat. They suggested that this result could
be explained by destruction of an anti-plasmin by heat.
It seems that anti-plasmin activity is found mainly in
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the alpha-2 globulin fraction (Jacobsson, 1955) but also perhaps
in the alpha-1 fraction (Norman and Hill, 195®) although
Jacobsson thought that alpha-1 activity was mainly anti-trypsin
and not anti-plasmin. Norman and Hill used the lysis of casein
as their indicator and so were measuring proteolytic activity
rather than fibrinolytic activity as such. As noted in the
historical section, anti-fibrinolytic activity has been associated
from, time to time with a fat component of plasma. Kwaan, Lai
and cFadzean (i960) felt that the anti-fibrinolytic activity of
their ascitic fluid was due to a lipoprotein.
Ratnoff, Lepow and Pillemer (1954) thought there might
be at least three plassin inhibitors, although this view is
unconfirmed. If there are two agents, as many seem to think,
the general feeling is that one reacts quickly with plasmin and
the other slowly. Hussey and Northrop (1923) reported that the
plasma inhibitive agent combined with trypsin to form an inactive
but dissociable compound. With the evidence about anti-plasmin
so uncertain, there has been no opportunity to study its total
potential, although claims have been made that total anti-
plasrain activity of the blood at least exceeds total plasrnin
potential. An anti-fibrinolysin fraction is presumably what
is dissolved away or destroyed by chloroform and ether, but if
the cliloroform is used in a certain way there is also rapid
destruction of active lysin (Lewis and Ferguson, 1950a)*
Ungar and Damgaard (1951) showed that the anti-
fibrinolytic activity of serum in guinea pigs and rats is
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significantly increased by corticotrqphin or cortisone. No
such increase was obtained in splenectomized guinea pigs. This
led to observations identifying splenin A activity with the
anti-fibrinolytic effect of corticotrqphin and cortisone,
Splenin B reduced anti-fibrinolytic activity. In contrast to
this Cliffton (1952) found that corticotrqphin and cortisone in
man caused a marked increase in spontaneous proteolytic activity
of the serum, but no effect on the anti-proteolytic activity,
Stefanini and Murphy (1956) reported that platelets
contained anti-fibrinolysin, either adsorbed or as part of their
substance. This would be an opposing function to that of
5-hydrozytryptamine which is also contained in platelets and has
been credited with initiating fibrinolysis (Rwaan, Lo and
McFadzean, 1957b). Anti-fibrinolysins or anti-plasmins prepared
v.
from man, dog and the ox do not appear to show species specificity
(Lewis and Ferguson, 1950s-)*
There is no great uniforaity of conxaent about the
anti-fibrinolytic activities in clinical states. For example,
Biezenski (i960) reported a relatively constant anti-fibrinolysin
level during pregnancy and that this did not differ from non¬
pregnant women. Naidoo, Hathorn and Gillman (i960) reported in
the Bame volume that the anti-fibrinolysin titres often fell
after delivery.
The list supplied by Sherry and colleagues of synthetic
inhibitors of plasmin and plasminogen activation is as follows.
Numerous organic substances, dyes and related compounds, heparin
•• ij.6 •»
and similar substances, basic amino-acids, their polymers and
esters, quaternary amines, methyl amine and urea, lauryl amine,
and E-aminocaproic acid. Also inorganic ions, particularly
the heavy metals -which inhibit or denature plasmin, and trypsin
inhibitors such as pancreatic trypsin inhibitor, soya bean
trypsin inhibitor and toxic phosphorus compounds. Barnett and
Baron (1959) found an inhibitor of proteolysis in the supernatant
fluid from some of their tissue cultures of human epidermoid
carcinoma.
A C01.KKM1? THEORY OF THE MBCHARIiS.i 01? CLOT LYBIB.
An attractive current theory of the means by which
fibrin clots are dissolved has been presented by Sherry, Fletcher
and Alkjaersig (1959), based on their omi work (Sawyer, Fletcher,
Alkjaersig and Sherry, 1960). They claim to have shown that
the rate of lysis of the clot is a function of the concentration
of the activator of plasminogen surrounding the clot, and a
function of the plasminogen concentration within the clot. If
the surrounding medium is enriched with plasmin, the clot lyses
no faster. They also showed that the lysis of clots in vivo
was dependent on plasminogen activator concentration and
independent of plasma proteolytic activity. Plasma inhibitors
prevented much increase of circulating proteolytic activity,
but were not aotive against the activator.
One of the significant points arising from this theory
would be the devaluation of tests for plasma proteolytic activity.
According to the theory, the ability of the body to dissolve its
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clots and Its exudates would be measured by the activator
level and not by the proteolytic activity of the blood, the
former being directly in proportion to the rate of lysis of
the clot, however local and remote the clot might be, the
proteolytic activity being a mere shadow of itself as a result
of serum anti-plasmin activity. The theory is attractive, but
has yet to be reconciled with the observation that activator and
"proactivator" appear to be adsorbed on to fibrin together with
plasminogen.
Fearnley (1953) allowed clots made from fresh plasma
to remain in contact vdth the serum for one hour. He then
removed them, washed them in saline and incubated them at 37°c
in veronal saline buffer. All the clots underwent lysis.
Clots similarly prepared from older plaana did not lyse,
presumably because of loss of the labile activator. bance
Feamley's clots were immersed in veronal saline, it is hard
to believe that lysis is proportional to the activator
concentration in the medium surrounding the clot.
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SQ.MI1 TECffiilQUES USED U'GIc 1K5 PIT 'jOMUCRftTIQK OF
FIBRDmFIb IN HUKAN BLOOD DESCRIBED ERITITiY
ACCORDim TP Tffi; fRIKCIPLDb mvpLVhD.
A. Techniques clerflonstratiry, the final. cordon pathway of all
fibrinolytic and anti-fibrimlytic influences in the specimen.
Same of the methods described probably alter the
balance of pro-fibrinolysixis and anti-fibrinolysins, but do so
empirically.
1. "hole~blood clot lysis;
If fresh venous blood from a healthy person at rest is
placed in a small sterile test tube kept at 37°C and observed at
intervals, the blood -mill first clot and then mil ordinarily
remain as a firm clot for all of the first 48 hours. .After
48 hours, observation is of questionable value. In the presence
of sufficiently active fibrinolysis the clot y&ll lyse -within
the first 24 hours and rarely, in considerably less time. The
volume of blood used is commonly 1 ml. in each tube. The test
will be discussed later.
2. Diluted whole-blood clot lysis:
Pearnley, Balmforth and Fearnley (1937) recommended
observation of clots made from a dilution of whole blood. Blood
obtained by venepuncture was kept at ice temperature and final
dilutions made from this to 1:10 in phosphate buffer at pH 7.4,
the mixture being clotted by thrombin. This was kept at ice
temperature for a half to one hour, brought to body temperature
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and then observed at intervals for lysis. Comment: Phosphate
buffer was used because it was almost isotonic and did not lyse
the red cells, although it had no superiority over veronal
buffer when used for plasma dilutions (Feamley, 1958). Laclcner
and Goosen (1939) appreciated how tied the laboratory worker
becomes when practising a technique where observations may have
to go on day and night for some time, and devised a photographic
method, the camera taking half-hourly exposures indefinitely.
The success of the photographs in this method depends on the
release of red cells from the clot which is floating on the
buffer. The red cells fall and settle at the bottom of the
tubes.
3» .hole-nlaaaa clot lysis:
If whole plasma clot is prepared similarly to whole
blood clot, as in technique 1, it will be subject to similar lytic
influences, but lysis is more easily observed. Moreover,
observation is profitable for many more days than with whole blood
clots. Plasma clot can be removed f^roan its serura, resuspended
in buffer and lysis still take place (Fearnley, 1933)* Comment:
Differences in lysis times from whole blood clots are often due
to faotors concerned in the preparation of the plasma clot, such
as temperature, anti-coagulant, calcium, thrombin, pH and perhaps
to the presence of red blood corpuscles themselves. Most of
these points are discussed later. Partial lysis of clot is very
difficult, usually inpossible, to assess visually. Only where
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lysis is rapid is there a time similarity with whole blood clots.
The latter take longer to lyse if they are to do so at all.
4- Diluted plasma clot lysis:
'viacfarlane in 1937 observed that clots made from plasma
diluted 1s 30 in saline lysed more rapidly and .more inevitably
than whole plasma clots. Biggs and Macfarlane (1935b) described
a method using citrated plasma in buffered saline at dilutions
of 1*16, 1*32, and 1:64« Thrombin was added and the clots
observed for complete lysis at 24 hours or at other chosen
intervals.
Fearnley and Lackner (1955) described a method involving
serial dilution of ice cold plasma (see technique 6) from 100 per
cent to 10 per cent, using 0.G4M. veronal buffer at pH 7.4 with
0.1 per cent calcium chloride. Clotting was spontaneous when
the tubes were brought to 37°C and were observed hourly until
lysis occurred. They found that the lysis time was a linear
function of the plasma concentration provided the pH remained
constant. In order to maintain a constant pli they added
additional calcium veronal buffer to each tube some two hours
after clotting had taken place. Comment: A method based
on parts of the Feamley and Lackner (1955) technique has been
used here and points arising from the method will be discussed
later.
5. .Measurement of residual clot after Incomplete lysis:
Bidwell (1953) described a method where a series of
identical plasma clots, in buffered saline, were incubated at
body temperature. At regular intervals of about half an hour
the clots were removed in turn, washed and treated with sodium
hydroxide. The release of tyrosine-like substances was then
assayed against a tyrosine standard using Folin - Ciocolteu's
phenol reagent (British Drug Houses). A graph could then be
drawn by joining the points representing amount of clot against
the time of incubation. This gave some measure of the rate of
lysis. Comment; The graphic presentation of results makes
it easy to compare different experiments. Unfortunately the
technique measures the amount of clot which is not lysed.
This makes the technique least sensitive where most is required
of it, namely the demonstration of slight degrees of lysis in
whole plasma clots. This difficulty is only overcome by prior
dilution of the plasma, but this adds an unknown factor to the
interpretation.
6. Refrigeration techniques;
Fearnley, Revill and Tweed (1952), recognising the
inactivation of fibrinolytic activity in shed blood at roan
temperature and at body temperature, developed a technique to
avoid this. They set up their experiments at ice temperature,
preparing different dilutions of plasma in buffer at pH 7.4.
Only when the dilutions were prepared was the temperature raised
to 37°C for clotting to take place. The dots were watched and
the time necessary for complete lysis recorded. Comment; Ho
anti-coagulant is necessary in these refrigeration techniques,
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because blood which is chilled to ice temperature immediately
it is withdrawn does not clot, at least for many hours. Thus
no pro-coagulants such as calcium or thrombin are necessary.
Refrigeration techniques demonstrate the weakness of mazy earlier
methods where fibrinolysis was rarely demonstrated in the resting
state of healthy people.
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7» I tagged fibrinogen and casein;
In vitro labelling allows one to follow the dissolution
1 31
of human or bovine clot made with trace amounts of I labelled
fibrinogen. lysis is measured, by the radioactivity released
into the surrounding solution in a given time. Comment:
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Methods using I labelled fibrinogen and casein are rapid and
apparently very reliable. Unlike the method of Bidwell
(technique 5 above), the measurement represents the amount of
clot lysed, instead of the amount of clot not lysed, and permits
one to be independent of plasma dilution. Clement and McNlcol
1 ^1
(1959) described the preparation and use of I tagged human
fibrinogen and appeared to show in one of their figures that
the increased rate of lysis after dilution was true and not merely
apparent. The method is sufficiently sensitive to show lysis
in unstressed normal people (Sawyer, Fletcher, Alkjaersig and
Sherry, i960). Heuson (1959) described the use of labelled
casein.
8. Assay of lysis of whole blood clot by means of haemoglobin
content of clot remaining;
Billimoria, Dryedale, James and Maclagan (1959) described
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a method which ignored the direct effect of lysis on fibrin
itself hut measured the amount of haemoglobin (as red cells)
trapped by the fibrin clot. Eighteen tubes of fresh whole
blood in phosphate buffer, diluted approximately 1:20 end
manipulated at ice temperature, were clotted by thrombin as
aliquots of the blood were added to each tube. The temperature
of the tubes was then raised to 37°C. Three tubes at a time
were examined hourly for six hours. The clots were washed free
of loose red blood corpuscles and then heated in sodium hydroxide.
The resultant alkaline heamatin density was read on a
spectrophotometer and the results plotted against time. The
50 per cent lysis times were noted. Comment: The accuracy
of the method depends on the uniform enmeshing of red blood cells
by each of the 18 clots. Results in triplicate must give
confidence to what seems in theory to be an awkward part of the
method, particularly in the presence of low fibrinogen levels.
It is an advantage that all observations are objective, but it
is uncertain as yet how the method con-pares in simplicity and
reproducability with other methods.
9. Constant fibrinogen content in test and control:
Aaelson and Roeder (1958) described five constituent
experiments leading to a conclusion that the fibrinolytic activity
in a sample bears an inverse relationship to the fibrinogen level.
The more the fibrinogen the less the demonstrable fibrinolysis.
This justified their method. To aliquots of normal plasma,
wMch they used as substrate, ®s added plasma defibrinogenated
by heat, from the patient and from a normal person as control.
After dilution between 20 and 30 times with saline, thrombin
was added and the lysis of the resulting clot after 2J+ hours
at 37°C was measured by tyrosine determination of the clots at
the beginning and at the end of the incubation. Comment: It
appears to an observer that the method has three main possible
weaknesses. 1. It appears incorrect to be measuring fibrinolytic
activity in plasma defibrinogenated by heat when sane fibrinolytic
agents are known to be heat labile. This point of criticism
was anticipated by the authors and was defended by their
demonstrating little difference when defibrinogenation was
achieved by using thrombin} but plasminogen (and perhaps
proactivator) may well have been adsorbed on to the fibrin clot
which they had to remove. Thus both methods may be representing
less than the true fibrinolytic content of the sample. 2. Plasma
from a normal person, if it is to be used as a control, must itself
be stringently controlled, because it may contain active
fibrinolysins, such as can result from recent exercise and other
recognised causes, all of which would make it unsuitable as a
/
yardstick. 3. Saline is slightly inhibitory to fibrinolysis
(Pearnley and Ferguson, 1958). Work which will be reported here
is in disagreement with the claim that fibrinolysis bears an inverse
relationship to the fibrinogen content.
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10. Thromboelastograph recordings:
This is no more than an excellent graphic record of
alterations in the physical state of blood and can be used to
record either clotting or the lysis of formed clot, together
with the time required for this to take place (Hartert, 1951t
von Kaulla, 1957) • Comment: The method requires expensive
apparatus.
B. Techniques involving: some analysis of the components of
the fibrinolytic system.
11. Fibrin -plate:
Perrnin (1947) described a method which has been used
widely. Fibrinogen solution was poured thinly into a flat-
bottomed glass dish and was clotted with thrombin. Measured
drops of various solutions were then dropped on to the clot,
these usually being derived from plasma. The lytic effect of
such drops was followed at intervals, the degree of lysis being
measured by the area of the clear space created in the semi-
opaque fibrin. If such plates are heated to about 80°C
adsorbed "proactivator" and plasminogen are destroyed., but the
fibrin is aparently unchanged. This leaves the plates as
indicators of protease activity in an added substance. Fibrin
from human fibrinogen has adsorbed plasminogen and "proactivator",
unless special precautions are taken. Fibrin from bovine
fibrinogen has adsorbed plasminogen but not "proactivator".
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Comment: Analysis of the fibrinolytic ingredients of test
solutions has been made possible by using heated and uhheated
fibrin plates, and bovine and. human fibrinogen. Many
important observations have been made by the method, not least
being the demonstration of tissue activator. In less
experienced, hands there were several technical difficulties
in using the fibrin plate technique, the chief of -which -was
the difficulty in obtaining a clearly demarcated and regular
outline to the lysed areas such as would be suitable for
accurate measurement. This applied particularly to plates
made with bovine fibrinogen. Sherry, Linderaeyer, Fletcher
and Alkjaersig (1959) have commented on this same point,
finding incomplete zones of lysis when using whole plasma
as the lysing agent. They found that euglobulin preparations
were much more successful on the fibrin plates and left a
clear-cut area to be measured. Bovine fibrinogen such as
prepared commercially has rather too clear a clot to be ideal.
Human fibrin prepared from fractionated plasma was more
satisfactory in this respect.
12. Euglobulin frectionation:
• llstone (1%1) added to 19 volumes of distilled
water and 0.32 volumes of 1 per cent acetic acid, one volume
of serum, and thus brought down the plasma euglobulin. When
this was redissolved in saline he found that the resulting
solution was more strongly lytic than the original plasma.
Euglobulin fractionation has been used many times since,
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sometimes with modification. Sherry, Lindemeyer, Fletcher
and Alkjaersig (1959) regarded euglobulin fractionation as
one of the more successful of the four methods they compared.
Kowalski, Kopec and Nierwiarowskl (1959) described the
euglobulin method as valuable, particularly for comparative
assay of fibrinolytic systems in large groups of patients.
They elaborated the method together with a description of
relevant biochemistry. The clots were observed every ten
minutes until lysed. Comment; The rapidity of lysis
makes close and regular observation possible until lysis is
complete, and avoids the need for an automatic camera.
The success of the method depends in large part on the
separation of the fibrinolytic factors which cane down in
the precipitate and the inhibitors which remain in the
supernatant.
13* Synthetic substrates:
Troll, hherry and Wachman (1954) investigated the action
of plasmin on synthetic substrates. They found tluit it attacked
those synthetic amino-acid esters which have arginine or lysine
as the amino-acid residue. This allows the use of synthetic
substrates such as benzoyl arginine methyl ester or tosylarginine
sulphonyl methyl ester, the use of which was described by
unray (1959). It was felt by Troll and his colleagues that
the same enzyme centres are involved in the proteolytic,
fibrinolytic and esterase activity of plasmin. Part of the
evidence for this came from the way arginine and lysine esters act
as canpetitive inhibitors to plasminogen activation. Kjeldgaard
and Ploug (1957) measured proteolytic activity by following the
degradation of a heparin-protamine complex. Comment; There
appears to be no differentiation in the synthetic substrate
methods between fibrinolysin activity and trypsin activity.
The method appears to suffer from the disadvantage which may
be theoretical only, that a fibrin clot has to be removed
from plasma before testing begins. Presumably variable amounts
of plasminogen and perhaps proactivator of plasminogen are
removed, at the same time, adsorbed to the clot. What is left
behind will then be measured.
Von Kaulla and Schultz (1958) compared different
methods for assaying fibrinolysis, and favoured a combination
of thromboelastography and a technique for determining euglobulin
lysis time as against the use of synthetic substrates.
Disappointing results with synthetic substrates were obtained
by Schults, Moorman, Katoush and Lincoln (1957), who measured
fibrinolysis by lysine ethyl ester and tosyl arginine methyl
ester assays. The method was sensitive enough to demonstrate
variations between one individual and another, and variations
in one individual from day to day and within the same day, but
failed to display the increased fibrinolysis known to be present
in certain sera. For this reason the method was condemned,
but perhaps unjustifiably. It appears that their plasma was
diluted 1:4 for the lysine ethyl ester and tosyl arginine methyl
ester assays but 1:25 for the control assay by a more standard
method of fibrin estimation. Moreover, the latter dilution was
made with calcium chloride solution which is inhibitory to
fibrinolysis. For these two reasons it is felt that some
reserve should be kept about the condemnation of the method
made by the authors themselves.
14. Investigation into the activity of individual fibrinolvsin
•precursors in the same specimen:
Phillips and Skrodelis (1958) used the lysis of casein
as their indicator. They estimated t!free pro-fibrinolysin"
(plasminogen) in plasma by the amount o. hydrolysis of casein
after activation by streptokinase. "Total pro-fibrinofysin"
was estimated similarly, using euglobulin in the place of whole
plasma (the preparation of euglobulin removed the albumin
inhibitor). "Active proteolysis" was measured by the hydrolysis
of casein by plasaa or euglobulin without activation by
streptokinase. "Proenzyme content" is calculated by subtracting
active proteolysis from streptokinase activated lysis.
Inhibitor activity is calculated by subtracting the streptokinase
induced lysis of plasma from that of euglobulin. Comment s This
technique applies a more fundamental approach to the study of
fibrinolysis and is an attempt to analyse which conroonent of the
fibrinolysis system is responsible for the waxing and waning of
fibrinolysis on different occasions. Such an approach is most
desirable, although some uncertainty is felt whether the methods
in use are exact enough for this purpose.
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15* f tagged. fibrinogen and streptokinase:
Although described in technique 7, this method is also
well suited for the critical analysis of individual components
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of the fibrinolysis system (Sawyer, Fletcher, Alkjaersig and
She.rry, 1960). Kline and Fishman (1957) labelled streptokinase
131
•with I, -with apparent success.
16. Anti'-fibrinolysis (antiT>lasmin) assay:
Sherry, Fletcher and Alkjaersig (1959) felt that anti-
plasmin assays were not worth while unless there was a source of
potent plasmin, uncontaminated by activator. Their technique
supplied plaamin of the required potency and purity by auto-
activation of plasminogen, glycerol being used as a stabiliser.
This approach to the problem of anti-plasmin assay seems the
only correct one for analytical work demanding results in terms
of an absolute, if arbitrary, unit.
Satisfactory results have been obtained by others
using methods which are open to some criticism on theoretical
grounds, but which give in practice reproducible results,
suitable for comparing the anti-fTbrinolytic activity of
different patients. Biezenski (i960) prepared 12 serial
dilutions of potent plaamin which he prepared by streptokinase
activation of plasminogen derived from hunan fraction III, by
Cliffton and Cannamela's modification (Cliffton and Cannamela,
1953) of Kline's method-. To each dilution of plasmin he added
an equal volume of diluted, serum from the patient and after ten
minutes incubation he added human fibrinogen and thrombin. The
anti-fibrinolytic titre was expressed as the lowest dilution of
the plasmin which was inhibited by the constant amount of serum
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added. The control with saline in the place of serum
resulted in the "absence of clot" in all the tubes. This is
presumed to mean clot-lysis in all tubes.
PHYSIOLOGICAL. Fi'TdOLOGIC-AL AMD IdKPiEIHUKUlI COKDITIOHS
ASSOCIATED WITH AIT E4CKEAHE OF BLOOD ITBRIKOLYSIg.
Ihysiolq^cal:
The part played by adrenalin in augmenting fibrinolysis
has already been described and is the best understood mechanism
involved in physiological increases of fibrinolysis. In any
example of increased fibrinolysis it is impossible to tell how
much of the increase is due to adrenalin and how much may be
due to other factors.
Pathological:
Largely owing to the work of fagnon, ".Mtmore and
Shulman (1952), the association of carcinoma of the prostate
■with abnormal fibrinolysis is widely accepted. The incidence
of this combination is as yet undetermined with certainty, but
was quoted by Tagnon, V/hitmore, Schulman and Kravitz (1993) aB
12 per cent of their cases of metastatic carcinoma of the prostate.
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Cirrhosis of the liver has been associated with abnormal
fibrinolysis for a long time (Goodpasture, 1914: Kwaan, McFadzean
and Cook, 1956). An association with abnormal fibrinolysis
has been described for carcinoma in various sites such as
stomach, breast and disseminated carcinoma of the bladder.
Fibrinolysis in multiple myeloma has been described and lias
been attributed to cryoglobulin of the Waldenstrom type and
to diminution of plasma albumin with its associated anti-
proteolytie activity (.' irridge, Bowman and Garber, 1958).
Systemic lupus erythematosus has been described in association
with fibrinolysis. Burns and whole body irradiation have
been associated with fibrinolysis, as have ulcerative colitis,
rheumatism, nephritis, lead poisoning, urticaria, Raynaud's
phenomenon, iritis, serum sickness, pregnancy toxaemia and
obstetrical accidents (Ratnoff, 1949) and polyqythaemia vera
(Bj/rknian, Laurell and Nilsson, 1956). Pulmonary and
pancreatic disease have both been described with an increase
of fibrinolysis, associated by Murray (1959) with tissue
destruction. Acute leukaemia has not infrequently been
associated with abnormal fibrinolysis (Pisciotta and bchulz
1955: Cooperberg and Neiman, 1955: Hillestaa, 1957: van
Creveld and Mochtar, 1960). Increased fibrinolysis in the
girl suffering from acute leukaemia described by van Creveld
and Mochtar was shown to have its origin in her platelets rather
than in the plasma. This list is by no means exhaustive but
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is sufficient to show the absence of obvious specific caramon
factors between the various disorders which have been described
in association with increased fibrinolysis.
Study of published reports of fibrinolysis in disease
shows that trauma has often been associated with the
demonstration of abnormal fibrinolysis and it is a point for
discussion how great a part is played by the underlying disease
process in the cases described and how much by the trauma itself.
Abnormal fibrinolysis was found during hepatic lobectomy for
local malignancy in five out of six patients when this was
looked, for, but clinically there was only surgical oozing
(Sucker, Siegel, Cliffton, Bellville, Howland and Grossi, 1957)J
during splenectomy (Kwaan and IIcFadzean, 195S) "here in one case
the plasma clot lysed in four minutes: during surgery of benign
adenoma of the prostate (F;asmussen and Ladehoff, 1959): in four
patients suffering from shock (Coon and Hodgson, 1952): and
after cardiac arrest following Caesarean section (Heuson,
Peers and Tagnon, 1958)• Three examples of abnormal bleeding
attributed to fibrinolysis were described by firkin, Reed and
Blackburn (1957) in association with operations for pilo¬
nidal sinus, fissure-iri-ano and a dental operation.
Experimental:
Local effect: Kwaan, Lo and MoPadzean (1957b)
injected 5-hydroxytryptamine paravenously and demonstrated a
consequent increase in fibrinolysis within the same vein and
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in the opposite limb. They suggested that the action of
the 5-hydroxytryptamine (like that of adrenalin and
ischaamia) was mediated by a cholinergic mechanism, and
implied that an important function of platelets was to
initiate fibrinolysis by virtue of the b-hydroxytryptamine
contained in them. Procaine injections in the vicinity
of an artery or vein led to the development of fibrinolysis
in the blood contained in the vessel (Kwaan, Lo and McFadzean,
1958a).
General effect: Peptone shock was used by
Kolf in 1905 as an experimental technique which stimulated
fibrinolysis in the blood stream. Nicotinic acid when injected
(but not nicotinamide) was shown by Weiner, de Crinis, Eedisch
and. &tdele (1959) to increase fibrinolysis, as did a small
dose of heparin in the presence of albumin (von Kaulla and
McDonald, 1958: Lackner and Merskey, 1959). Aspergillin
0 was purified with a view to therapeutic use as a lytic
provocateur, and was tried on a limited scale but does not
appear to have been followed up (Stefanini, Adamis, Coardi,
Horace, Marin and Mele, 1959). Insulin injections produced
a biphasic response, the increase in fibrinolysis being on
the rebound and probably attributable to adrenalin secretion
in response to hypoglycaemia (Fearnley, Vincent and
Chakrabarti, 1959). After unsuccessful trials of several
other preparations, Fearnley, Chakrabarti and Vincent (i960)
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obtained a sustained increase of fibrinolysis in six out
of eight patients after the administration of sulphonylurea.
One of the points relating to technique in
measurement of fibrinolysis is the citrate effect vhich
increases the lytic activity of the isolated euglobulin
fraction of human plasma. This may do so by increasing
activator activity (Buckell, 1958).
Thrombolytic activity: Streptokinase itself
was used successfully as an injection, in dogs and in man,
by Sherry and Alkjaersig (1957). Streptokinase-activated
plasmin has also been used (Grossi, Cliffton and Cannamela,
1954: Back, Ambrus, Eiiipson and Shulman, 1958). Kuegsegger,
Nydick, Hutter, Freirnan, Bang, Cliffton and la. Due (1959),
using plasmin, treated experimentally induced coronary
thrombosis in dogs with apparent success. Chymotrypsin was
used for therapeutic lysis of experimentally induced arterial
thrombi in dogs (Keirle, Glueck, Neely and Altemeier, 1960).
In man similar results appear to have been obtained
(Cliffton, 1957: Ambrus, Airibrus, Back, Sokal and Collins,
1957). Ten patients with thirteen episodes of thrombo¬
phlebitis were treated with various forms of fibrinolysin
(often activated with streptokinase) and there was dramatic
recovery, although no immunity to further thrombosis (Sokal,
Ambrus and Ambrus, 1958). Koser (1958) used streptokinase
activated euglobulin in 52 patients with various forms of
thromboembolic disease. This gave rise to "cautious optimism".
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It T)&3 therefore followed "by a controlled study of the effect
on acute deep thrombophlebitis of plaanin therapy, given
usually by a three—hour infusion. This regime appeared to
give benefit (Moaer, Eulavik and Ilaj jar, 1960). Sussman
and fitch (195S) treated three patients suffering from
recent hemiplegia with a slow infusion of fibrinolysin
(plasmin) after locating the site of occlusion by arteriography.
One patient showed partial clearing of the internal carotid lumen
after treatment. Another patient's arteriographs showed no
filling of the middle cerebral group of arteries before
treatment but .good filling eight days after treatment was
begun. The authors failed, of course, to prove that it was
their therapy which led to the improvement.
PHYSIOLOGICAL. PATHOLOGICAL AMD ElPERIMKmh CONDITIONS
ASSOCIATED 7/ITK AH INHIBITION OP FIBRINOLYSIS.
Predominantly phvsiolo.rd.cal:
Fran the early months of pregnancy onwards and
during labour-, inhibition of fibrinolysis has been demonstrated,
although fibrinolysis returned to normal within the first 24
hours after delivery (BiezenskL and Moore, 1958: Gillman,
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Naidco arid Iiathorn, 1959) • The inhibition -was attributed
to a reduction in lytic enzyme rather than to increased
anti-fibrinolytic activity (Bicsenski, 1960). Alimentary
lipaernia appears to depress fibrinolysis (Greig, 1956:
Buckell and Elliott, 1959b: Billimoria, Dryodale, James
and Maclagan, 1959), possibly by means of the increase of
beta-lipoprotein and chylomicra which are inhibitory (Greig
azd Runde, 1957). Mitchell and Briers (1959) found no
depression of fibrinolysis as a result of suspensions of
cholesterol esters and emulsions of neutral fat prepared
in the laboratory, but found that cholesterol oleate
suspensions were inhibitory. Nitzberg, Peyman, Goldstein
and Proger (1959) found an association between the fibrinolysis
time and triglyceride levels and serum turbidity.
Predominantly pathological:
Rwaan, Lo and McFadzean (1959) demonstrated
inhibition of fibrinolysis in primary carcinoma of the liver
as well as in some other malignant tumours. They felt able
to suggest that the test might be used as an indicator of the
onset of carcinoma of the liver in a patient already suffering
from cirrhosis. In such a patient fibrinolysis would remain
responsive to adrenalin and ischaemia until the onset of
malignancy. The inhibitor responsible could be extracted
in saline from the tumour itself and was active against
activator of plasminogen and was not an anti-plasmin. Hume
(1956) showed inhibition of fibrinolysis in venous blood for
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eight days after myocardial infarction. Lackner and lerskey
(1959) found that there fas fluctuation of lysis times after
myocardial infarction, although on the whole, lysis times
were longer at first. Nestel (1959) demonstrated depression
of fibrinolysis in a group of 3° ;iien suffering from intermittent
claudication. Fearnley, Vincent and Chakrabarti (1959) found
that fibrinolytic activity in diabetes mellitus was reduced
initially by insulin Injections and suggested that this,
together with the rebound fibrinolytic effect when adrenalin
is secreted in response to hypoglycaemia, might be related to
carbohydrate metabolism. A deficiency in lung fibrinolysis
has been demonstrated in hyaline menibrane disease by lieberman
(1959) and Lieberroan and Kellogg (i960), as also after radio¬
therapy to the lungs (Fleming, Szekacs, Hartney and King,
1960).
Predominantly experimental;
Exercised iachaemic muscles appear to play an
inhibiting role on fibrinolysis (Kwaan, Lo and MoFadsean, 1958a).
The clotting process appears to mask lysis which would otherwise
be demonstrable in thrombin-clotted specimens (Fearnley and
Ferguson, 1958)* Red cell stroma is fibrinolytic, according
to Pennin (l%-7)» Calcium has been used relatively freely
in fibrinolytic systems set up in the laboratory both before
and after the demonstration by Feamley and Tweed (1953) that
calcium partially inhibits fibrinolysis. Calcium as the only
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clotting agent leads to very considerable inhibition of
blood lysis (Fearnley and Ferguson, 1958). An
inhibitory effect of calcium has been confirmed here.
According to Medart (1958) calcium does not inhibit the
activity of plasmin, but stabilises the substrate fibrin.
Even saline has been incriminated as an inhibitor of
fibrinolysis (Fearaley and Ferguson, 1958). Large doses
of heparin have inhibited fibrinolysis (von Kaulla and
McDonald, 1958). Beer "was shown by Fearnley, Ferguson,
Chakrabarti and Vincent (i960) to be inhibitory to fibrinolysis.
In this respect at least, beer equalled white wine. The
first observations on the therapeutic use of the soya bean
trypsin inhibitor were made by Heuson, Peers and Tagnon (1958)
who injected the substance intravenously into a patient who
was bleeding profusely on the occasion of cardiac arrest
following C&esarean section, with resultant rapid disappearance
of fibrinolysis in her blood. The patient died later without
further bleeding. The Lima bean has also been used
successfully in laboratory experiment and appears to act
in a similar way to the soya bean trypsin inhibitor (Lewis
and Ferguson, 1953)* Corticotrophin has been shown to lessen
or stop the lysis of experimental ear vein thrombosis in
rabbits (Kwaan and McFadzean, 1956a). Corticotrcphin,
cortisone and prednisone have been reported to inhibit the
fibrinolysis of cirrhosis (Kwaan and. McPa&zean, 1956b) and
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that produced by ^-hydroxytiy^^tamine but not that induced
by adrenalin (Kwaan, Io and McPadaean., 1958b). These
■writers made the position even more confusing by claiming
that cholesterol-induced inhibition (of fibrinolysis)
inhibited both the action of 5~bydro:<ytzyptamine and of
adrenalin and was thus distinct from the corticotrophin
action. Stefanini and Gen&el (1953) reported favourably
on the use of cortisone in "fibrinolytic purpura", and
reported one such case associated Tilth prostatic carcinoma.
Epsilon-aminocaproic acid was used for the first time in man
by lilsson, Sjoerdsma and Waldenstrom (i960). They claimed
significant depression of fibrinolysis for at least seven
hours after oral or intravenous therapy. An apparently
isolated report of the success of toluidine blue in inhibiting
fibrinolysis arising in patients with carcinoma of the
prostate came from Lombardo (1959).
PHYSIOLOGICAL miCTUATIOIT IN FIEbE-QLYflS
There is a diurnal variation of fibrinolytic activity.
Pearnley, Balmforth and Fearnley (1957) recorded the lysis times
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of blood taken from fifteen day nurses at 4 a.m. (twelve of
them being asleep) and from the same girls when they were
tq? and about at 4 p.m. They also recorded the b3.ood lysis
time in fifteen night nurses on duty at 4 a,m. and in the
same girls at 4 p.m. when twelve of thera were asleep. The
results from the day and night nurses were vexy similar.
Less fibrinolysis appeared to take place at 4 a.m, than at
4 p.m. The physical activity which is involved by night-
duty did not upset this rhythm in the majority, only one
night nurse lysing faster at night. Buckell and Elliott
(1959a) confirmed these findings in men, using Bidwell's
(1953) technique and the euglobulin lysis time as described
by Buckell (195S). They found that the variation was
greater in the younger subjects, Btllimoria and colleagues
(1959) estimated the haemoglobin remaining in diluted whole-
blood clots after exposure to lysins. They agreed about
there being a diurnal variation in fibrinolysis but found
it to be significant only when the subjects were not in bed.
THE LlGIMCTIICk OF THE LOCaTIOH OF EldnihOhlTIO FACTORS
It may appear that the site of production, or of
residence, of fibrinolytic factors is of as little apparent
importance as the site of production of clotting factors.
This is by no means so. Over many years a massive literature
has accumulated around the subject of fibrinolysis, concerning
its increase, and its lessening, and its component factors.
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There is hardly a physiological or pathological state in
■which fibrinolysis has not. been assayed. let one can still
question the basic significance of fibrinolysis. The part
played, by fibrinolysis in physiology is mere conjecture and
the part it plays in disease is quite uncertain. Against
this background the site of production of fibrinolytic
factors assumes greater significance if only because a
study of it permits fresh conjecture on the more fundamental
problems of fibrinolysis.
The relatively insoluble tissue activator has
been demonstrated in most tissues, although Albrechtsen
(1957) found liver tissue to be almost inactive. host tissues
are therefore a ready source of local fibrinolytic activity
which is possibly independent of a generalised whole-body
response. Tissue fibrinolysis may play a part in local
response to injury by restricting the spread of fibrinous
damage with its sequel of fibrosis. It is possible that
the emergence of healthy alveolar walls from a lung lately
swamped by lobar pneumonia, can be attributed in part to
the defensive action of the tissue activator which is known
to be present in the lung. In contrast to this, tissue
activator has been shown to be congenitally absent in lungs
affected with hyaline membrane formation. Ideberman (1959)
and Idebeman and Kellogg (i960) first showed this in the
new born, and Fleming, Szakaes, Ilartney and King (i960)
showed the same absence of tissue activator in the lungs of
two men who died shortly after radiation to the chest and
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who had the typical hyaline membrane formation, Spill*
over of tissue activator is a potential source of plasma
activator, although some physico-chemical change would be
required, because plasma activator is so much more
soluble,
The activator and proactivator content of tears,
milk, saliva, urine and prostatic secretion is easily
rationalised as a means of keeping narrow ducts clear and
free from clot.
The fibrinolytic activity of whole blood is
assayed most often, but can be rationalised least well.
Certain observations and experiments give a lead. There
appears to be a difference between the fibrinolytic activity
of arterial and venous blood., Chaplin (1954) fours!
fibrinolysis to be three times greater in the umbilical
cord artery than in the vein. Fearnley and Ferguson
(1957) found that the lytic activity in arterial blood was
less than in venous blood using arm vessels. They made the
observations that venous blood lysis time is no measure of
arterial lysis time and that the lytic agent may arise in
the periphery. Mole (1948) had already suggested that
"the fibrinolysin" was produced by the endothelial lining
of the vascular channels, particularly peripheral ones, and
body cavities. Kwaan, Lo and McFadzean (1957a: 1957b)
injected adrenalin, acetylcholine or 5-hydroxytryptamlne
intravenously, or paravenously, into limbs with restricted
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outflow of blood /and demonstrated an increa.se of lysis in
the segment concerned.. Particularly interesting was the
simultaneous Increase of lysis in the vein of the
opposite limb, apparently mediated by a neurological reflex.
Atropine inhibited both the local and the reflex increase.
Ait:cries and capillaries seem caimble also of a similar
production of fibrinolytic activity. Their deductions were
that fibrinolytic activity may be attributable to ischaemia
of vessel walls, possibly secondary to constriction of the
vase. vasoruni. Tils isehaemia causes stimulation of some
cholinergic mechanism, resulting in release of activator
into the circulation. The main source for this agent thus
may be the vessel walls. This allows one to postulate
that the function of the fibrinolysin found in the
circulating blood is that of maintaining a free channel
for the blood.
There seerae to be no particular location known
for inhibitory factors. Those which have been recognised
have, for the most part, been demonstrated in the blood
stream. There their function may be to remove what is
left over from a. local excesu somewhere in the body.
Alternatively, their raost important action may be to block
the activity of circulating lysins so that the latter are
effective only when adsorbed on to fibrin. This latter view
is widely held.
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I'roof has been lacking that fibrinolysis is important
to the healthy body. In other branches of medicine it has
sometimes required a congenital deficiency to draw attention
to the physiological function of a substance or a body
secretion. In the study of fibrinolysis in the past,
there has been no demonstrated example of a congenital
deficiency of a fibrinolytic factor with an associated
dysfunction or pathology inevitably associated with it,
and so acting as a marker of the abnormality. It is there¬
fore of particular interest to study the reports of
Lieberman (1959) aud Lieberman and Kellogg (1960) to
which reference has already been made. It would appear
that fatal hyaline membrane disease of the newborn is,
in their early experience, inevitably associated with a
deficiency of tissue activator in the lung. They showed
that tissue activator normally appears as early as the
third month of gestation. There was suggestive evidence
of tissue activator deficiency in organs other than the
lung, notably the pancreas. There was an unproved
impression that the condition of hyaline membrane disease
of the newborn is familial, the mother of such babies tending
to have multiple neonatal deaths suggestive of hyaline
membrane disease. If the connection between these factors
is ever proved, it would be the first example of a hereditaxy
76
failure of fibrinolysis, and its further development
■would help greater in displaying at least part of the
physiological role of tissue activator.
CHAPTER TWO
METHODS, MATERIALS AND NATURE OF RESULTS
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1. PLASMA. FIBRIimSIS AiV AY
Introduction
The method of assaying fibrinolysis used through¬
out this -work is a modification of that described by
Pearnley and Lackner (1955) unless specifically stated to
the contrary. The choice of this method was determined
more by a chance of timing than as a result of exhaustive
study of different methods. Until 1956 we had measured
fibrinolysis by the method of Bidwell as quoted by Biggs
and Macfarlane (1955b)* This has been described briefly
in chapter one, technique 5* The newly published method
of Fearnley and Lackner had much to commend it and justified
trial. It observed the lysis of whole plasma as well as a
series of dilutions of plasma down to 10 per cent. All
manipulations were performed at ice temperature, which
preserved the labile factor involved in fibrinolysis and
rendered anticoagulants and procoagulants unnecessary.
Specimens were then brought to body temperature for clotting
to take place and were observed at intervals for clot lysis.
It was hard to Imagine a more untarnpered in vitro technique
for the study of fibrinolysis and this seemed to commend
the method.
About this time, a patient who had presented
dramatically with hypofibrinogenaemia during minor surgexy
to the prostate was reinvestigated for plasma fibrinolysis
using the chilled dilution method. Another patient showed
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unusually powerful fibrinolysis, using the same method.
Such was the interest aroused by these patients that it was
felt undesirable to change the method of assaying fibrinolysis
until the significance of the findings on them was made
oleer. To some extent this thesis has developed in an
endeavour to put into perspective the findings in these two
patients. Clearly it was impossible to change methods in
the middle, without losing much of the information already
gathered, even though a change was seen eventually to be
desirable because of difficulty in presenting results.
Nevertheless, modifications of the method were frequently
run in parallel when there was enough plasma. Results from
these experiments in parallel have not been presented as a
separate study because they were changed from time to time
and in no case, except where they duplicated the method
exactly, did they appear to be giving as helpful information
as was already being received. It was not felt reasonable
to break away entirely from the dilution method so long as
the aims of the investigation remained unchanged.
The technique described below is applicable to all
oases in the main series and in the control series unless
otherwise stated.
Equipment used:
Container with broken ice.
Broad elastic bards to support test tubes
suspended in the ice.
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Sterile
3 test tubes, 1-gby 10 era., round bottomed,
toughened glass, siliconed.
1 siliconed 30 ml. all glass eccentric nozzle
syringe with a 1-g-" needle of 19 standard
wire guage external diameter.
11 test tubes 12 by 15 mm. (3" by ), in rack.
2 graduated 1 ml. pipettes.
'1 Pasteur pipette -with rubber teat.
Centrifuge - MSB multex, with 50 ml. buckets.
Incubator at 37°C.
Pye Universal pll meter.
Buffer:
Veronal buffer was prepared at pH 7.4, using a
mixture of 5^.1 ml. of 0.1 M. barbitone and 41.9 ml. of
0.1 M, H01. In such assays as have been so marked the
same buffer was used with the addition of 0.1 per cent
calcium chloride.
The buffer was put into universal containers in
appropriate amounts for each experiment. These were
then autoclaved in one batch, so that sterile buffer
was always available in small amounts. The pH was
rechecked on an aliquot after sterilization.
Glassware:
Washing of glassware included preliminary brushing
and rinsing, boiling in "sterosyl" (laporte Chemicals
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Ltd.), further brusMng under running water and then
triple rinsing, followed by boiling in distilled water
and oven drying. Tubes were plugged with cotton wool
before dry air sterilisation. Pipettes were cleaned
in chromic acid and rinsed many times in tap water and
distilled water before drying by passage of acetone.
Pasteur pipettes were cleaned similarly and were
plug; red with cotton wool. Siliconing of syringes and
large tubes was repeated only at intervals. Syringes
were washed and sterilized by dry heat inside an
individual container. It was found convenient to
wrap rip all the pipettes required for one experiment
in a large brown paper envelope and they were sterilized
in this. None of the glassware was used for any other
purpose.
FIG. 1: The equipment required for one experiment using
the chilled dilution technique. The pipettes are shown
without their wrappings. An additional parcel of pipettes
has been shown in order to demonstrate the form in which




All venepunctures were made by the same person,
•with the exception of about ton instances, and blood was
removed, with few exceptions, at 10 a.m. or within one hour
on either side. All patients had eaten a hospital breakfast
and. were still in bed. A sphygmomanometer cuff round the
arm was blown up in all cases to 100 mm. Hg. immediately
before insertion of the needle. Samples were acceptable
only if the venepuncture was clean. 32 ml. of blood were
withdrawn into a syringe and then the blood was allowed to
run gently into two 15 ml. test tubes suspended in broken
ice until each tube was filled to near the level of the cotton
wool bung, which usually allowed 12 ml. in each tube. One
mil of the blood remaining in the syringe was run into a
small test tube for subsequent observation of lysis. The
remainder of the blood was added to potassium oxalate
(approximately 2 mg. per ml. of blood) for fibrinogen
estimation. This arrangement permitted considerable
uniformity of timing, specimens from other hospitals being
manipulated after the same interval as from the wards of the
same hospital. No anticoagulant was used at this stage, or
subsequently, in the fibrinolysis assay.
The test tubes containing the blood were transferred
from the beaker of ice to 50 ml. centrifuge buckets and were
packed around with more broken ice and ice water. These were
balanced and centrifuged at 2,000 revolutions a minute for
ten minutes.
While the blood was being centrifuged, buffer was
pipetted using a sterile technique, into a row of ten sterile
test tubes in a rack, each tube with its cotton wool plug.
The first tube was left empty: 0.1 ml. of buffer was put
into the second tube: 0.2 ml. into the third tube: 0.3
ml, into the fourth tube and so on, until 0.9 ml. into the
tenth tube. Usually a second row was prepared for
duplication or further experiment.
The centrifuged plasma, still ice cold, was removed
from the packed red cells by a Pasteur pipette and transferred
into another 15 ml. sterile test tube suspended in the container
of ice. Pram this the plasma was pipetted, using one of the
graduated pipettes, into the ten test tubes in the rack, such
that each tube ultimately contained 1 ml. of liquid. This
involved transferring 1 ml. of whole plasma into tube 1: 0.9
ml. into tube 2: 0.8 ml. into tube 3 and so on, until 0.1 ml.
into tube 10. Immediately after each quantity of plasma was
added, the appropriate tube was shaken briefly to mix the
buffer intimately with the plasma. The rack then contained
ten tubes of plasma in serial dilution from 100 per cent to
10 per cent, and this, together with the tube containing 1 ml.
of whole blood, was placed in the incubator. No procoagulant
such as thrombin was added. It was usual for the rack to be
placed in the incubator half an hour after the venepuncture.
Clotting never occurred before incubation began.
The tubes were observed after approximately half an
hour to make sure that a clot had formed in each tube.
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Thereafter the tubes were examined at intervals until each
clot had lysed. The technique found to be most satisfactory
for examination of the clots -was to tap each tube once or
twice, observing the tube meantime against fairly bright
artificial light. This sometimes betrayed the presence of
a ghost clot which vanished on such gentle agitation. It
was felt with experience that unnecessarily vigorous tapping
would not usually disrupt a normal clot and that error would
more likely stem from failure to tap, rather than from over-
shaking. The end point was regarded as complete disintegration
of clot. Not infrequently there still remained at the
bottom of the tube a small amorphous sediment which did not
disappear even after further incubation.
At first a great many of the tubes were cultured
after lysis had taken place to see whether infection could
have played any part in the lysis. Cultures were invariably
sterile. It was decided eventually that the technique had
been shown to be sound, so far as contamination was concerned,
and that further culturing was unnecessary. It was considered
that a turbidity would certainly develop in plasma incubated
for several days at blood temperature if the specimen hod
been contaminated. This never happened, and it seems safe
to claim that the lysis of the plasma clots was not influenced
by any bacterial contamination.
After the setting up of an experiment it would have
been ideal to observe each tube every hour until lysis took
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place. Lysis, however, proved to be utterly unpredictable
in the early stages for any one particular patient. It
was possible to observe the tubes assiduously for almost 12
hours and then to leave the laboratory finally for the night,
fully satisfied that nothing was happening. By morning,
however, several tubes, and in some cases all tubes, had
lysed. It was therefore only by desire that tubes were
observed hourly or two hourly until lysis took place. In
practice overnight gaps existed. It was partly for this
reason that such care was taken to make sure that experiments
were set up at the same time of day, and also not later in
the week than Wednesday, in order that the observations due
on Saturday and Sunday could be made less frequently without
disturbing comparative values. Almost all the control series
fell under this more strict regime. The patients who had
carcinoma of the prostate had to be accepted for examination
as opportunity presented and the day of the week was difficult
to control. It was usually possible to arrange to take the
specimen of blood at about 10 a.m.
BIG. 2: An experiment in progress. Prom right to
left the tubes are in sequence, rising from 10 per
cent plasma on the extreme right to whole plasma on
the extreme left. The 10, 20, 30 and AO per cent
clots have lysed completely. The 50, 60, 70 and
80 per cent clots are partially lysed (this is not
*
apparent in the photograph for the 60 per cent clot).




The nature of the results obtained;
This must inevitably involve some discussion of
the method itself, but it is necessary to do so at this stage
in order to explain the type of results obtained and the
steps taken to render them suitable for cocqparative purposes.
The raw material for interpretation, obtained at the end of
each experiment, was a series of ten figures. These
represented the lysis time in hours of each of the ten plasma
clots which were made, in the first place, from plasma in
serial dilution from 100 per cent to 10 per cent. The
dilute plasma clots usually lysed first, lysis proceeding
in sequence towards the whole plasma clot.
hen Feamley and Lackner (1955) used their technique,
which was almost identical apart from a larger clot and the
use of calcium veronal buffer, they found that they were able
to plot their results as a sigmoid curve but not as a straight
line. They proceeded to show that this was due to a rise in
pH, most apparent in the concentrated plasma clots. This
change in pH could be obviated by layering excess of buffer
on top of each clot sane two hours after incubation. By
such means the lysis times in the ten tubes formed a straight
line when plotted against the dilution. The general slopes
of the sigmoid and the straight lines were similar. Fearnley
was using buffer containing calcium, but in our hands the
layering on of buffer containing calcium at pH 7.4 did not
always give a straight line. Indeed, the clots sometimes
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seemed loath to lyse at all and the parallel experiments,
set up as described above, seemed more satisfactory. For
this reason Fesrrley' s layering method was abandoned, although
it is felt in retrospect that this may have been done for the
•wrong reason. A change of buffer, particularly to one
without calcium, might have been more successful. It would
appear', however, that a straight line relationship between
the lysis time and the concentration cannot be expected by the
method used here. Indeed, it was virtually never found.
Even if one accepted the apparent impossibility of
plotting the ten figures from each experiment as a straight
line, other alternative graphic presentations might have been
possible. Certain important differences between patients
were, however, obvious. It was seen that the general pattern
of lysis in a minority of experiments was totally unlike
that in the .majority, and in the experiments presented by
Fearnley and Lackner. To take one example, the whole plasma
clot occasionally lysed first. It lysed before the 10 per
cent plasma clot in six out of 101 consecutive assays. This
prevented easy comparison of different experiments.
In addition to variations in the overall pattern of
lysis between different patients there was no constancy about
the smooth flow of lysis times from each tube to its neighbour
within the same experiment. The explanation for this does
not seem to reside in the pll, even although the pH varied with
the different concentrations of plasma. The lysed clots from
13 experiments were examined for pH, and a smooth flow of change
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•was always observed from one tube to its neighbour. The
mean rise of pH was from 7.4 in the 10 per cent tube to
9.1 in the 100 per cent tube.
Obvious errors of technique are not likely to be
responsible for the irregularity because the same person,
practising care and using the same technique, performed
almost all the 10,000 pipettings of plasma required. The
cause of the tube to tube inconsistency remained unanswered
and -would appear to be a weakness in the method. It is felt
that very minor points may have been responsible.
With a view to discovering the best method of
presenting the results from all experiments, the available
figures were studied. It seemed appropriate from a
statistical approach to present the results of each experiment
as a single figure using the 50 per cent plasma clot lysis
time, thus disregarding the remaining dilutions. Here an
attempt will be made to show by diagram that this decision
was reasonable and that the 50 per cent clot lysis time is an
optimum point on the main trend of the lysis times in all
experiments.
Attention will be restricted at this stage to all
of 101 assays performed during an arbitrary period oi nine
months during the period of greatest activity in the laboratory
when the technique was -well established and was uniformly
practised. The cases included 11 of carcinoma of prostate
and 90 from the control series of both malignant and non-
malignant conditions. The technique followed was identical
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in all cases and the buffer never contained calcium* The
ten lysis times from each experiment were plotted against
the Initial plasma concentrations and the general shapes of
the resulting graphs were studied. Three figures have been
prepared to show three extremes of shape obtained. Although
drawn from actual experiments, these figures should be
accepted for their general outline and not for the
significance of individual points on them.
Most of the assays conformed in general with one
or other of these shapes. The first figure (figure 3)
represents the common relationship, which is a gently curved
line. Figure A and figure 5 arc variants which were less
common, but occurred sufficiently often to be of importance.
In order to give an idea of the data from which all
the results have been calculated, the actual lysis times of
the clots in each of the ten tubes are given in detail in
the tables below. The times recorded in table I have been
plotted in figure 3, which is a sample of the usual pattern
obtained in a majority of patients. 73 patients out of the
101 (73 per cent) conformed to this in greater or lesser
degree. Table I itself includes the lysis times from only
seven of these patients, such as had a greater number of
individual readings (the optimum being a different reading
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FIG. 3: The lysis time plotted against the
initial plasma concentration in seven of the
patients -where lysis progressed in an orderly
fashion from dilute to concentrated plasma
clots. Where one observation in the original
experiment has recorded for the first time the
lysis of two or more adjacent clots (see table
i), only the more concentrated of these has
been plotted in the figure. This is acceptable
because the general trend shows it to be the
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CONCENTRATION OF PLASMA IN BUFFER BEFORE CLOTTING
FIG-. 4: The lysis time plotted against the initial plasma
concentration in four of the patients showing an "escarpment"
type of curve. Where one observation has recorded for the
first time the lysis of two or more adjacent clots (see table
II), only the more recently lysed has been plotted, as
judged by the general pattern of lysis. Plasma from W.J.
seven days later showed a figure 3 type of curve although the
buffer came from the same batch. Many of the patients in
this group showed a "rising tail" such as is shown here by
J.B. A "rising tail" occurred most commonly when the more
concentrated plasma clots had not lysed within about three
days, and does not appear to have significance in this method
of fibrinolysis assay, being probably an artefact of time and
pH. Patient J.B. in this figure and J.T. of figure 3 were
examined on the same day, suggesting that the variable factor
lay in the patient rather than in the method.
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Table III gives the data from which figure 5 has
been prepared and represents, in general pattern, about 5 of














































































FIG-. 5: The lysis time plotted against the initial plasma
concentration in two patients with a U-shaped curve where
the 10 per cent clot lysed late and adjacent clots lysed
earlier in sequence from there. Ti/here one observation has
recorded for the first time the lysis of two or more adjacent
clots (-see table III), only the more recently lysed clot has
been used, as judged by the general trend. The "rising
tail" is discussed with figure 4. The patient G-.T. showed
the same phenomenon when re-examined after 14 months, both
curves being recorded here. Patient J.H. in this figure
was examined on the same day as J.G. of figure 35 the different
patterns obtained suggesting that the variable factor lay in
the patient and not the technique.
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The two patients out of the 101 not yet accounted
for had patterns which were unclassifiable as a result of
wide tube to tube variations.
In the light of such variables it was difficult to
present results from one assay of fibrinolysis which were
easy to compare with the results from another, although It
should perhaps be stressed that the problem would have
appeared simple had a single random dilution of plasma been
selected for study. Mary figures were prepared on plain
and on logarithmic paper, with a view to diagramatic
presentation of all results, but none of these was satisfactory.
There remained three possible approaches to the problem, all
of them using individual lysis times:
1. To follow the lysis time of whole plasma as
representing the nearest approach to in vivo
blood. This was not feasible because only 63
per cent of the whole plasma clots ever lysed,
and they usually did so only after a few days.
2. To follow the lysis time of the 10 per cent
plasma clot only. There was much to commend this
idea, for it is a dilution used by other workers
when presenting results. It has been shown quite
clearly here that the 10 per cent lysis time need
not be in harmony with the lysis times of even
slightly sore concentrated staples. Moreover, It
can reasonably be claimed that a concentration of
plasma which usually lyses within the first 24 hours
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must, for accurate -work, be observed at regular
intervals throughout the 24 hours if a false
uniforjiiity of results is to be avoided.
3. To use the 50 por cent plasma lysis time.
Pram a study of all the lysis times and from
observation of figures 3, 4 and 5, it was seen
how the 50 per cent clot lysis time seemed to
be more nearly universally appropriate than any
other. It was decided, therefore, to use this
lysis time for the presentation of results.
Having decided to present the lysis time of 50 per
cent plasma clots in preference to the alternatives, a
further problem presented itself. It sometimes happened that
the 50 per cent clot lysed during the night when no
observations were being made and by morning sane adjacent
tubes had also lysed. It was difficult to know what time
to allocate for the 50 per cent clot itself. Moreover,
there was sometimes inconsistency in the smooth progress of
lysis from one tube to its neighbour of the nest dilution.
A formula was therefore devised with the help of the department
of statistics in order to smooth off uncertainties and
irregularities around the 50 per cent tube.
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The formula.:
(2 - PL) ( u - L )
p50 s L + (Pa- PI,)
Pj-q « the lysis time in hours of the $0 per cent
clot, corrected -where necessary by adjacent
figures.
Value L is the observation time in hours such that
not more than half the clots have lysed, but
had it been the next figure higher iaore than
half would have lysed.
Value U is the observation time in hours, such that
net less than half the clots have lysed, but
had it been the next figure lower less than
half would have lysed.
= the proportion lysed by L
Py = the proportion lysed by U
The formula is easy to use, most of the figures lending
themselves to .mental arithmetic after a little practice. The
formula contributes nothing where the 50 per cent clot lysis
time is unambiguous. In such cases the formula supplies the
same figure as when the time is read directly from the results.
The ten lysis times of the assay on patient W.B, are reproduced




P « 31 - g " '° (37 - 31)50 A u10 — —10
sb %. hours
The columns under the heading of P^q in tables I, II and III
serve as other examples of the use of the formula.
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For the remainder of this work the symbol F^ will
be used freely without further explanation and in sane instances
use will be made of the symbolism to describe the whole plasma
clot lysis time as P-jqq» and the ten per cent clot lysis time
as although the formula remains applicable only to F^q.
while the lysis time P^q is regarded as the best single figure
with which to present results, the times for P.qq and will
sometimes be supplied in addition, out of interest, to allow
comparisons to be made. Usually the trends are the same.
Reproducabilitv of the method:
Reproducability studies were carried out on 63
specimens of plasma. Two experiments on each plasma were run
in parallel and were set up at the same time using the same
buffer. The P^q lysis times were listed and a comparison
made of the figures from each.
There was very little difference between the figures
in each pair. 26 of the 63 pairs of experiments had identical
P^O lysis times. In the remainder, the experiment set up at
the front of the rack lysed more quickly in 25 instances, while
the one in the back row lysed more quickly in only 12. The
difference between the two rows was between one and four hours,
which is too slight to affect the significance of the results.
The tendency for the front row to lyse a little before the back
row was an impression which was gained early in the work, but
it is dearly of little significance. The explanation is not
known, but the front row was pipetted before the back row, and
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some factor may have influenced the results at that stage*
While the majority of experiments did conform to the
pattern of lysis of figure 3, it seemecl that the pattern of
lysis could vary from patient to patient and from one examination
to the next. Enough repetition of work •was done on different
patients on the same day and on the same patient on different
days to suggest that the most important variable factor in
the pattern of response lay in the patient and not in the
technique, although nothing approaching proof of this can
be presented. It was therefore not possible to assume that
second assays on the seme patient would give the same general
pattern of lysis as in the first assay, although this was usually
the case. The P^q figure nevertheless remained the most valid
method of comparing the two.
Fibrinolysis was also assayed by means of fibrin
plates. Only a restricted investigation was made using this
technique, and such modifications as were made to the method
of Astrup and MUllertz (1952) are given in the appropriate
section devoted to "Experiments on fibrinolysis using fibrin
plates" in chapter three.
2. PLASMA FIBRINOGEN ESTIMATION
Almost all the fibrinogen estimations in the control
series have been by recalcifioation of plasma and isolation
of fibrin clot according to Cullen and van Elyke (192C)
followed by Kjeldahl digestion and distillation. Mary of the
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plasma Samples fron patients suffering from carcinoma of
the prostate -were estimated by the rapid turbidornetric
method of Podraore (1959) using sodium sulphate and a grey
wedge photometer, although usually the longer method was
employed on the same specimen.
Birring the course of this work there -were two types
of circumstances where plasma fibrinogen estimation presented
peculiar problems.
Fibrinogen estimation in the presence of
acute hypofibrinogenaemia.
13hen the plasma fibrinogen falls catastrophically,
as in patient E.S. (chapter four, case 1), and to a lesser
extent in patient J.H. (chapter six, case A), or much more
commonly, where one fears that the fibrinogen level may have
fallen, because the patient is bleeding profusely and the blood
is not clotting normally, then a rapid method of fibrinogen
estimation is not only desirable but is essential. The
patient's life may depend on a rapid and accurate diagnosis
of the clotting defect. With this need in mind, rapid methods
of fibrinogen estimation were reviewed in the literature and
two were selected at first, as being easy to perform in an
emergency without prior preparation. The turbidometric method
of Podmore and allied methods, of which there are several,
were not at first considered suitable for such very rare
emergency use, although ultimately they were adopted.
The first method which was chosen is qualitative
only and involves the adding of 0.2 ml. of commercial thrombin
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solution (made up to 50 units per ml.) to one or two ml. of
whole blood freshly removed from a vein. If there is no
obvious clot within one minute, fibrinogen deficiency is to
be suspected. The same test performed with whole plasma
from oxalated blood takes a little longer to perform but is
very much easier to read and interpret, and is to be preferred.
A normal control is advised in order to demonstrate the potency
of the thrombin and size of a normal clot.
The second method which was chosen is quantitative
in a rough way, and can be performed in any laboratory possessing
thrombin and a centrifuge. This is the method recommended by
Wolf (1954). Oxalated (not heparin!sed) plasma from the
patient and a control is diluted to one part in ten with saline.
2 ml. of this are placed in the first of a row of six test
tubes, and doubling dilutions in saline made in successive
tubes down to 1s320, the final volume in each tube being 1 ml.
To each tube 0.1 ml. of thrombin vising 50 N.I.H. units per ml.
is added. Clotting is practically instantaneous. Kb more
than a minute need elapse before each tube is examined in front
of a good li ht for the presence or absence of clot. The
smallest clot is difficult to see, whether this is from the
patient or the control. It is a disadvantage of the method.
For those familiar with the wisp which is the smallest clot,
the results ere reasonably accurate. The smallest visible
clot is usually the result of clotting a solution containing
approximately 0.001 g. fibrinogen per 100 ml. The following












those tests are recorded where a second assessment of fibrinogen
concentration to made by another method, or There tests in
parallel gave helpful information.
Although symbols are given for the size of c}ot,
these are ignored in the assessment. Only the presence or
absence of clot is of significance. The normal range for
plasma fibrinogen is taken to be 0.2 - O.if g. per 100 ml.
and the tubes are in doubling dilutions. Consequently a
difference of two tubes between the last clot in the patient's
row of tubes and the control means a difference in fibrinogen
content to a factor of four. The second last column of
table IV shows that the method often works out fairly
accurately, even in an emergency.
Fibrinogen estimation in the presence of
active fibrinolysis.
When the plasma clot from patient E.A.S. was
prepared for estimation of fibrinogen by the Kjeldahl method.,
it appeared normal. The clot was then left at room temperature
as is customary using that method., but in the meantime it lysed.
An aliquot of the same specimen had already been examined using
a turbidometric method and the fibrinogen content was 0.49 g.
per 100 ml. Because of the impossibility of preserving the
clot in the presence of lysine active at roan temperature,
without modifying the locally standardised laboratory method
for such an investigation, it was felt that a turbidometric
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method of estimation of fibrinogen should always be available
for emergency use, however infrequently this might be called
upon. The equipment required is simply maintained - a
Medical Research Council grey wedge photometer, a 10.5 g«
per cent sodium sulphate solution and a standard graph from
which to calculate results (Podmore, 1959). Although most
of the patients in the main series had plasma fibrinogen
estimations by both methods, there was no subsequent instance
when the clot was recognised to lyse before the Kjeldahl
estimation could be performed. The results of turbidometric
estimations have therefore been omitted because they ran the
same pattern as by the Kjeldahl method and the figures themselves
were almost the same. Moreover most of the control series
had plasma fibrinogen estimation by Kjeldahl method only.
3- IIAEi.SGLQBIN ESTIMATION
The haemoglobin concentration was measured using
a Medical Research Council grey wedge photometer. 100 per
cent = 14# 8 g./l00 ml. (King, Mootton, Donaldson, Sisson and
Macfarlane, 1948).
4. PLATELET COURT
Platelets were counted by Lempert's (1935) method.
Normal range from 150,000 to 350P00/c.raa.
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5. yxqc
The technique used here has been described and
discussed by Quick (1942). Human brain thromboplastin and
0.023 M« calcium chloride« used. The anticoagulant •was








The control series -was gathered together to
provide information with which to compare changes found in
a series of patients suffering from carcinoma of the prostate.
A preliminary study of the figures in the early stages of the
prostate series had shown wide variations from one patient
to another and it seemed very likely that only falsely
justified conclusions would "be reached unless a large control
series was prepared.
The problem of selecting the controls was not
straightforward. It was difficult to decide what comprised
a control for a patient suffering from carcinoma of the
prostate. Patients suffering from benign hypertrophy of the
prostate had much to commend them as controls. They were of
similar age and the same organ was affected. however, it
has been claimed that histological malignancy can be demonstrated
in a high proportion of elderly men not suspected to be
suffering from carcinoma (Pranks, 1954). Moreover, it was
felt that only patients in the ward should be Included because
of the known influence of exercise and excitement on fibrinolysis
suoh as would, more likely affect out-patients. This largely
restricted available cases of benign hypertrophy of the prostate
to emergency admissions with acute retention of urine, or to
post-operative cases, neither of which were ideal. It was
decided therefore to accept cases of benign hypertrophy of
the prostate as they arose, but in addition to seek out
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approxLmately equal numbers of men of all ages, the one
grow having been admitted to hospital because of a malignant
condition, the other group because of a non-malignant condition.
As far as possible days of stress for the patient -were avoided
and no sample was taken v,dthin a day or- two after surgery
■without due note being made.
hhTHOD
All patients were examined for fibrinolysis by
the same method, using serial dilutions of plasma in buffer,
followed by observation for the times of clot lysis. 'This
method has been described in detail already. Blood samples
were taken from the patients near 10 a.ni. in almost all cases
and all patients had eaten a hospital breakfast. Specimens
were noiroally taken only on a Tuesday or a Wednesday of each
week.
CHOICE OF PATIENTS
There were 138 patients in the control group. 21
of these had been admitted- to hospital because of benign
hypertrophy of the prostate and these have been treated as a
separate group. Most of the remaining 117 controls were
allocated for the purpose by house surgeons, whose choice was
fairly randan and was quite independent of the question of
fibrinolysis. 62 of these had been admitted to hospital
because of a variety of conditions, mainly surgical in interest
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but none of them malignant. The remaining 55 were known to
be suffering l*rora a malignant condition elsewhere than in the
prostate. Patients were commonly chosen who had been admitted
to the ward within the previous few days but the day of
admission itself was avoided. Almost all the 83 patients in
the non-malignant group were in a general surgical ward,
while almost all the 55 patients in the malignant control
group were in a radiotherapy ward. Only the first examination
for fibrinolysis on each patient has been accepted for this
part of the study.
RESULTS
QBblEVATIQIIE SUBJECTED TO bl'ATIbTICAL AI1AL3KIS
The influence of age fibrinolysis
Little would be gained by presenting; the lysis times
of all the ten tubes of each experiment for the reasons
presented in the last chapter. Therefore only the lysis times
of the 50 per cent clots (IEq) have been supplied. These
have been listed for all 138 patients in table XXXII in
appendix 2. The 101 patients whose patterns of results
were discussed in chapter two are included in this table*
except those suffering from carcinoma of the prostate, who
are included in table XXXIH in appendix 2. The three sub¬
groups of the control series have been tabled separately, as
benign prostatic hyperplasia, non-malignant miscellaneous
disorders and non-prostatic rralignant miscellaneous disorders.
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1hen the lysis times were arranged in sequence
according to the age of the patient, it became apparent at
once that there was probably an effect of age. The figures
were examined for their statistical significance.
The lysis times were taken by decades, as they have
been presented in table XXXII in appendix 2, and the mean lysis
time for each decade has been plotted against the mean age,
in figure 6. Each of the three sub-groups of the control
series taken separately and then together shows an increase





































FIG. 6: The relationship of age in years to the lysis
times (P^q) ^or "the three sub-groups of the control
series. The mean age for each decade has been plotted
against the mean lysis time together with two standard
errors on either side. The downward trend of the mean




An analysis of results from the carcinoma of
prostate group will be presented in the next chapter.
It is necessary to anticipate this to the extent of
stating that the carcinoma of prostate series 3hows
the same increased rate of lysis -with age as is shorn
by the control group. Therefore all three sub-groups
of the control series and the main series of carcinoma
of prostate have been taken together to prepare the
figures plotted in figure 7. These points form
virtually a straight line, particularly from the age
of 40 onwards, where there were more cases in each
decade. This shows clear evidence of an increased














FIG-. 7: The relationship of age in years to the lysis
times (P^q) for the entire control series and the main
series of carcinoma of prostate, treated as a single
group. The mean age for each decade has been plotted
against the mean lysis time. The increased rate of




The comment made on the statistics is as follows.
"In each series there is a marked tendency for the average
to decrease with age. This is too obvious to require
significance testing, particularly as it occurs in each series
in exactly the same way. The average P_Q level (of the
carcinoma of prostate series) is lower than that in the control
groups, but this effect is no greater than would be expected
because of the higher average age of the carcinoma of prostate
group.
"There is no suggestion of departure fran normality
of distribution (which might require examination of idLnirauin
values as well as the means) and so it can be concluded that
the groups do not differ in any significant respect.
"The only suggestion of a difference is In the
70-80 age-group, but as this is not borne out by diffex-ences
in the age-groups either above or below it may be assumed to
be a chance effect. It would certainly not be significant
in the conventional sense."
Reference will be made again to these results in
the main discussion which follows chapter six. There some
of the broader issues of fibrinolysis will be discussed.
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The effect of adrenalin and excitement
A normal male control aged yd volunteered to be the
subject of an investigation into the effect of adrenalin on
fibrinolysis. On two previous occasions his ten-dilution
fibrinolysis experiment had failed to lyse in any tube, even
by 240 hours. On the morning of the experiment, to which he
was not looking forward, the lysis time can be seen in table
V to have shortened considerably. light minims of adrenalin
1:1000 were then injected slowly into the deltoid muscle and
a second blood sample removed several minutes later. This
was at the period of maximum discomfort, when a minor headache
had developed, pupils dilated and pulse increased from 60 per
minute to 80 per minute. An identical fibrinolysis assay was
performed on the second specimen.
TABLE V
Two base-line fibrinolysis assays,
followed by one during mild anxiety
and finally one during the unpleasant








Previous assay 1 ++: ++: ++
Previous assay 2 ++: •m": ++ m
Before adrenalin ++: 36: 13 0.27
After adrenalin 70: 14: 6 0.28
++ Wo lysis by 240 hours
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Although the number of times the assay procedure was
practised numbers several hundred, and the venepuncture was
almost invariably performed by the same person, there was
ordinarily no way of assessing the anxiety felt within the
patient at the time of the sample. There was, however, one
man aged 60 who had been admitted on the preceding day with a
view to operation for varicose veins. Before, during and
after the venepuncture he was talking with much nervous
anxiety about the progress of the professorial ward round
which was slowly approaching his bed. It was clear that he
was unusually anxious at the time of the venepuncture. his
lysis time (P^q) was only 15 hours and his whole plasma, clot
had lysed by 29 hours, which is faster than usually occurs.
Comment: The findings in both these subjects may be used in
support of published work, notably that of Biggs, Macfarlane
and Pilling (1947). Adrenalin and anxiety both appear to increase
the fibrinolytic activity of the blood. The effect of anxiety
is presumably mediated by adrenalin.
In the context of this work, these experiments,
together with others not quoted of less certain authority, give
a measure of the change which can be demonstrated by the ten-
dilution assay method, without it necessarily reflecting
pathological conditions. They give a reminder that controls
for fibrinolysis experiments are difficult. Even a normal
person, being excited, can give quite a different result from
the same person mentally at rest.
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"he immediate effect of surgery on fibrinolysis
Table VI shows the effect of surgery on fibrinolysis
as shown in two patients diagnosed as suffering from carcinoma
of the prostate.
table vi
The immediate effect of surgery on fibrinolysis

















711 66: 25 16: 14: <14 15 mln.
lysis time in hours
Comment: This table shows that one of the immediate effects
of surgery can be a considerable increase in the rate of
fibrinolysis. Macfarlane's (1937) observation has rhus been
repeated. In the context of this work it can be pointed out
that very rapid fibrinolysis, such as is associated with
surgery, can clearly be present without any unusual clinical
bleeding.
The effect of heparin on the fibrinolysis assay
A man aged 54 was in hospital for investigation of
a vascular disorder. A ten tube dilution assay was 3et up in
the morning immediately preceding an intravenous injection of
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10,000 international units of heparin. Forty minutes after
the heparin injection, when the vtele blood clotting time ■was
more than 30 minutes, the fibrinolysis assay was repeated.
The results are shown below.
Pf-Q before heparin » 55 hours
Pj_0 after heparin « 66 hours
Comment: There does not appear to be ary significance in the
difference here. In the presence of an obvious increase in
the whole blood clotting time, it is reasonable to assume that
if heparin, given as here, dees cause any difference in the
lysis time such a difference must be small.
Fibrinolysis related to the plasma fibrinogen level
A man aged 66 who died four days subsequently of
carcinoma of the bronchus had P^Q lysis times of ten and nine
hours on two assays made in parallel on the same specimen.
These lysis times are faster than was ordinarily found, yet
his plasma fibrinogen level was 1.06 g. per 100 ml. Clearly
the high fibrinogen level in this patient did not stand in the
way of fast fibrinolysis. Adelson and Boeder (195^), however,
appeared to show that the fibrinogen level bears an inverse
relationship to the fibrinolysis present in the sample. In
view of the apparent importance of this point, lest it be used
as a criticism of the method used here and of conclusions drawn
from it, the following table was prepared. All the 12 examples
in the main series and its controls, who had a plasma fibrinogen
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level greater than 0.80 g. per 100 ml. have "been tabled
•with their lysis times. .Similarly the 12 lowest plasma
fibrinogen levels (range from C,1? to 0.26 g. per 100 ml,)
have been listed with their lysis times.
vn
The lysis times associated with the 12 greatest
fibrinogen levels and with the 12 least fibrinogen levels





G.C. 83 Sarcoma of thigh 1.16 79
H.W, 66 Carcinoma of bronchus 1.06 10
G.P. 68 Acute cholecystitis 1.00 144
W.W. 76 Carcinoma of prostate 0.98 166
P.G. 76 Carcinoma of prostate 0.94 86
R.Y. 63 Multiple infections 0.90 ++
T.G. 68 Carcinoma of prostate 0.90 52
fijt. 64 Carcinomatosis 0.89 43
D.S. 67 Carcinoma of bladder 0.88 96
W.M. 61 'lastro-entero-colic fistula 0.86 176
T.M. 40 lesection gastric ulcer 0.81 95
R.L. 79 Carcinoma of nasal antrum 0,81 47
T.H. 82 Paget's disease 0.17 39
E.R. 61 Chronic granulocytic leukaemia 0.18 48
P.W. 68 Carcinoma of bladder 0.20 65
I.H. 71 Carcinoma of prostate 0.21 ++
G.M. 30 Anxiety 0.23 118
O.H. 69 Carcinoma of prostate 0.23 69
T.S, 38 ? 0.24 165
J.L. 38 Incisional hernia 0.23 105
A.T. 67 Carcinoma of prostate 0.26 68
J.D. 73 Carcinoma of prostate 0.26 7
H.P. 14 Carcinoma of prostate 0.26 120
J.T. 78 Benign prostatic hyperplasia 0.26 67
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PIG. 8: The relationship of 12 high
plasma fibrinogen levels to the lysis
times associated with them, and of 12




Comment: It can be seen from the general arrangement of
the points that when the fibrinogen level is unusually high
some clots lyse quickly. Similarly -when the fibrinogen
level is low, or low normal, some clots lyse slowly. There
seems to be no evidence here to suggest that high fibrinogen
levels inhibit lysis or that the method used masks lysis at
high fibrinogen levels.
The influence, of sex on fibrinolysis
Apart from the group in table VHI, all the patients
examined have been men, because the series lias concerned
carcinosna of the prostate and the controls required for this.
The following table shows the plasma lysis times found, in
seven women whose blood was examined incidentally to the main
series.
TfiBLE VIII
The lysiE times in seven women of
different ages and diagnoses
Hame Age Diagnosis Lysis time
(hours)
P100'P50sP10
B.B. 26 Capillary defect 97: 94: 94
A.C. 46 Acquired deficiency of
antihaemophilic factor
47: 47: 23
E.H. 52 Biliary cirrhosis ++; 68: 68
E.B. 55 Functional disorder ++:117: 26
F.E. 60 Metastatic carcinoma 93: 93: 93
E.B. $ 65If Cirrhosis of liver« n 0 ++: ++: 9066: - : 42
A.H. 71 Retinal bleeding ++: ++: 72
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Comment: The figures in this table can be compared with those
in the control series in figure 6. There seems to be no
clear-cut difference between the two sexes but the number
of cases is far too small and the method insufficiently refined
for any conclusion to be possible about lesser differences.
Such insignificant differences as are shown tend towards a
longer lysis time in women. In a series of 30 men and 30
women between the ages of 18 and 40, Feamley and Tweed (1953)
also found a somewhat longer lysis time in the women compared
to the men, but doubted whether the difference was significant.
The effect of calcium on fibrinolysis
Although it will be shown that calcium in the buffer
has not materially affected the results in the main series of
patients, this is not to inply that calcium plays no part in
fibrinolysis. Many of the early experiments where calcium
was used showed a delayed lysis, particularly of the more dilute
plasm©, clots. Delayed lysis of dilute plasma clots can also
occur using veronal buffer at pH 7.4 even in the absence of
calcium, as has already been shown, but the frequency of its
occurrence with calcium appears to be greater.
Two experiments are presented below to demonstrate
differences which are claimed to be due to the calcium present
in the buffer. The two assays on each patient were set up
simultaneously using the same specimen of plasma but different




The inhibitory effect of calcium in two experiments.






A.C. 63 Inguinal hernis ++s 71: 47 ++: 49: 23
E.M. 56 Peptic ulcer ++: 51i 23 ++: 31: 7
++ No lysis by 240 hours
Comment: Although the use of calcium has not infrequently been
recommended in techniques for demonstrating fibrinolysis,
analysis of the part it play3 has usually shown it to be
inhibitory to fibrinolysis. Fearnley and. Tweed (1953)
demonstrated the inhibitory effect of calcium although they
continued to use it subsequently (Fearnley and Lackner, 1555)>
Kedart (1958) found that calcium, magnesium, manganese, cobalt
and sine were approximately equally effective in reducing the
rate of proteolysis by trypsin. The effect may be by a
protective action on the fibrin rather than by an inhibition
of the plasmin. The two experiments which have been shown
in table IX, in addition to many others which were less well
controlled, all support the evidence that calcium is inhibitory
to fibrinolysis.
Experiments on fibrinolysis usin,- fibrin plates
Experiments were carried out on plasma from patients
without known malignant disease in order to assess some of the
claims made for the fibrin plate technique. Plates were
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prepared by a method which was largely that of Astrup and
Mttllertz (1952) but bovine fibrinogen as supplied by The
Amour Laboratories (at that time Armour and Carpany Ltd,)
was used in place of freshly prepared ox fibrinogen. Nine
ml. of fibrinogen solution in buffer at pH 7,8 were poured
into each of several petri dishes and were clotted with 0.8
ml. of thrombin (Maw) 50 E.I.K. units per ml. This made a
thin smooth layer of fibrin in each dish.
The Amour fibrinogen contained only 40 - 50 per
cent of clottable protein and also contained 40 - 50 per cent
by weight of sodium citrate. Presumably because of difference
in preparation it was found that a concentration of 0,8 g. per
100 ml. of this bovine fibrinogen was more suitable than the
recommended 0.1 - 0.2 g. per 100 ml. of freshly prepared ox
fibrinogen. Buffer was prepared by adding to 66.2 ml. of
0.1 M. sodium diethyl barbiturate, 33»8 ml. of 0.1 M.
hydrochloric acid and 32 ml. distilled water. Streptokinase
(Burroughs Wellcome and Company) contained 5,000 Christensen
units per 1 ml.
When plates were to be heated in order to inactivate
plasminogen, it was found to be satisfactory to leave them at
90°G for 20 minutes. Drops of the solution to be tested
were always of 0.03 ml. and were placed carefully on the fibrin
plate. The area of lysis was measured by multiplying
diameters at right angles after an appropriate incubation
period at 37°C, usually 24 hours.
Figure 9 illustrates the results of one experiment
designed to test the relative effects on heated fibrin plates
of streptokinase by itself, bovine fibrinogen by itself
(although containing such fibrinolytic factors as were not
excluded by the fractionation), a mixture of both, and trypsin.
«
FIG-. 9: Serial dilutions of various substances
on heated fibrin plates after incubation for 24












Observations; 1. Urihe&ted bovine fibrinogen had almost
negligible spontaneously-activated
plasain activity on the heated plate*
2. Streptokinase itself had no lytic
activity and did not appear to activate
bovine fibrinogen*
3* The trypsin effect, used here as a
positive control, ms considerable.
»
Figure 10 illustrates the effect of streptokinase
on human plasma using unheated fibrin plates. Fresh oxalated
plasma was obtained from two patients in hospital as a result
of non-malignant disorders. Four dilutions of each were
made in saline. The same concentration of streptokinase
was used as before. The results from the two patients were
similar and therefore only one set has been recorded.
40
FIG. 10: The effect of incubating four dilutions of
the same human plasma on an unheated fibrin plate and
of adding a constant amount of streptokinase to each
dilution of plasma. The unit of area is arbitrary.
Observation: Although there appears to be definite
plasmin activity in the plasma of the
spontaneously-activated type, this
activity has been increased by the
addition of streptokinase.
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Figure 11 illustrates the relative effect on
unheated fibrin plates of a euglobulin prepared from pooled
human plasma according to the method of Milstone (194-1);
of trypsin; and of streptokinase, in the same concentration
as used above.
250r
FIG. 11: Trial of a preparation of euglobulin





Observations and Conclusions It is clear that u'ilstone' s
euglobulin, activated by streptokinase, can be an
extremely powerful lytic agent. Very little
importance can be placed on the relative strengths
of the substances used, as illustrated in the figures,
because further analysis of varying concentrations
was not undertaken. Note that the effect of
streptokinase on unheated bovine fibrin was greater
than that of streptokinase with bovine fibrinogen on
heated fibrin (figure 9). The apparent effect of
streptokinase on an unheated bovine fibrin plate is
itself of interest.
The fibrin plate method is clearly one of
importance. Difficulty was experienced, however,
in obtaining sharply defined areas of lysis on the
plates. It was felt that the method itself demanded
*
special study before results of value could be obtained
from it. The method was therefore not used in
parallel with that of the lysis time of formed clots.
CHAPTER FOUR
THE MAIN SERIES




If in fact prostatic carcinoma leads to an increased
rate of fibrinolysis, as claimed by Tagnon, Whitmore, Schulman
and Kravitz (1953)» this may be demonstrated in several ways.
The mean of a whole series of assays will show the difference,
provided most of the patients have an increased rate of lysis;
or if the majority lyse normally, but there are enough individual
examples of increased lysis, this also will weight the mean as
will be apparent in a distribution figure. If there is an
all-or-none mechanism and the incidence of abnormal lysis is
very low, then the mean may not show a difference from the
controls, and yet individual examples of abnormal lysis may
still exist.
Choice of patients
There were 68 patients in the main series. All
of them were suffering from carcinoma of the prostate. The
diagnosis was proven histologically in 44 and was beyond all
reasonable doubt, although without histological proof, in 17.
The diagnosis in the latter was supported by the presence of
osteoplastic secondary deposits in bones, or raised serum acid
phosphatase levels, in addition to the characteristic findings
on palpation of the prostate. In seven it was a clinical
diagnosis made on the history and after rectal examination,
without strong enough supporting evidence to make the diagnosis
unchal1engable. These points of difference have been shown in




separately in the analysis but no difference -was found and they
are therefore being treated here as a homogeneous group of
carcinoma of the prostate. The patients are unselected by as
much as no patient -was refused inclusion in the series where
the opportunity of seeing Mm was known, and this covers
approximately three and a half years from 1956 to the middle
of 1960. The group is not a true random selection, however,
because notice of patients was invariably by courtesy of
members of the hospital staff, and this led to a majority of
patients arising from two surgical units which had a special
interest in this type of case. Two patients (to be described
as case 1 and case 2) were examined in the first place because
of a bleeding episode, and in this sense were selected. The
remaining 66 patients were examined as part of a research
investigation into carcinoma of the prostate, without special
regard to bleeding, and in this sense were unselected. A
few patients in each decade of age were examined of necessity
as out-patients and were included in the group, but can be
identified in table XXXIII in appendix 2. Although multiple
examinations were made on many patients, only the first assay
has been used for the main analysis.
Method
All patients were examined for fibrinolysis by the
same method, using serial dilutions of plasma with buffer,
followed by observation for the times of clot lysis. This
is the method already described, and used in the control series.
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It was not possible to take blood samples at such regular
times of the day or of the week as in the control series
but the majority of specimens were taken around 10 a.m.
Calcium buffer was used in 23 assays and the effect of this
is discussed separately.
RESULTS
OBSERVATIONS SUBJECTED TO STATISTICAL ANALYSIS
The times of lysis as obtained from assays on all
68 patients have been included in table XXXIII in appendix 2.
The mean lysis time (P^q) for each decade, together with the
range Included within twice the standard errors in either
direction, has been shown in figure 12. This has been super¬
imposed on the results from the control series, as shown
already in figure 6,
Because the results from the control series have
already been presented, part of the results from the carcinoma
of prostate series have had to be anticipated. This has
arisen because both the control series and the main series showed
a definite speeding of lysis with age. Moreover the three
sub-groups of the control series did not differ within themselves
in this respect nor with the main series of carcinoma of the
prostate. Therefore all groups were taken together in the
preparation of figure 7, which shows clear evidence of an
increasing rate of lysis associated with increasing age.
It was noted that a greater proportion of patients
in the carcinoma of prostate group had been examined when
PATIENTS WITH Co. of- PROSTATE
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FIG. 12: The relationship of age in .years to the
lysis times (P^q) for the main series of carcinoma
of prostate superimposed on those for the control
series. The mean age for each decade has been
plotted against the mean lysis time together with
two standard errors on either side. The downward
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FIG. 13: The relationship of age in years to the
lysis times (E^q) for all groups, excluding assays
where calcium was used in the buffer. The general
trend is the same as in figure 12.
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calcium "buffer -was in use than had been the case in the
control series. Figure 13 was therefore prepared from all
the results of the main series and the control series,
excluding all assays ■which had been made using calcium buffer.
This figure can be compared to figure 12 visually and also by
statistical assessment. Calcium made no material difference
to the conclusion. Calcium thus seemed to play no
significant part in delaying lysis in these groups of
experiments as measured by the lysis time of the 50 per cent
clot.
It was apparent on statistical examination that the
average P^q level in the carcinoma of prostate group was lower
than that in the control groups, but this was no greater than
would be expected because of the higher average age of the
carcinoma of prostate group. In addition there were 13
out-patients in the main group. All that was left, there¬
fore, was to see if there was an incidence of abnormal lysis
in a small proportion of patients, insufficient to weight the
mean significantly. It urns noted, however, in the statistical
analysis, including observation of scatter diagrams prepared
for all groups, that there was no suggestion of departure from
normality of distribution such as might require examination
of minimum values as well as the means. The scatter diagrams
have not been included, because they do not contribute anything
positive in themselves and the constituent points have already
been recorded in tables XXXII and XXXIII in appendix 2 and
have been incorporated into figure 6 and figure 12.
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OIHiiK KI'IiATED OBSERVATIONS
It was felt that a non-statistical approach should
also be made to the problem of whether carcinoma of prostate
Wis associated with a bleeding tendency attributable to abnormal
fibrinolysis. Possibly one or two isolated cases might form
a group by themselves and in that sense be clinically
significant but yet be too few to affect the statistical
conclusion.
The lysis times of all cases in the main series
falling outside the range of twice the standard errors, shown
in figure 12, were placed together but no obvious clinical
lioraogeneity was noted. Therefore a stricter standard was
applied. Ill lysis times (P^q) from table XXXII and table
XXKIII which are less than an arbitrary figure of 20 hours
have been collected in the following table. These figures
are from the main series and its controls, comprising 206




The nine instances out of the sin
series anfl. the controls vixerc the
50 per cent clot lysis tiae was 20
hours or less









Case 2 83 Carciaoea of
prostate In 4 0.49
Cars 8 75 Carcinocsa of
prostate In 7 0.26
J.B. 71 Carcinoma of
prostate In 19 0.61
W.F. 60 Varicose
Veins In 16 0.43
H.W, 66 Carcinoma of
bronchus In 10 1.06
w.w. 76 Careinoina of
ileu&t In 16 0.54
E«&« 63 Carcinaaft of
prostate Out 8 0.46
J.E. 70 Carcinxa of
prostate Out 14 0.43
E.H. 72 Carcinoma of
prostate Out 20 0.44
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Those patients included in table X, -whether as
in-patients or as out-patients, were several of them ill but
none of them, with the possible exception of case 2, which
will be described on page was obviously bleeding or
bruising on the day of the venepuncture. Thus the patients
■chose Pf-Q lysis times are less than 20 hours do not appear
to form a homogeneous group by showing evidence of a bleeding
tendency, such as would be in contrast to the remaining 198
whose Pp.Q lysis times were longer than 20 hours.
If one examines the in-patient lysis figures, three
cane from the main series of carcinoma of the prostate and
three from the control series. The influence of age on
fibrinolysis was more apparent in the main series, where 37
patients were over 70 years old, as compared to only 27 in
the control series. The two least figures are from patients
who had carcinoma of prostate. No conclusion seems possible
from this approach.
The range of the three out-patient figures is
similar to the range of the out-patient figures which will be
presented in figure 15» There the fast lysis is attributed
to a factor operating in sane patients when and because they
are out-patients. It is assumed, therefore, that the fast
rate of lysis here is related in some way to the fact that
the men were out-patients at the time of the examination.
Finally note was made of all patients whose whole
plasma clot CP-jo(P ^ad lysed by 24 hours. This is in line
with the approach made by Tagnon, VZhitmore and Shiftman (1952).
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Such lysis occurred in three out of the 55 in-patients in
the carcinoina of prostate series. The first was in case 2
(see page 147) where there •was purpura and some haematuria,
the patient being examined because of this; the second
was in case 8 (see page 165) where there was no clinical
evidence of a bleeding tendency; and the third was in a
man aged 58 where the diagnosis was confirmed histologically
and the carcinoma had not obviously metastasised. He
showed no evidence of a bleeding tendency at the time, and
was well clinically two years later. In the control series
there was only one patient where the whole plasma clot lysed
in less than 24 hours. This was in a man aged 71 who had been
readmitted one week before because of pyuria. Prostatectomy
six weeks previously had shown benign prostatic hyperplasia.
There was thus no homogeneity with regard to a
bleeding tendency in this group of four patients where P^qq
was less than 24 hours.
Conclusion: While statistical analysis has shown a
convincing positive effect of age on fibrinolysis affecting
the main series and the controls alike, as discussed in chapter
three, it has failed to show the presence of abnormal
fibrinolysis peculiar to carcinoma of the prostate. There
was no difference between the 68 patients in the carcinoma of
prostate group and 138 patients in the control group.
Statistical analysis has also shown that calcium in the buffer
has not affected the conclusions based on the lysis time of
the 50 per cent clots.
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Using a direct approach, it has not been possible
to show a satisfactory correlation between fast lysis times
and clinical bleeding, either in the main series or in the
control series. The incidence of lysis of whole plasma
clots within the first 24 hours iB approximately 5 per cent
in the main series, when attention is restricted to the 55
who were in-patients. This is presented here in order to
supply a figure which is roughly comparable with, but only
half the size of the figure of 12 per cent given by Tagnon
and his colleagues (1953) in a series of 48 such patients.
If the only two patients (case 1 and case 2) who were examined
because of a bleeding tendency are excluded from the series
at this stage because of bias of selection, the incidence of
such lysis is reduced to two out of 53 in-patients (4 per cent),
which is not materially different. It is felt, on the basis
of evidence which has been presented, that such figures are
arbitrarily derived and are without known clinical importance.
Moreover, the incidence of abnormal fibrinolysis, whether it
has clinical significance or not, is of little interest unless
environmental influences are reduced to a minimum and unless
the influence of age is taken into account when assessing
results.
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CADE HIDTQRIBD WITH II^rVlLtLX, CO,.JEHTARIES
Case history 1
The history and laboratory findings of a certain
patient suffering from carcinoma of the prostate played an
important part in the evolution of this -work. It seems
correct, therefore, that the case history of this patient
should be given some prominence, together with a report of
the laboratory findings. Because the early part of the stoxy
has already been published (Swan, "food and Daniel, 1957) only
a summary will be presented at this stage and this will cover,
in addition, the remainder of the patient's life. Greater
detail of the case, much of it taken from the publication of
Swan, Wood and Daniel, has been included in appendix 1. These
details are of the seme authorship as here, except for the
early clinical case history.
A man E.S. aged 71 was admitted to hospital on 6.3-56.
because of recent haematuria and a history over the previous
six months of backache arid urinary symptoms. A firm diagnosis
of carcinoma of the prostate was made after consideration of
the results of rectal examination, total serum acid phosphatase
of 220 Gutman units per 100 ml. and, ultimately, the histology
of the prostate itself. Before going to the operating theatre
he had appeared as well as might be expected, but during the
couirse of prostatic biopsy (using the perineal approach) and
orchidectorny, the patient began to bleed locally. Very soon
afterwards his blood pressure fell and severe shock developed,
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associated with a generalised bruising and bleeding from all
raw areas. Pears were felt for his survival. In the
laboratory his blood was found to be almost without fibrinogen,
using the method quoted by Scott (1953) of adding thrombin to
oxalated whole blood. Treatment by intravenous fibrino en
was apparently life saving, and the patient recovered
uneventfully thereafter. Investigations on specimens of
blood removed at the time of the shock, and. next day, confirmed
the low fibrinogen level, but failed to show any fibrinolysis
by two methods. Stilboestrol therapy was begun ten days afer
the operation.
In the course of the following three years the
patient was admitted to hospital a further four times. The
reasons for his readmissions were straightforward at first.
He suffered from the formation within the bladder of calculi
and debris. Although he underwent multiple endo-cystoscopies
and one supra-pubic cystoatomy, there was no suspicion of
further hypofibrinogenaemia or of the development of abnormal
fibrinolysis. These were sought each time, lest there should
be a recurrence of trouble. It was noted, however, on the
fourth admission that the fibrinolysis times had become shorter,
using identical techniques, although they were not outside the
apparent normal range.
Not until his fifth and final hospital admission,
about three years after the episode of acute bypofibrinogenaenda,
was there clear evidence of further haematological trouble.
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The cause for admission on this occasion ms severe
haemoptysis and was associated with ready bruising into the
skin. The fibrinogen level was 0.08 g,/100 ml. , which was
greater than that during the acute episode when it had been
less than 0.02 g./l00 ml. The fibrinolysis times had
shortened so much as to be apparently significant, and the
platelet count was clearly below normal on two occasions (see
table XI).
He died shortly afterwards at home and no
autopsy was performed. The clinical story of his death
was suggestive of a massive pulmonary infarction as the
result of an embolus which may have come from the leg. In
comment, it may be said that proof of increasing vascular
thrombosis in the presence of such active plasma fibrinolysis,
as was shown latterly in this patient, would have been of
near fundamental Importance to the understanding of the
significance of fast fibrinolysis in vivo. It is
therefore a source of great regret that this observation
was lost to us because he died at home.
The important laboratory findings on all five
admissions have been summarised in table XI, and the
relationship of demonstrable fibrinolysis to plasma fibrinogen
levels can be seen in figure 14.
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TABLE XI
The time relationship o±' various investigations which
were repeated during five admissions to hospital
(patient E.S. )
Date Plasma ilbrin- Acid Alkaline Urea lib Platelets
fibrin¬ olysis phos¬ phos¬ mg.fi, 100/, = /c.nsn.
ogen time phatase phatase 14.8 g (Lerapert)
g.$ (hours) G.U./ K.A.U./
100 ml. 100 ml.
16.2.56. - 220 30 - - -
HIRST ADMISSION
8.3.56. mm mm 82 24 mm 97 •»
14.3.56. <25 Ho lysis a - - mm - -
15.3.56. 80 No lysis 56 - 72 150,000
19.3.56. 390 Similar to - - 68 -
control 36
20.3.56. - 16 mm 44 - -
27.3.56. - - 12 47 - 64 -
6.4.56. - - 7 52 - - mm
13.8.56. m - 4 14 31 mm -
SECOND ADMISSION
17.10.56 , 380 p50 * 96 - mm 22 108 -
IKIED ADMISSION
26.11.56 , 460 P50° 99 2 mm - -
FOUBT ADf .iSt ION
26. 8. 58. 280 P60 ' 52 7 23 37 90 165,000
3.9.58. 320 >5'
11
ro VjJ mm - mm -
26.1.59. - 46 34 46 m -
FIITH ADMISSION
12.2.59. 80 p50 = 6 30 32 - 72 40,000
17.2.59. 75 p50"= 5 - - - 63 -
#19.2.59. — - - - 64 198,000
21.2.59. 60 mm - - mm 58 -
24.2.59. 80 p50= 8 «■» mm mm 62 mm
26.2.59. — - mm mm 63 107,000
2.3.59. 80 p50= 6 26 58
-
63 *
s method of assay described in appendix 1. if Corticotrophin
injections were begun on 19.2.59. ..
Acid phosphatase has been measured in Gutman units (G.U.) and alkaline
nhosnhatase has been measured in Klnr Armstrong units fKAA .IT- V
FIG-. 14: Patient E.S. The relationship of assays
of fibrinolysis (P^q) an(3- plasma fibrinogen, plotted
against time. Fibrinolysis assays in March, 1956
were made by a different technique from tho^made
subsequently - see text.
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Without venturing at this stage on an explanation
of the events, it would appear that the dramatic first episode
was of intense loss of fibrinogen without fibrinolysis and of
very short duration. The middle two to three year period
was one of urinary troubles vdth normal plasma fibrinogen and
without any abnormal fibrinolysis. The third period was
pre-terminal and was associated with a partial depression of
fibrinogen and severe fibrinolysis and tiiranbocytopenia.
Points arising from this case history are discussed from time
to time in the text.
Case history 2
The case history of another patient is of sufficient
importance to justify inclusion here in some detail. Laboratory
observations have been included.
An S3 year old man F..A.C. was admitted as an emergency
case on 6.3*56. because of acute retention of 'urine with over¬
flow incontinence. There was some haenaturia. He gave a
history of urinary troubles for the previous three months. On
examination the prostate was enlarged and very hard, feeling
like a carcinoma. The blood pressure was 190/120 inm. Hg. and
there was clinical evidence of left ventricular failure.
On the day of admission he threw two fits showing all
the characteristics of epileptic fits, but lacking any preceding
aura. They were followed by amnesia. The fits were attributed
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to cerebral arteriosclerosis, or,less likely, to hypertensive
encephalopathy or a combination of both (and. there was also
a raised blood urea). The intention had been to remove the
prostate surgically in order to relieve urinary obstruction,
but his general condition -was poor, and it ms considered that
he -was temporarily unfit for surgery. He v/as therefore
transferred to a medical unit for treatment of "left sided
heart failure secondary to hypertension and myocardial ischaerrda".
He ms given digoxin and a mercurial diuretic ("mersalyl")
and from 7.5.56. ms given stilboestrol 5 rag. thrice daily.
He had not taken oestrogen therapy before.
Nine days later (15.5.56.) there -was further
haematuria and he developed purpura on the legs and trunk with
some bruising. Mersalyl injections were not stopped and the
purpura subsequently cleared up despite this.
As a result of the fibrinolysis investigation of 26.5.56.
and 6,6.56. the dose of stilboestrol was doubled. A third
assay of fibrinolytic activity on 18.6,56. was apparently normal.
During the latter period the patient's general condition had
Improved slightly, but his complete dependence on a catheter
forced the decision to operate, there being no longer a strong
haematological contraindication. He was returned to a surgical
ward, but on the night before the intended operation he fell
out of bed and died.
Autopsy on 27,6.56. was about 36 hours after death.
There was a long bruise on the chest without an associated fracture.
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Most of the blood in the body was fluid. No solid clots
were seen. Eternal bone ma:* row appeared to be in good
condition. Widespread atheroma of blood vessels was found.
In the brain there was an area of cavitation in the occiput,
the area being rich in stainable iron. This was presumably
the seat of the epileptiform attacks. In the light of the
autopsy findings and after consideration of the histology,
the cause of death was considered to be bilateral pyelonephritis
iri^e patient suffering from adenocarcinoma of the prostate.
The brain lesions were regarded as resulting from old infarcts:
adhesions in the abdomen were attributed to hqpled obliterative
tuberculous peritonitis. There was also left ventricular
hypertrophy. There was no evidence of metastases from the
adenocarcinoma.
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xestimatedbyaturbidornetricmetho(Pod a re,1959)* TheKjeldahlmethodw simpossibletp rformb cau theclotwhichhadapp arednormalitsformation lysedhortlyafterwardsfabe orethinvestigation couldbec npleted.
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Other relevant observations are as follows
1. The sterile whole blood clot of 26.5*56. had almost
disappeared after two hours at 37°C. The whole
blood clot of 6.6.56. behaved similarly.
2a. Sterile plasma of 26.5.56. was kept at 4°C for two
days. It was then diluted 50 times and recalcified.
The clot appeared normal and was left at room
temperature, but had lysed bj the following morning.
When 1 ml. of normal plasma was added to the same
tube, it clotted normally but this clot also had
disappeared by the subsequent day, although kept
only at room temperature.
2b. No thermal range of activity was demonstrated, but
it was noted that the clots formed by the addition
of thrombin to oxalated plasma in serial dilution
1:10 to 1:320 (as part of an emergency method of
estimating the fibrinogen content in the plasma
(Wolf, 1954)) all lysed within six hours at room
temperature.
3. As an independent experiment some plasma obtained on
26.6.56. was diluted 1:100, One part was recalcified
and thb other part was clotted with thrombin, being
kept at roan temperature. The thrombin clot lysed
more than six hours before the calcium clot.
A. Observations on the thromboplastic and fibrinolytic
effect of extracts of this patient's prostate, removed
at autopsy, are made in the appropriate section devoted
to in vitro tests with prostate extracts.
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£vcrgnia-. up the case as a whole, there appear to be certain
points of irrportance.
Abnorrnal fibrinolysis was first suspected on the
1 basis of purpura in a patient diagnosed as suffering from
carcinoma of the prostate. Proof of the connection between
purpura and this pathology cannot be supplied because it was
seen so rarely.
Powerful fibrinolysins were demonstrated in the same
specimen of plaaaa as also contained a normal or increased
amount of fibrinogen. This implies fibrinolysis without
apparent fibrinogenolvsis in vivo.
The fibrinolysin survived well in its own plasma,
both at room temperature and at 4°C for two days, and during
that time did not appear to lyse fibrinogen in the same
specimen. A good clot could subsequently be formed from such
plasma but, being formed, was lysed shortly afterwards, even
at room temperature. Tlius we have fibrinolysis without obvious
fibrinogenoivsis in vitro, and the maintenance of powerful
fibrinolytic activitv at room temperature. This was the
only patient There the Cullen and van hlyke (1920) clot lysed
entirely before the assay, and the observation was therefore
controlled by almost all the remaining fibrinogen assays.
This patient's fibrinolysin was active at room
temperature against the clot from a normal person.
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Considerable diminution of fibrinolysis ami some
clinical improvement coincided -with the doubling of the
stilboestrol dose to 30 rag. a day. It is Impossible to be
certain that improvement in fibrinolysis ms unrelated to
the treatment which he is&s receiving for heart failure.
This is an example of increased, fibrinolysis,
possibly of a pathological type, in a patient suffering from
histologically proven carcinoma of the prostate without
demonstrable metastases.
Case Mstory 3
A 66 year old man F.V. was admitted into a surgical
ward from 5»5«56. until 21.5»56. He was suffering from
chronic ill-health, loss of weight and backache. He was
found to have a hard enlarged prostate, bony destruction of
the bodies of lumbar vertebrae 1,2 and 3, consistent with
metastases, and his serum acid phosphatase level was raised
as shown in table XIII. After a period of grave Illness he
improved dramatically within a day or two of starting
stilboestrol therapy, but survived only eleven months. He
did not die in hospital.
TABLfiXIII
Themoreimportantlab r toryfindings(p tientF.V.)
Date
Plasma fibrin¬ ogen &.%
Fibrinolysis inhours
Acidphos¬ phatase G.U./ 100ml.




















































































4.3.57.Deteriorating.April19 7UD O.P.=out-patientexaminationes imat dbyWolf0954)methon y.
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Points of note:
1. Although bony metastases were apparent when he was
first seen, no abnormal fibrinolysis mas demonstrated
in his plasma.
2. During a period when he was beginning to feel very
much better and appeared to be responding clinically
to stilboestrol, the lysis time did not lengthen.
if anything, it shortened (15.5.56.)
3. Prostatic massage did not shorten the lysis time.
This is discussed in the section devoted to prostatic
massage, later in this chapter.
4. The two out-patient assays of fibrinolysis were very
much faster than earlier ones, and at these times
the patient was feeling very well. Although the
amission of night observations made the P^q readings
unsatisfactory on 2.7.56. and 16.7.56. (the lysis
time was presumably considerably less than 17 hours),
the whole plasma clot lysis by 17 hours was never¬
theless significantly fast.
5. This patient's plasma was used for* a laboratory experiment




A 64 year old man T.L. ms referred to hospital
because of pain in the anterior urethra, felt on micturition,
and a pain in the left lumbar region, relieved by micturition.
The prostate was big and hard.
1st admission: 21.9*56. - 27.9.56. Cystoscope was passed
with difficulty through an obviously malignant prostate.
The bladder was dirty and intramural extension of malignant
growth from the prostate was considered possible. He was
given stilboestrol 90 rag. a day.
2nd admission: 20.11,56. - 23.11.56. Cystoscopy. Bladder
mucosa cleaner.
3rd admission; 30.1.58. - 5.2.58. General and local
deterioration. Buttocks feeling frozen. Bilateral
orchidectoray performed* This operation was followed by
symptomatic improvement for a while. Less pain*
Appetite better.
4th admission: 10.7,58. Acute retention of urine for 24
hours. He developed minor fits. Increasing urinary
failure until he died four days later.
Autopsy: Carcinoma of prostate with secondaries in bladder,
lymph nodes and liver (none in lumbar vertebral bodies).
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Points of note:
1. Considerable increare of - fibrinolysis was found.
15 minutes after surgery (bilateral orchidectocy
tinder general anaesthesia). The fibrinogen level
remained constant.
2. Ho convincing evidence of any speeding up of
fibrinolysis during the last two years of the
patient's life.
Case history 5
A 69 year old man F.P. had been diagnosed in 1953
as suffering from carcinoma of the prostate. This had been
discovered almost incidentally in the course of follow-up of
bladder papillomatosis by which he had been troubled
intermittently since 19h3« a biopsy of the prostate was
reported as showing a spheroidal cell adenocareinoria. lie
was then treated with stilboestrol for two years. Just
before this admission he lost control over micturition. He
was admitted to hospital on 28.7.57. with a view to relief of
urinary obstruction. Orchidectony arid trans-urethral
resection of the prostate were performed. Stilboestrol was
I
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resumed after having been stepped for over a year. X-ray
of lungs, skull, pelvis and spine showed no evidence of
metastases. Despite treatment his general condition
deteriorated. He died uraemic, in hospital on 8.2.58.
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Fibrinolysis inhours
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1. Active fibrinolysis of the immediate post-operative
period -mas demonstrated.
2. There was no clear-cut evidence of the effect of
bilateral orchidectomy on fibrinolysis.
3. The plasma fibrinogen level increased as the illness
progressed.
Case history 6
An 81 year old man W.C. was admitted to hospital on
28.8.58. because of acute retention of urine over the previous
four days. He had suffered irom urinary trouble ten years
previously, for which prostatectomy had been performed. It
was not possible to find out the nature of the tissue removed
but it was presumed to have been benign. On this occasion
malignancy was not suspected until the operation of trans¬
vesical excision of the left lobe of the prostate and resection
of the bladder neck, when a craggy mass was found with
apparent infiltration at the site of the former resection.
The first specimen for fibrinolysis assay ms taken in the
post-operative period, about four hours after the patient
returned from theatre and before any stilboestrol had been
given. Ho evidence of metastases was found at any time.
- 1'62 m
TABLE XVI























11. 9.58. O.58 46 48 Clot - 56
Stilboestrol 10 mg. daily from 13.9.58.
10 mg. thrice daily from 23.9.58.
25. 9.58. 0.64 23 23 Lysed 15 -
10.10.58. «■» 23 22 Lysed - -
11.10.58. 0.44 22 22 Lysed m -
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Points of note:
1. There was no obvious increase of fibrinolysis
four hours after operative surgery.
2. Three subsequent assays of fibrinolysis over a span
of 17 days are consistent within themselves. It
is unusual to find the whole blood clot lysed by
24 hours and this is often accepted as clear evidence
of increased fibrinolysis, but in the light of work
presented here the advanced age of the patient
should be taken into consideration.
Case history 7
A 68 year old man W.J. was admitted to an orthopaedic
ward on 25.6.59. coraplaining of severe pain in the back but
no urinary symptoms. He gave a history of feeling an ache
around the shoulders starting about five months previously*
By the time of his admission the symptoms were consistent with
the radiological appearance of rarefaction of the first and
second lumbar vertebrae with a probable compression fracture
of the latter and a possible secondary deposit in the third and
fourth cervical vertebrae. The diagnosis of carcinoma of the
prostate was made on rectal examination and on the strength of
an unusually high serum acid phosphatase level. He was
treated by traction and with stilboestrol. His pain was noi
relieved easily and morphine was necessary at first. ken last























7. 7.59. 0.48 47 56 860 24
Stilboestrol 5 mg. tbi.ce daily (from 8.7.59.)
14. 7.59. 0.77 71 30 - «•»
21. 7.59. - 79 55
Stilboestrol 5 ®g. daily
24. 8.59.
(O.P.) 0.46 31 23 35 84
2.11.59.
(O.P.) - - «•» 18 66
1.12.59.
(O.P.) 0.41 45 23 11 8
11. 4.60. - 2 /
O.P. = out-patient examination
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Points of note;
1. There seems to be no apparent relationship here
between very high serum acid phosphatase levels and
fibrinolysis. The observation on 7.7.59. that the
■whole plasma clot lysed before the 50 per cent clot
is not unique and need bear no relationship to this.
2. Both fibrinolysis assays which were made when the
patient was an out-patient are faster than those made
as an in-patient. The significance of this is
discussed elsewhere.
Case history S
A 73 year old man J.D. was referred to the ear, nose
and throat department where he was admitted on 28.11.57.
Two days previously he had developed sudden dysphagia. Until
that time he had swallowed quite normally, but suddenly found
that he could take neither solids nor adequate fluids, although
he managed to swallow very small amounts of liquid and to
suck losenges. His previous history included the operation
of excision of the bladder trigone and wedge resection of the
left lobe of the prostate on 17.1.57. Histological examination
of the prostate showed on extensive poorly differentiated
amall alveolar-cell carcinoma. Metastases were not recognised.
He had taken stilboestrol tablets to a total daily dose of
20 rag. until the onset of the dysphagia.
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The pharynx and larynx were examined clinically
but nothing was seen to account for acute dysphagia. The
pharynx was red and oedematous. A barium swallow showed
no abnormality about a week after the onset, by -which time
his swallowing was improving. Cervical osteophytes were
seen which "could account for the syrnptoms". The first
and only fibrinolysis assay was made on the day of his
discliarge from hospital, although he was still in bed at
the time the specimen was removed. The assay showed
unusually fast lysis, all clots, including the whole blood
clot, having lysed by eight hours. The patient was not
seen again and is believed to have died within the
subsequent three months.
Comment; Couplete lysis by eight hours was one of the
fastest rates of lysis demonstrated in any patient. It is
put forward as a suggestion that the patient had bled into
his paraoesqphageal tissues, and so had developed dysphagia,
but no proof for this can be offered. The fact that the
patient was due to go home that day could have caused
excitement in the patient and thus led to a falsely fast
rate of lysis, although it is recalled that the man showed
no outward evidence of excitement at the prospect of going
home.
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The remaining 60 case histories have not been
presented individually here because of the sameness of their
story and because of the lack of Individual distinction about
most of the results obtained from them. The clot lysis
times of all patients, together vdth the corresponding
plasma fibrinogen level, have been listed -in table XXXIII
in appendix 2. An indication has also been given there of
cases •where the diagnosis was proved histologically, and
those where the diagnosis was beyond reasonable doubt, as
already described. Although no further formal case
histories will be presented, relevant information concerning
the clinical "course of certain patients will be supplied in
appropriate sections.
The remainder of this chapter will be devoted
to observations made on the data with a view to clarifying
uncertainties surrounding the influence of metastatic spread,
oestrogen therapy and bilateral orchi&ectomy on fibrinolysis
associated with carcinoma of the prostate. The effect on
fibrinolysis of massage of a prostate known to be the seat
of malignant disease will also be described. -In addition
to supplying observations on two physical properties of an
actively fibrinolytic plasma, laboratory experiments have
been carried out into the thrombqplastic and fibrinolytic
properties of prostatic tissue. These will be presented.
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THE PART PJAYEP BY I^TASIASEfc IK DIffERMMDC THE Rffl
OF FLAfl'E FBKIIDLYdld.
Metastases were recognised in 22 out of the 68 cases
of carcinoma of the prostate (see table XXXIII in appendix 2).
16 of these were in-patients at the time of the examination.
When the P^ lysis times of the in-patients were cosnpared to '
the mean for the appropriate age in the carcinoma of prostate
group j as is shown in figure 12, the points all fell equally
round the mean. Only one of them (P^ = 19) was clearly
less than twice the standard error below the mean. This
patient, J.B., a man of 71 years, was in considerable
discomfort at the time of the examination, due, it was
believed, to secondary osteoplastic deposits which were
present in the upper lumbar spine, with possible nerve root
involvement. The diagnosis of carcinoma of the prostate was
made on clinical, and radiological grounds, without histological
evidence. 'There was no evidence of a bleeding tendency at
any stage of his illness. This patient thus showed no
unusually distinctive qualities such as would put him in a
class apart from the others, except by virtue of a slightly
faster rate of fibrinolysis.
It is considered of great interest in this context
that unusually vigorous lysis which was demonstrated, on two
occasions on the plasma from EJUS. (case 2) was found in a
patient ,on whom subsequent'autopsy showed no metastases.
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Cosxaent: Patients known to have metastases from prostatic
carcinoma do not appear to be any more likely to demonstrate
unusually fast rates of plasma lysis than the .group as a
whole,
THE PhhlJEHCB OP OESTROGEN OK gJEFJHOLITIC ACTIVITY.
Ten patients who had prostatic carcinoma were
examined before receiving stilboestrol therapy and again
while receiving stilboestrol. Three of these ten patients
were examined only once in the ward and once in the out¬
patient department. As a result of the uncertain validity
of comparisons made between in-patient and out-patient
figures (this will be discussed later), these three patients
have not been included in the following table. Those who
remain were in-patients at the time of both examinations.
If multiple examinations were made, the last before
stilboestrol therapy and the first during such therapy were
selected. The dosage employed varied from 10 - 90 mg. a
day, most commonly 15 or $0 mg. in divided doses. Table














































Comment: There is probably no Important significance in
these figures unless to cast great doubt on the ability of
oestrogen to diminish fibrinolysis as assayed in these
patients. It is possible to cite the example of E.A.S.
(case 2), who was already receiving stilboestrol and therefore
is not included in this table, as one where the patient
improved clinically when the stilboestrol dose was doubled
to 30 nig. daily and wliose lysis rate diminished simultaneously.
It is equally possible to cite the case of P.V. above, to
support the opposite point of view. This patient suffered
from metastatic carcinoma of the prostate with destruction of
vertebrae and had a brick hard enlargement of the prostate
with a raised serum acid phosphatase level. lie Improved
"dramatically" on stilboestrol therapy, but his plasma
fibrinolytic activity four days after starting oestrogen
therapy, when he was already feeling much better was, if
anything, greater than it had been before.
Clearly there is still a place for studying the
influence of oestrogen on "pathological" fibrinolysis in
carcinoma of the prostate, assuming that such exists as an
independent entity. Except for a rare case, however, it is
difficult to know .Just what constitutes pathological fibrinolysis
specifically associated with carcinoma of the prostate. . E.A.S.
(case 2 ) is the best example in this series of apparently
pathological fibrinolysis, but his advanced age of 83 is just
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the age when fibrinolysis appeared most active in the control
series. Too few assays were made before the patient died to
allow one to be certain of even this one case as a reliable
example.
The possibility that oestrogen may increase the
rate of lysis in certain patients should be borne in mind as
a result of table XVIII where the lytic activity appears a
little more pronounced in five out of seven patients after
starting oestrogen therapy. Patients suffering from
carcinoma of the prostate are not appropriate for studying
the influence of oestrogen on physiological fibrinolysis
because of the undesirable number of variables and uaiknowns
which are present.
THE EFEECT OH PIERIHOIJffilS OF QBCHIDECTQMI FOR
PROSTATIC GABdKQMA.
Two patients suffering from carcinoma of the prostate
were deemed to require bilateral orchidectony• Plasma was




Fibrinolysis before and after orchidectany.
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++ no lysis by 240 hours
The rate of fibrinolysis was not obviously abnormal
in either of these patients before orchi&ectorry, and there-
is nothing in the post-operative rates of lysis to suggest
an important change in than at the times of the examinations.
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PROSTATIC MASSfi.CE
Effect on plasma fibrinolysis apd flbyinogep
Shortly after a patient (case 1) had almost died
as a result of hypofibrliiogenaemla in the course of prostatic
biopsy, it -was felt that the precipitating cause could have
been the release of tissue substance frcm the cancerous
prostate. It as therefore decided to massage the prostate
of patient F.V. (case J>\ who was known to be suffering from
carcinoma of the prostate, and watch the effect. The risk
involved was thought to be small because of the close
observation being made. The prostate was massaged for five
minutes. At the end of a further twenty five minutes a blood
sample was taken and a ten-tube fibrinolysis test set up.
The results of this test were compared with an identical test
which had been set 15) Immediately before the massage began.
The lysis time of the 50 per cent plasma clot (P^q) was 47
hours as measured before massage and 46 hours as measured after
massage (table XIII).
Comment: Prostatic massage had no effect on plasma
fibrinolysis as assayed in this patient.
With reference to patient E.S. (case 1) who developed
a fulminating hypofibrinogenaeicia during a prostatic biopsy,
which probably involved some prostatic massage, it should be
noted that abnormal fibrinolysis was not demonstrated in him,
either at the time or for two years subsequently.
Effect on serum acid phosphatase
Seven out of 68 patients diagnosed as having a
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carcinoma of the prostate showed acid phosphatase levels
very slightly higher than four Gutman units per 100 ml.,
■which is the upper limit of normal for the laboratory
concerned. There is no finality about four units being
the exact limit, and indeed slightly higher figures are
commonly accepted as being of very doubtful significance
if not actually normal. These seven patients are listed in
table XX below and comprise all those who had levels between
four end ten Gutman units per 100 ml., provided that this
•was not a recession from a higher level. An indication of
the timing of the specimen is also given.
TABLE XX
The timing of specimens where the





C.W. 7.0 At outpatient visit (rectal
examination made)
J.M. 6.0 Third day after admission
E.T. 4.5 Day of cystoscopy
c.c. 4.6 No comment
D.P. 8.0 Day of cystoscopy
H.R. 4.9 First day seen (rectal examinat¬
ion made)
G.W. 6.0 Day after admission (? rectal
examination)
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No conclusion is possible from these figures and
the comments made -with them. The case records do not supply
the time of day when the specimens were taken nor the time of
all the clinical examinations, so it is impossible to relate
the two retrospectively. It is suggestive, however, on
circumstantial evidence, that in several of them some form
of prostatic massage, either digitally or by cystoscqpe, ma
given before the blood sample was taken for acid phosphatase
estimation.
This evidence, such as it is, may be relevant in
the light of the observations of Daniel and van Zyl (195*0
who found a rise of serum acid phosphatase level following
palpation of the prostate in three out of 24 patients with
benign prostatic hypertrophy.
More relevant to the work of Daniel and van Zyl
is the acid phosphatase level on a patient W.N. who was
feared to be suffering from carcinoma of the prostate when
first admitted to hospital. The prostate was a little
enlarged. There was slight difficulty with micturition,
and diarrhoea. He was found to have a serum acid
phosphatase level of six Gutman units per 100 ml. This
specimen was known to have been taken almost immediately after
rectal examination. His symptoms were subsequently shown to
be due to an intestinal carcinoma and not to a carcinoma of
the prostate. Later estimations of acid phosphatase were
all less than four Gutman units per 100 ml.
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Comment: Although prostatic isassage is known
to increase the output into the serum of ecid phosphatases
this is not peculiar to patients suffering iron carcinoma of
the prostate, and can occur in cases of benign hyperplasia
of the prostate as in the case cited here.
TIVO HIYflCfh PROPHRTIKL gOB&EigJD BY AN ACTIVELY
xTBiVIIIOLYTIC PLASMA.
1* Survival of fibrinolvsin in the cold.
Plasma was withdrawn from a patient (case 3) with
a known diagnosis of carcinoma of the prostate, and whose
lysis time was fast C^qq = on the occasion of an
out-patient examination. A ten-tube dilution test for
fibrinolysis was set up at the time, the remainder of the
specimen being oxalated (Heller and Paul (1933-34-) mixture),
and then stored for 19 hours at 4°C. At the end of this
time a second ten-tube fibrinolysis test was set up, using
thrombin as clotting agent. The fresh-specimen clots were
all lysed by 17 hours. The stored-specimen clots had none
of them begun to lyse by six hours but had all lysed by 22
hours. (This served as a control for the adsorption
experiment described below,) While the two figures are not
directly comparable, they are both fast, and there cannot be
an important difference between the lysis times of the fresh
and the stored specimen.
The survival in the cold of the fibrinolysin from
case 2 has already been described.
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2. Adsorption of fibrinolvsln.
Four drops of prepared aluminium hydroxide (Biggs
and Macfarlane, 1957a) were added to 4 ml. of the stored
specimen of plasma described above. This was incubated at
37°C for 5 minutes and the adsorbed plasma separated off,
after centrifuging for 5 minutes at 3»0°0 r.p.m. The
adsorptive power of the alumina was controlled by the Quick
one-stage "prothrombin" time which was prolonged on the
specimen to nearly 4 minutes. A ten-tube fibrinolysis test
was then set up on the adsorbed specimen. All tubes lysed
between 6 and 22 hours, and in this respect did not differ
at all from the unadsorbed plasma.
Comment: The active fibrinolysin in this plasma did not
obviously lose its potency after storage for 19 hours at 4°C.
The fibrinolysin was not adsorbed by aluminium hydroxide in
a controlled experiment.
LABORATORY EXimEMENTb OK PROSTATIC TI:. ,.UB
Thrornbqplastic activity of tissue extracts
Benign hypertrophy of the prostate (preparation 1.
acetone-extracted)
A prostate which was shown histologically to be
the seat of benign hypertrophy was removed at operation. It
was washed in saline and blood vessels and membrane removed
so far as this was possible with such a tough material. The
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remainder was chopped finely and ground with acetone in
several changes, according to the method advocated "by Biggs
and Macfarlane (1957b) for the preparation of human brain
•» ' -f
"thromboplastin". The residual particles were dried overnight
in a dessicator. Finally, 0.5 g. of this preparation was
added to 10 ml. saline. This was placed in a water-bath
at 37°0 for 15 minutes with inversion at intervals. The
murky supernatant was then used as a potential source of
thromboplastin, being run in parallel with human brain
thromboplastin as a component of Quick's one-stage "pro¬
thrombin" time. The following are the results on plasma
from two healthy people and from five patients on anti¬
coagulant therapy with phenindione. Results were made in
duplicate and the averages are presented in table XXI.
TABLE XXI
A caparison of thrombqplastic activity in
acetone-extracted prostate (benign hypertrophy)
with brain similarly treated.
bource of plasma Brain suspension Prostatic suspension
Normal 1 13 196








Comment: There appears to be practically no tlirombqplastic
activity in this prostate, -which -was the seat of benign
hyperplasia, after acetone extraction.
Benign hypertrophy ox the prostate (preparation 2.
buffer-extractedJ
A prostate which was removed at operation from
another patient, aged 81, because of benign hypertrophy, was
taken immediately to the laboratory. The tissue was washed
in saline to remove obvious blood and was then cut -with
scissors and a scalpel into as fine particles as possible.
The small bits were dropped into a mortar with about 8 ml.
of veronal buffer at pH 7.4. The fibrous particles were
ground as much as was possible, for the remainder of half
an hour. The whole was then sieved, crudely and the liquid
part used for the following three experiments.
(a) The technique as for Quick's one-stage "prothrombin"
time was performed using prostatic extract as the source
of thromboplastin, and this was compared with the
activity of brain tliromboplastin. The effect of
storing the prostatic extract at 4°C was noted.
The results were made in triplicate and the means
are presented in table XXII.
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TABLE XXII
A comparison of the thromboplastic activity in






















plasma 14 17.5 19 18 26 99.5
Normal
plasma x 16 15 * - 91
unit « seconds
x plasma incubated for 30 minutes before the test
with (a) brain or' (b) prostate extract or (c) saline.
(b) The heat stability of the thromboplastin activity of the
same preparation of prostate extract is shown in table
XXIII. The figures which have been presented are
the means of results in triplicate and represent the
clotting times of equal volumes of normal plaama,
brain or prostate extract and calcium solution.
TABLE XXIII
The effect of heat on the thromboplastic
activity of prostate extract.
Without heating After 56°C for
10 minutes
Brain suspension 14 21
Prostate suspension 16 22
unit ® seconds
(c) The same prostatic extract was filtered through IVhatman
filter paper No. 1, the filtrate am the residuum then
being examined separately for throrobqplastic activity,
as already described above. The means of results in
triplicate have been recorded in table XXIV.
TABLE XXIV
The different tliramboplastic activities of














plasma 14 16 19.5 16
unit = seconds
Comment: In contrast to the results of acetone extraction
(table XXI), there appears to be considerable throrabqplastic
activity in the prostatic tissue which was prepared by veronal
buffer extraction from a prostate which was the seat of benign
hyperplasia. This activity is quite comparable in potency
with that of brain thromboplastin (table XXII). Its
activity diminished gradually with storage as a suspension
over several days at 4°C. The activity seemed to reside
chiefly in the particles (table XXIV). The preparation was
slightly sensitive to heat at 5>6°C in exactly the same degree
as the brain thromboplastin tested (table XXIII).
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Carcinoma of the prostate (preparation 3.
buffer-extracted)
At autopsy, about 12 grans of believed carcinoma
tissue was selected and taken from the prostate of EJUS, (case
The autopsy was made % hours after death. The diagnosis of
carcinoma was confirmed by histological examination. This
tissue was cut up and ground in 15-20 ml, veronal buffer at
pH 7.4* borne of the resultant fluid was filtered through
¥7hatman No. 1 filter paper and the remainder was pipetted off
for use.
The thrcmboplastic activity of the preparation was
assessed by Quick's one-stage "prothrombin" time. The means
of results in triplicate are presented in table XXV.
TABLE XXV
A comparison of the thromboplastic activity of
buffer-extracted prostate (malignant) with brain,





On day of preparation 14 18
5 days later (stored
at A C) 14 * 26
unit « seconds
* the brain suspension was
freshly prepared
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Carcinoma of the prostate (preparation 4.
bm'fer-extracted)
At autopsy on a patient K.G. three days after
death, that part of the prostatic tissue which looked malignant
■was cut out and treated similarly to the previous specimen
(preparation 3) above. The diagnosis of carcinoma of the
prostate was confirmed histologically. Only 8 ml. of
buffer was used to prepare the extract. The resultant
fluid was almost opaque even sifter centrxfuging at 3»000
r.p.m. for 15 minutes. The supernatant fluid was used for
the experiment.
The thromboplastin activity of the preparation
was assessed by Quick's one-stage "prothrombin" time, When
the prostatic extract was substituted for brain suspension
(the control time for wlich was 14 seconds), the mean time
was 28 seconds.
Comment: These experiments using malignant prostatic tissue
from two different patients show definite evidence of their
possessing thromboplastin activity. Their weaker activities
compared to brain should be noted in the context of the time
after death when the extracts were prepared. When
preparing brain thromboplastin, it is customary to insist
on as fresh tissue as possible, in order to make an efficient
preparation.
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librinolytic activity of tissue extracts
Benign. hypertrophy ox' the prostate (using
preparation 2)
The same prostatic extract ■which had shown potent
tliromboplastic activity was mixed with normal plasma of
diminishing concentrations in veronal buffer at pH 7.4,
before clotting with thrombin. A range of ten dilutions
of plasma was made, only the two extremes of which are recorded
in table 3QCVI below.
TABLE XXVI
The fibrinolytic activity of
(non-malignant) prostate extract.
Normal
plasma 1.0 0.1 1.0 0.1
Prostate
extract 0.4 0.4 - -
Buffer
pK 7.4 - 0.9 0.4 1.3
Thrombin
50 units/ml. 0.1 0.1 0.1 0.1





The experiment was repeated after storage of the
prostate extract for four days at 4°C. The whole plasma
clot again lysed within 24 hours, the control clot remaining
intact. The 10 per cent clot was only partially lysed.
«• 136 "•
Comment: This tissue extract, from a prostate which -was the
seat of 'benign hyperplasia, was actively fibrinolytic and
remained so after storage in the cold for four days.
Carcinoma of the prostate (preparations 3 and 4)
Experiments identical in method to the one just
described were performed using preparation 3 and preparation
4 from prostates which were the seat of carcinoma. The
results have been incorporated into table XXVII.
TABLE XXVII
The fibrinolytic activities of extracts
of two carcinomtous prostates
Normal
plasma 1.0 0.1 1.0 0.1
Prostate
extract 0.4 0.4 •
Buffer
pH 7.4 0.9 0.4 1.3
Thrombin
50 units/ml. 0.1 0.1 0.1 0.1
At 2 hours
Preparation 3 Clot Clot Clot Clot
Preparation 4 Clot Lysed Clot Clot
At 24 hours
Preparation 3 Lysed Lysed Clot Clot
Preparation 4 lysed lysed Clot Clot
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Comment 8 The carcinomatous prostatic tissue from both
these autopsies appears to have had strong fibrinolytic
activity. It is not possible to exclude the possibility
of contamination with organisms, but bacterial growth is
unlikely to be responsible for the lysis which took place
within the first two hours (preparation 4).
Summing up; The importance of these laboratory observations
on tissue extracts from benign hyperplasia of the prostate
and from carcinoma of the prostate is the apparent identity
of their behaviour in these particular experiments. Bach
extract showed both throoiboplastic and fibrinolytic activity.
CHAPTER FIVE
FOLLOW-UP STUDIES
Follow-up of plasma fibrinolysis





Certcdn. difficulties presented themselves in
following patients suffering from carcinoma of the prostate
when the follow-up was for purposes of research only. Almost
all the patients were elderly, some of them over eighty years
old, and even a visit to hospital by ambulance was a
formidable undertaking. One such patient was so sick in
the ambulance that he refused ever again to attend his proper
surgical advisers at the hospital. In order to minimise
such trouble, follow-up visits were not maintained at regular
Intervals. It was decided instead to note the effect of
time on repeated assays made on patients already in the ward
or attending the out-patient department in any case. A few
patients were asked to attend for the purpose.
It was found that 20 patients had been re-examined
after intervals of two weeks to three and a half years, and
a comparison has been made of the figures obtained. One
grouping of these figures shows a significant trend, and such
other information as has been gathered wd.ll be presented in
relation to this.
It was decided in addition to study survival in its
relationship to fibrinolysis, % of the 68 patients having
died by the time the series was completed. Of the other 3k
patients, several were untraced and may have died.
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i
TIE .fldkCI Off IAIHG AN Ogi'4:Ah'IEIA'
The first grouping suggested itself in the
analysis from observation of the figures in relation to the
clinical data. All patients who were ever e:csrdned as
in-patients and subsequently as out-patients have been
included in this group, without exception. r,here are seven
such patients. They do not, of course, represent a cross
section of all patients in the main series, because only the
relatively fit were able to attend. However, no stock
was taken of their previous fibrinolytic activity in
determining their later attendance. In three of the
patients the carcinoma appeared to have metastasised.
Results: Figure 15 shows the findings on these seven
patients. The left half of the figure represents whole
plasma clot lysis and the right half the 50 per cent clot lysis.
These are two dilutions taken from the ten dilution assay and
are shown together to demonstrate that the same trend is
apparent in each. Each half of the figure therefore
contains one line from the same experiment. The left hand
point on each line represents an in-patient lysis time and
the right hand point the follow-up lysis time on the same
man as an out-patient. 'Where such a patient had more than
the minimum two investigations required by this group, either
in the wards or as an out-patient, the adjacent in-patient and
out-patient examinations respectively have invariably been
selected without prior regard to the time interval between them.
The horizontal line represents time but has no scale, the time
intervals varying from two weeks to 41 months, with a mean of

























FIG. 15: The plasma lysis times of seven patients,
first as in-patients and then as out-patients. The
vertical scale represents the lysis time in hours.
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It can be seen that the lysis time in all cases
■was shorter at the fallow-up than it had been when last
examined, in the ward.
Discussion: The shortening of the lysis times at follow-
up, after intervals of as little as two weeks and as long
as 41 months, is obvious and uniform in the group. In
explanation of this, the first suspicion should probably
fall on the environmental state of the patient and upon the
difference between resting in the ward and sitting in the
out-patient department after a journey. On the other hand
there are important alternative explanations which are related
to the underlying pathology. Indeed, it was our interest
in the possible increasing influence of carcinoma of the
prostate upon fibrinolysis which prompted the follow-up
examination in most cases. It is necessary, therefore, to
discuss some of the alternative suggestions which would explain
an increase of fibrinolysis -with the passage of time.
THE EEEBCT 0*' ADVAM'H'jS YKAKB
The increase of lysis with advancing years on follow-
up figures can certainly be discounted as an explanation of
the trend shown in figure 1fj, where lysis has speeded tip in
periods as sitort as two weeks. A study of the composite
line in figure 7 (see chapter 3) shows that the increase in




THE EFFECT OF ADVMCDCr DISEASE
This requires serious consideration. Tagnon,
Whitmore, Schulman and Kravitz (1953) related abnormal
fibrinolysis in such patients to the metastases and thus
to the total amount of carcinomatous tissue in the body,
all of -which was capable of releasing the lytic agent.
Thus a growing carcinoma releasing lysin could be expected
to be associated with a progressive shortening of the lysis
time. Even so, one would still not expect to find,
deterioration in patients very recently discharged from
hospital and feeling much fitter than before. Moreover,
the normal, distribution of lysis times from patients where
the carcinoma had metastasised has already been discussed
in chapter four.
If an increase in the rate of fibrinolysis can be
explained by an advance of the underlying carcinoma, the .same
increase should also be demonstrable in patients examined
first as out-patients and subsequently as in-patients: in
patients having multiple examinations as in-patients: and
in patients having multiple examinations as out-patients.
Table XXVIH below shows the effect of the passage
of time on the three patients in the series who were admitted
to hospital after an out-patient fibrinolysis assay.
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TABLE SVni

















S.H. 22: k : u 48: a : x 2 **»
A.M. 68: 35: 25 77: 80: 69 4 -
D.P. 65: 47: 41 46: 26: 22 5 +
(lysis times in hours)
« observations at different time intervals make
carparisons impossible. All lysed quickly.
It would appear that two of the three patients lysed
more slowly after admission to hospital and one more rapidly.
The second table in this group, table XXEX, shows
the effect of time on the eight patients who had more than one
fibrinolysis assay when in hospital. Assays made at intervals
of less than two weeks have been excluded, this being the
minimum time involved in figure 15» Where more than two
in-patient assays were made, the first and the last only have
been accepted for inclusion here.
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TABLE XXIX
Differences between Lysis times of




















P.A. 96 s 59: 48 ++J ++: 77 4
c.c. ++: 98: ++ ++: ++: ++ 10
+
W.J. 47: 56: 28 45: 23: 10 5 +
T.L. 70: 35: 22 71: 55: 25 16 -
FJP. 50: 50: 25 50* 20* 7* 1 +
E.A.& 8: 4: 3 46: 29: 22
3
4
E.S. ++: 96: 48 6: 6: 4 28 +
w.c. 46: 48: 57 22: 22: 22 1 +.
(lysis times in hours)
* the patient died within 48 hours. The figures
obtained one week earlier were ^qq*4' : P5Q "*! P10^
++ no lysis by 240 hours
It would appear from the table that approximately
equal numbers showed an increased lysis time as showed a
diminished time. There does not appear to be any uniform
shortening of the fibrinolysis time during stay in hospital.
The third table in this group, table XXX, concerns the
three patients of the series who had more than one fibrinolysis
assay performed as out-patients.
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TABLE XXZ
Di ferences between lysis times of



















G.T. 72; 55: 144 972: 96 14 ?-
W.J. 51: 18; 7 54: 23: 10 5 -
F.V. 17: 17: 17 16; 16: 16
V " ' '
(lysis times in hours)
There is no evidence to suggest that there is uniform
increase of lysis in patients examined at intervals in the
out-patient department
Although the numbers of cases are small in these three
tables, the evidence is definitely against a uniform group
increase of lysis related to the passage of time, such as
could be related to increase of the carcinoma. The evidence
to be supplied shortly on the relationship of fibrinolysis to
the timing of the specimen before the death of the patient also
supports the claim that there is no uniform increase of lysis
with the passage of time.
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THE EFFECT? OF SPECIFIC THERAPY
Although it has been claimed that stilboestrol
is capable of diminishing fibrinolysis when given to patients
suffering from hormone sensitive carcinoma of the prostate
(Tagnon, Schulrnan, Whitmore and Leone, 1953) - and this
appears to have been demonstrated here in case 2, which has
been described in greater detail ~ it remains possible that
in other patients a reverse effect upon fibrinolysis may
result. However, in two patients of the group of seven in
figure 15 stilboestrol therapy had already been started
before the first assay, and in one no stilboestrol was ever
given. In the four others, stilboestrol therapy was begun
between the two examinations. Btilboestrol would not,
therefore, appear to be responsible for the increase of
lysis which was shown in all the patients. Further
observations on the effect of oestrogens on fibrinolysis
have already been made in chapter four.
■I'TBLDIOLYBIh IN hllATION TO AUWIVAL IN CjulCIKOhA
OP THE FHOfcTATE
Figure 16 has been prepared so as to examine the
relationship of fibrinolysis to approaching death. The
first fibrinolysis assay made on each of 3° patients who
had been examined within the last two years of life has been
plotted in relation to the time in months before death.
These points are shown in the figure.
X
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FIG. 16: Scatter diagram showing the relationship
of the lysis times of clots prepared from 50 per
cent plasma to the time before death. The circles




Analysis of these points has failed to show any
significant trend towards increased or diminished lysis as
death is approached. i Scaiming analysis of the scatter
diagram is unconvincing and can show different trends according
to the inclination of the viewer. More points might have
shown a trend one way or the other hut there is enough
evidence here to show that there is no clear change towards
the end of the lives of these patients, despite a high
proportion having died of causes attributed to their carcinoma.
DISCUSSION OF THE EVIDENCE OBTAINED AT IDII0\7-tIP
The evidence which can be analysed from the follow-up
investigations has drawn attention to the frequency with which
out-patient fibrinolytic activity is greater than it was
previously as an in-patient. This cannot be explained
solely on the basis of increasing age, increasing disease or
oestrogen therapy. Nor can it easily be related to the
imponderables of the last few months of life, even when many
of those who died were believed to do so because of the
carcinoma.
There is no new discovery about fibriiiolysis
increasing after exercise, or in relation to emotion, but
previous work on these points had not proved that out-patient
work must necessarily be avoided. The patients in this series
came almost without exception by ambulance, and none of them
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■walked more than a few steps before the venepuncture. Fearnley,
Chakrabarti and Vincent (i960) stated that "diurnal variability,
the knovm effects of exercise, and the possible effects of
meals" had made than confine their study to in-patients.
With this approach we would now agree.
Within the limitations of the small numbers involved,
the evidence is uncertain so far as oestrogens are concerned.
Table XVIII shows more patients whose lysis times became faster
on oestrogen than became slower. The method as used here is
not definitive enough to make a fine assessment of the effect
of oestrogens on fibrinolysis and it requires an independent
study to assess the part played by oestrogens in physiological
3tates. This is a relevant problem. Current research often
associates fibrinolysis with vascular thromboses, and nyocardial
infarction is much less common in women than in men.





ANALYSIS. OP FIBRIKOGBN LEVELS
Fibrinogen estimations were carried out on all
speoimens of blood removed for fibrinolysis assay. Such
estimations were related to the main problem of fibrinolysis
but were secondary to it. The plasma fibrinogen levels
have been arranged by age and grouped in table XXXI. The
figures have been taken from table XXXII and table XXXIII
in appendix 2.
TABLE XXXI
Comparison of the mean fibrinogen levels
as found in each decade in the main series










Carcinoma of prostate Benign prostatic
hyperplasia
50-59 7 0.46 2 0.46
60—69 18 0.46 11 0.50
70-79 26 0.54 5 0.44
80-89 6 0.46 2 0.54
Control malignant Control non-malignant
50-59 9 0.52 12 0.37
60-69 16 0.56 18 0.54
70-79 9 0.53 2 0.40
80-89 2 0.72 2 0.27
unit * grams per 100 sal.
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If the grand means of the fibrinogen levels in the
malignant prostate end benign prostate groups are compared
with each other, no difference is apparent, either on visual
scanning or after statistical analysis; nor is there any-
apparent e-feet of age on plasma fibrinogen level.
It is clear that the group in the control series
with malignant disease haE a higher fibrinogen average than
any other group, but analysis by simple methods was not
possible because variance between age groups was significant,
indicating that the .groups were not homogeneous. However,
there is no obvious variation of fibrinogen with age in any
group.
Comment:
1. There is no apparent change in fibrinogen level
with age.
2. There is a great similarity of mean fibrinogen
level in 68 patients with prostatic carcinoma and
20 patients- with benign prostatic hypertrophy.
3. Each of the remaining groups lacks homogeneity
and cannot be sinply analysed. The overall
raised plasma fibrinogen levels In the control
carcinoma group is in contrast to all other groups,
including that of carcinoma of the prostate.
The following two case histories have been included
because each patient developed hypofibrinogenaemia.
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Case history A
A man J.H. aged 54 was admitted to hospital as a
list case on 28.6,56. He gave a history of renal pain over
the previous 18 years. In 1938 he had undergone a left
nephrolithotomy and a second one had been performed in 1945,
this time on the right side. On the present occasion the
syruptons were of dysuria and frequency, together with
persistent pain in the left loin. Bis general health was
not good. His blood urea was 107 mg. per 100 ml. X-ray
showed, bilateral staghora calculi. Surgery was considered
his only hope of survival.
Operation; The perinephric space was obliterated and the
(left) kidney could only be freed by stripping the capsule.
This led to considerable capillary oozing. The largest
calculus and the majority of the smaller stones were removed
through the pelvis and three were removed through incisions
in the renal substance. At the end of the operation the
patient's condition was poor, despite blood transfusions.
Two and a half hours after the end of the operation
he had made little response to ten bottles of blood. The
patient was therefore returned to the operating theatre and
the wound partly opened without anaesthetic and packed with
0
two rolls of gauze and three large abdominal packs.
Two hours later (four and a half hours after the
operation) the patient was found lying in a large pool of
blood. An emergency nephrectomy was then performed in his
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bed in the •ward, again without anaesthetic. Bleeding was
seen to be corning Bran many small points, including the
original incision. Local measures did not stop the bleeding.
At this stage haematological advice was sought,
but blood for examination had to be taken from the femoral
artery. The specimen so obtained was divided into parts
for subsequent examination.
The whole blood formed a gelatinous clot which
retracted poorly. The wolf (1954) method (see chapter two)
for fibrinogen assay suggested that fibrinogen depletion was
half that of the control, althou h it is an unconvincing
teBt at this level of difference. The Quick one-stage
prothrombin time was 26 seconds (control 13 seconds).
On this evidence 4.5 grams of the fibrinogen fraction
of human plasma was reconstituted with water and given
intravenously. Calcium gluconate was injected and more fresh
blood given. A total of 42 pints of blood was given during
the operative and immediate post-operative period. Some
improvement took place and significant bleeding did stop, but
too many aids were given for any one of them to be recognised
as the most important. The patient lived a further five days,
dying then of the circulatory and general failure from which
he had never wholly recovered. The histology of the kidney
which was removed showed relatively little recognisable renal
tissue, and autopsy showed the remaining staghorn calculus in
the other kidney.
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The follewing observations were made on the blood
sample removed at the time of the emergency.
Fibrinolysis: The whole blood clot showed, no sign of lysis
when observed at 24 hours after incubation
at 37°C. Plasma assay, using oxalated plasma,
clotted by thrombin and thenby the standard
method of this work, showed no lysis in any
tube by 24 hours.
Fibrinogen estimation: (using Podmore's method, 1959)
Fre-fibrinogen therapy sample, 0.13 g. per
100 ml. Post-fibrinogen therapy sanple 0.23 g*
per 100 ml.
Correction experiments on the prolonged Quick one-stage prothrombin
time. The patient's time of 26 seconds was
reduced to £0 seconds by "factor V" plasma,
to 19 seconds by serum, end to 21 seconds by
added bovine fibrinogen. The methods used
were in accordance with Biggs and Macfarlane
(1953a). The platelet count was 85,OCX) per
c.nsa. (lower range of normal = 150,000/c.taa.).
Interpretation: It is almost impossible to interpret these
findings with accuracy because the primary cause of the bleeding
was not established. If it was due to local causes arising
from difficult surgery, then the subsequent haematological
findings may have been caused by excessive use of blood transfusions.
This has been described before as leading to multiple deficiencies
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of coagulation factors but only rarely to hypofibrinogenaeraia
(Krevans and Jackson, 1955)• On the other hand, it remains
possible that this was an example of defibrination due to
intravascular clotting. It is of interest to note that the
blood removed from the patient when he was severely shocked
showed no evidence of fibrinolysis.
Case history £
This is one case of obstetrical bleeding and is only
relevant because of the associated hypofibrinogenaemia. The
case will be described briefly and has been included only
for the sake of completeness.
A woman N.W, aged 22 developed an ante-partum
haemorrhage at the 35th week. There was moderate bleeding
and bruising at venepuncture sites. Ohe vomited half a pint
of blood and vaginal bleeding increased. Plasma fibrinogen
was 0.11 g. per 100 ml.
She was treated vdth two bottles of triple strength
plasma without it making any apparent difference, but this
therapy was concurrent with the delivery. After the placenta
was delivered fibrinogen fraction from human plasma was
injected and this appeared to be responsible for stopping all
abnormal bleeding. The child died shortly before delivery.
Comment: The triple strength plasma may have been Ineffective
because the placenta was still in the uterus, and the fibrinogen
may have gained the credit for the recovery because the
placenta had by then been delivered and there was no further
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source for thromboplastin release into the maternal circulation.
The source of the hypofibrimgenaemia in such patients is
•widely believed to be due to intravascular coagulation secondary
to release of thromboplastic substances into the blood stream
from the placenta (Page, Pulton and deadening,
GENERAL DISCUSSION
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The special association of serious bleeding with
prostatic carcinoma has been described from time to time
(Jurgens and Trautwein, 1950: Harder, Weiner, Shulman and
Shapiro, 1949! Seale, Jampolis and Bargen, 1951: Cosgriff
and Leifer, 1952) but Tagnon, Whitmore and Shulman (1952)
appear to have been the first to give prominence to
fibrinolysis as the cause of the bleeding. They first
defined fibrinolysis as the dissolution of a whole blood clot
within 24 hours when kept at 37°C and then described two
cases of spontaneous bleeding associated with fibrinolysis,
but the plasma fibrinogen level was not known in either.
In an addendum they reported the case of a third patient,
showing fibrinolysis where there was also fibrinogen depletion.
Then they deliberately looked for fibrinolysis in 14 other
patients with carcinoma of the prostate, they failed to find
it. These patients, who were between 53 and 78 years old,
were not bleeding at the time of the examination.
In the subsequent year Tagnon, Whitmore, tchulmn
and Krawitz (1953) gathered together all their cases, Including
two new ones which they described in detail, and published a
report of fibrinolysis in six out of 48 patients with carcinoma
of the prostate. This may be the largest published series.
Five out of these six patients had bleeding manifestations
believed due to the fibrinolytic enzyme and in at least three
of them there was also a deficiency of plasma fibrinogen as
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well e.s a prolongation of the prothrombin time. The carcinoma
had metastasised in all the patients -who bled. In vitro
experiments showed that the carcinomatous tissue both from
the primary site and from metastases liad considerable
fibrinolytic activity and digested fibrinogen, prothrombin
and factor V in addition. The writers suggested that such
tissue juice escaping into the blood stream was the immediate
cause of the fibrinolysis, the fibrinogen depletion and the
prolonged prothrombin time which they found in vivo. This
Implied a pathological type of fibrinolysis.
Tuch of the work which has been reported in the
preceding pages here has resulted from the stimulus of Tagnon's
observations. The pattern of the work first began to take
shape from a desire to clarify our understanding of what
happened to one particular patient in whose prostate a
carcinoma had developed. He almost died as a result of
hypofibrinogenaerda in the course of prostatic biopsy and
orchidectomy, yet neither at that time nor for same years
subsequently did the patient show any unusual activity of
plasma fibrinolysis. hen it comes to explaining the crisis
which occurred, one can find no equivocation in the claim by
Tagnon and his colleagues that fibrinolysis is the essential
corponent in such patients, and that it is fibrinolysis which
is associated with intravascular digestion of fibrinogen and
other coagulation factors. This seems to prevent Tag-nan's
theory being a suitable explanation of the acute emergency in
our patient where there was no evidence of abnormal fibrinolysis
at the critical tine.
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It would be unexpected to find the lives of such
patients threatened by serious bleeding from two different
mechanisms, one resulting from fibrinolysis and the other
not even associated with fibrinolysis, yet both associated
with hypofibrdnogenaffinla. Therefore it seems profitable
to discuss whether the relationship of fibrinolysis to
fibrinogen depletion has been correctly interpreted up to
the present time.
There are several problems to be solved. Is
fibrinogen depletion necessarily related to fibrinolysis at
all? Is either fibrinogen depletion or fibrinolysis
dangerous when occurring without the other, or must they
occur together to cause c inical bleeding? Is abnormal
fibrinolysis an extreme form of the physiological or is it
ever primarily pathological? These points will be discussed.
Laboratory work has demonstrated, time and time again
that plasmin digests fibrinogen as well as fibrin. Tliis
observation is not questioned, but great uncertainty is
felt about its application in vivo. Experimental studies
very corn only use streptokinase or clxLoroform as a means of
plasrnin production, but neither of these two substances is
physiological and there is no validity for assuming without
proof that they re-create physiological 3tates, or even
pathological conditions of a non-specific type. A certain
amount of support for their possible validity comes from
plasm fractionation procedures but these also are subject
to artefact conditions.
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Doubt cast upon the in vivo application of so
much good, experimental work is more than an academic exercise
because experimental work on plasmin is the only justification
for attributing clinical iypofibrinogenaemia to fibrinolysis
except in cases where it is claimed there is a pathological
lytic agent which acts directly. The management of the
patient depends upon one's interpretation of the mechanism
underlying clinical bleeding;. If the low plasma' fibrinogen
in a patient is due to digestion of fibrinogen by plasmin in
the circulation, then the sensible treatment is to inhibit or
remove the digesting agent. This can be done, apparently
with success, by the use of the soya bean trypsin inhibitor,
E-aminocaproic acid and other preparations. If the low
fibrinogen level is not due to digestion but is due to
excessive consumption of plasma fibrinogen by premature
clotting, which is the most important alternative explanation,
then anticoagulants such as heparin would appear to be the
rational therapy, for maintenance and prophylaxis, if not
for the acute episodes. Successful treatment with heparin
has been reported in purpura fulminans associated with
i'lypofibrinogenaemia (Little, 1959).
The evidence against in vivo digestion of fibrinogen
is fairly strong. It hen often been observed in clinical-
laboratory work that the plasma fibrinogen level has been
normal in the presence of very active fibrinolysis. Tide
has been shown after exercise, in cirrhosis of the liver, after
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obstetrical accidents and in cadaver blood (if this may be
mentioned here) and these have bfeen documented in the section
devoted to plasmin in chapter one. Fearnley (1956) stated
that prolonged incubation of citrated plasma, whether diluted
or undiluted, from patients with cirrhotic livers gave no
reduction of fibrinogen content even when fibrinolytic activity
was great.
The work here amply confirms this apparent
dissociation of fibrinogen level and fibrinolysis. The
nine fastest rates of lysis in the whole series of 206 patients
were associated with fibrinogen levels of the order of 0.26
to 1.06 g. per 100 ml. (table X), Even the patient (case 2)
whose fibrinolysis was very active at room temperature, giving
some justification for suspecting a pathological element to
the fibrinolysis, had raised plasma fibrinogen levels of
0.49 and 0.62 g. per 100 ml. on two occasions when lysis was
very active. Moreover, the lytic potential in the same patient
was able to survive in the plasma in vitro over the course of
days without any apparent detriment to the fibrinogen, but as
soon as the same fibrinogen was converted to fibrin, lysis
took place rapidly.
Thus the evidence in favour of naturally occurring
fibrinolysis being specific for fibrin seems better than the
evidence in favour of its also being fibrinogenolytic. There
are, however, at least two alternative explanations for the
same phenomenon. The first is that the fibrinolysis is
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held inactive in a reversible combination by plasma
antilysins (nussey and Northrop, 1923) but is released
from the antilysins by its adsorption on to fibrin when
clotting occurs. There is much to commend, this explanation.
The increase of lytic activity found on sane occasions in
the plasma of patients might then be explained by a return
of same of the lysin to the plasma on its release free, the
fibrin to which it had been adsorbed and which it had only
recently digested. Antilysins would hold the released
fibrinolysin Inactive in the plasraa until more fibrin was
presented to it or until the tltre fell again in the course
of body metabolism.
A second explanation, which is entirely theoretical,
is that the lytic activity in the plasma may remain at a
precursor stage (plasminogen) until it is activated directly,
or more likely indirectly, by same component of the clotting
mechanism, both in vivo and in vitro. Such activation would
clearly occur too late for the demonstration of fibrinogenolysis,
even if the fibrinolysin (plasmin) were also fibrinogenolytic,
because the fibrinogen would already have been converted to
fibrin. There is nothing mutually incompatible about these
two explanations because neither is complete in itself. They
could occur together. The work of Fearnley and Ferguson
(1958) would favour the clotting process having ar inhibitory
effect on fibrinolysis and is evidence against thpbecond of the
explanations. Further elaboration of theory is not Justified without
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experimental work at the fundamental level of what
coagulation factor or para-factor of coagulation could
influence fibrinolytic events. Such work cannot be
performed easily "without refinement of the individual
components of the fibrinolytic system greater than is
at present possible.
It is important to know whether fibrinogen depletion
or fibrinolysis is dangerous to the patient when present as a
single finding. Congenital deficiency of fibrinogen has
been described by Henderson, Donaldson and Scarborough (1%5)
and by Alexander, Goldstein, Rich, Le Bolloc'h, Diamond and
Borges (1954) who investigated very carefully sane of the basic
aspects of coagulation in their patients. They described
two boys and one girl who suffered from repeated spontaneous
and post-traumatic haemorrhages into skin, muscles, joints
and loose tissues resulting from severe fibrinogen depletion
as an isolated abnormality. Clinically the condition
resembled haemophilia.
In the partial deficiencies of fibrinogen, the
actual plasma level at which bleeding can occur may not be
of primary importance. A slight injury with absent fibrinogen
may be as serious as a more severe injury with a higher but
still deficient fibrinogen. Patient U.S. (case 1) had stepped
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bleeding at a plasma fibrinogen level of only 0,08 g. per
100 ml. There was no demonstrable fibrinolysis at the time.
It is in the determination of the critical level of plasma
fibrinogen below which bleeding will occur in the appropriate
circumstance that secondary fibrinolytic activity could
perhaps play an important clinical part, and, being present,
could perpetuate bleeding. However, it seems correct to
believe that fibrinogen deficiency of sufficient degree can
be responsible for serious bleeding even in the absence of
other abnormalities.
The reverse situation of unusually active
fibrinolytic activity without fibrinogen depletion is probably
seen relatively commonly by anyone performing frequent
fibrinolytic assays, but the part played by active fibrinolysis
in causing or perpetuating bleeding is not really established.
It has been claimed from time to time (Tagnon, Thitmore end
Shulman, 1952) that lysis of a whole blood clot by 24 hours
at 57°C may be taken as evidence of (abnormal) fibrinolysis.
In such cases the whole plasma clot, which is much more easily
observed for complete lysis, usually lyses a little before the
whole blood clot. In the present main series of 68 patients,
six whole-plasma clots lysed by 24 hours (three of these
being from out-patients), yet in only one of these was there
any bleeding tendency, and it was not alarming. One may
also cite Macfarlane in 1937 and our own work reported here
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as examples of fierce fibrinolysis in patients during and
after surgery when the surgeon had found haemostasia to be
normal. It is clear that active fibrinolysis by itself
need not be associated with bleeding.
If one proposes that bleeding has resulted from
a combination of hypofibrinogenaemia and fibrinolysis there
seems to be no easy way of assessing individual responsibility.
Some success has been claimed from the use of anti-
fibrinolytic therapies, but there has usually been an
absence of the dramatic success which has so often attended
the administration of intravenous fibrinogen in cases of acute
hypofibrinogenaemia. Misson, Ljoerdsma and Waldenstrom
(1960) described an ill man who had acute promyeloblastic
leukaemia and was bleeding. His plasma fibrinogen level
was 0.07 g. per 100 ml. and his whole blood clot lysis time
was 15 minutes. He was treated with E-aminocaproic acid
and. the haematuria and melaena ceased simultaneously, although
he died a few days later.
The combination of fibrinolysis and fibrinogen
depletion has often been described in association with
carcinoma of the prostate. Tagnon, Schulman, Whitraore
and Leone (1953) described a close follow-up lasting 150 days
of a 58 year old negro in whom the carcinoma had metastasised.
They noted that fibrinolysis was intermittent but when
present it was associated with a simultaneous fall of plasma
fibrinogen and an increase of the prothrombin time. In
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addition there were fluctuations in the platelet count
which were roughly parallel -with the fluctuations of the
fibrinogen level. Oestrogens appeared to cause a beneficial
•/
effect on fibrinolysis, on the fibrinogen level and on the
prothrombin time. Testosterone was detrimental. Two
cases of carcinoma of the prostate were described by Crane,
Ware and Hamilton (1933)• In the first, afibrinogenaemia
developed seven hours after trans-urethral resection of the
prostate, but the only evidence for fibrinolysis in this
case was obtained preoperatively. Operative haemostasia
was normal. Their second case showed both hypofibrinogenae;nia
and fibrinolysis. Kellock and Gallagher (1958) described a
case of metastatic carcinoma of the prostate where both
fibrinolysis and a fibrinogen level of 0.10 g. per 100 ml.
(and a platelet count of 40,000 per c.mm.) were present at
the same time. Lombar&o (1959) described an example following
trans-urethral resection of a malignant prostate. Four hours
after the resection the plasma fibrinogen level was 0.04 g.
per 100 ml. with complete lysis of the patient's
(hypoflbrinogenaemic) clot in one hour. Stefan, Chrobak and
Groh (1960) reported the case of a man with metastatic
carcinoma of the prostate #10 presented with unilateral
bleeding from a kidney and was found to have hypofibrinogenaeraia
(0.14 g. per 100 ml.) and fibrinolysis.
The work of Tagnon and his colleagues has so
Impressed itself on those interested in fibrinolysis that it
is difficult to determine whether the frequent publication of
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cases of fibrinolysis in carcinoma of the prostate represents
a false incidence due to the publicity given to the problem,
or -whether in fact there is really an incidence in carcinoma
of the prostate which is greater than in other pathological
states. It is also possible that bleeding -which has resulted
from fibrinogen depletion has led to many of the studies which
have shown fibrinolysis.
The following are some published e:camples of
fibrinogen depletion from causes other than carcinoma of the
prostate. i lary of them have been associated with fibrinolysis.
Coon and Hodgson (1952) described a patient where the fast
lysis and fibrinogen depletion followed open cardiac massage,
and it seems possible that tissue Juices were released into
the blood stream in the process. They also described a patient
who had an operable carcinoma of the bronchus. His plasma
showed fibrinolytic activity "in inverse relationship" to
changes in plasma fibrinogen. When the tumour was removed
surgically, fibrinolysis and plasma fibrinogen both returned
to the levels found on admission. Depression of fibrinogen
has -also been found after surgery for carcinoma of the kidney,
where there was no obvious fibrinolysis (Phillips, Skrodelis
and Furey, 1959)J after benign prostatectomy, associated with
fibrinolysis (Scott, Matthews, Butterworth and. Frommeyer, 1954:
Loaabardo, 1959) J after lobectomy (Chalnot, Michon and Mme.
Lochard, 1952: Baumann, 1952); after pulmonary resection,
associated with fibrinolysis (Soulier, Mathay, Le Bolloc'h,
Daumet and Fayet, 1952); after abortion by intra-uterine
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injection of hypochlorite solution, associated ■with fibrinolysis
(Soulier, Petit and Lpbolloc'h, 1952); associated with
carcinosis of the bone marrow having metastasised from carcinoma
of the gall bladder in one case and from the stomach in another,
fibrinolysis being temporarily observed (Braun and Horaiyi,
1951); associated with pre-terrainal c&rcjLixxna of the stomach
and an undiagnosed case of hepato-sp1enor.iegaly (Bennike and
"lillertz, 1952); in acute myelogenous leukaemia together with
increased fibrinolysis (Cooperberg and ITeiman, 1955)* Phillips,
Howlay and Habif (1956) demonstrated scsne bypofibrinogenaejaia
1 .
often with fast lysis in nine cases during surgeiy, usually
of a major type, including aneurysm resection, radical mastectomy,
bile duct surgery and partial gastrectomy in a patient suffering
from cirrhosis of the liver. Many examples have been
published of fibrinogen depletion associated with premature
separation of the placenta (Page, Fulton and Glendenin.g, 1951)
where the presentation is usually acute, and with retention of
a dead foetus (Pritchard and Ratnoff, 1955) where the development
of fibrinogen depletion is usually slow. IlypofibrinogenaenrLa
associated with amyloidosis (Bowman, 195^) is presumably due
to failure of liver production. Haeraolytic transfusion
reactions have led to lypofibrinogenaemia, without fibrinolysis
(Jackson, 1956) and massive compatible blood transfusions may
rarely be followed by hypofibrinogenaemia (Krevans and Jackson,
1955). To this list we would add our case of J.H. (case A,
chapter six) where hypofibrinogenaeraia followed major operative
and transfusion interference because of bilateral staghorn
calculi in the kidneys.
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The terminal few months of life of the patient
E»S, (case 1, claspter four) can perhaps be compared to thoBe
Of tlae negro followed so closely for 150 days by Tagnon and
his colleagues. During this period, which was without
operative interference, the patient E.S. maintained active
lysis and a moderate fibrinogen depletion, in contrast to
his initial presentation during operative surgery. At that
time there had been a dramatic hypofibrlnogenaemia, but after
treatment it was followed by haematological good health for
some years until the malignancy escaped from control. It
is submitted that the evidence in this patient towards the
end of his life is consistent with a hypothesis of chronic
spontaneous secretion of clotting substances into the blood
stream, with continuous consumption of fibrinogen at such a
rate as to overtax Ms liver in its capacity as fibrinogen
producer. Such a chronic hypercoagulation is not inconsistent
with the leg thrombosis from which the patient suffered and
with the pulmonary embolus from which it seems likely that he
died. It is also reasonable to assiaae that most of the
products of intravascular coagulation would be removed by the
active fibrinolysis which was so easily demonstrated.
Evidence in favour of intravascular coagulation is
by its nature difficult to prove. The only indicator of
coagulation is the clot itself, and intravascular fibrin is
virtually always removed by lysis before it can be demonstrated,
except in rare and often catastropMc examples (e.g. McKay,
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Mansell ard Hertlg, 1953)* All that aiay be left with which
to demonstrate intravascular coagulation is a demonstration of
changes such as are consistent with coagulation* Such a concept
of the occurrence of intravascular coagulation is in keeping
with the interpretation of the findings made by . apaport and
Chapman (1959) in a patient Buffering from carcinoma of the
prostate. This patient showed hypofibrino; :enaemia, diminished
factor V and true protiircrabin, and a moderate tlirocibocytcpenia
(but no definite increase in fibrinolysis).
If one supposes that intravascular coagulation has
been occurring due to a spill-over of thromboplastin prostatic
tissue juices, the fibrinogen depletion is explained but not
the fibrinolysis. Because the fibrinolysis which was
demonstrated in E.S. (and in other patients in the main
series and in the controls) seemed to have no obvious
peculiar characteristics of Behaviour it is suggested that
the fibrinolysis was of a physiological type. A hypothesis
has already been put forward that adsorbed fibrinolysins may
become available for re-use after lysis has taken place, and
could thus be responsible for a rise in plasma titre in any
case where intravascular coagulation lias occurred in the
presence of a normal fibrinolytic system. If, however,
the fibrinolysis which was demonstrated in the laboratory had
characteristics suggestive of "pathological" fibrinolysis (for
example strong activity maintained at room temperature) this
might be attributable to tissue juice being present in excess
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in the blood stream and acting directly on the fibrinolytic
mechanism. £uch an occurrence in an obvious form, presuming
it occurs at all, seems to be very rare. The only patient
in the present series where "pathological" fibrinolysis may
be suspected had a plasma fibrinogen level slightly above
normal (case 2).
It is interesting to speculate •whether the heat
stability of the fibrinolytic system in case 2 could have been
due to the presence of the tissue activator of Astrup and
Terrain (1947) arising perhaps from the prostate. Ordinary
plasma activator is heat labile but tissue activator is heat
stable and is known to exist in the prostate (Pjasmussen and
Albrechtsen, 1960) as well as in most other tissues. It is
felt that an investigation into the heat stability of the
activator in the plasma of patients suffering from carcinoma
of the prostate might be a profitable line of research,
designed to prove the existence of a direct acting pathological
fibrinolysin not ordinarily demonstrable in the plasma.
Without a study of the thermal range of physiological
fibrinolysis, particularly when very active, it would be
unwise to assume that heat stability is of itself an indication
of a pathological type of fibrinolysis.
There still remains an unanswered problem of how
hypofibrinogenaemia can sometimes be found with fibrinolysis
and other times -without it. In addition to this question
involving the relationship between clotting and fibrinolysis,
a point which has been discussed already, there are also matters
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of fact which .may have "been misinterpreted from time to time.
It is well recognised by those who have had to deal with the
serious anergency of acute hypofibrinogenaer&a that there is
little time for studied research during the emergency and the
first specimen of blood may be left in the laboratory before
the assay for fibrinolysis is set up, for long enough to
destroy some of the physiological lysins, particularly if the
specimen is not kept refrigerated (I'earnley, Revill and Tweed,
1952). During the period of hypofibrinogenaemia the use of
homologous fibrin,or of an alternative substrate, is obligatory.
Specimens removed some hours later after successful therapy
with intravenous fibrinogen may still slrow a low fibrinogen
content but if the patient is recovering there is no reason
why fibrinolysis should still be active. It remains possible
that increased physiological fibrinolysis was missed for these
reasons in the case of E.S. when first seen, and in some other
published cases.
A decision whether abnormal fibrinolysis is an extreme
form of the physiological or is primarily pathological must
remain at the moment one of opinion. To a large extent it is
the problem of whether fibrinolysis can be divided into primary
and secondary types. It is hard to imagine that the short,
sharp episodes of fibrinolysis associated with routine surgery
are anything but secondary, and it is of interest to note how
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active lysis can be 011 such occasions. Ldmilarly adrenalin
has induced very active lysis in some subjects, although the
example quoted here using a smaller dose -was less dramatic.
While most of the examples quoted throughout this work are
suggestive of a physiological or secondary fibrinolysis, the
one exception to this (case 2) ws so obviously different as
to draw attention to itself by lysing the clot completely at
rccan temperature. This observation was controlled because
almost all the other samples were treated similarly in the
course of fibrinogen assay, and in none other did this obviously
occur. It is suggested that this represents the one and only
fair example of what may be called pathological fibrinolysis
out of assays on 206 patients, 63 of these being diagnosed as
having a carcinoma of the prostate.
If one may summarise the hypothesis here, it is
that fibrinolysis can be primary or secondary. The secondary
type is very common and is related in some unproved way to
blood coagulation and to adrenalin. It can be called physio¬
logical fibrinolysis. The primary type of fibrinolysis is
much less cannon and results from the escape of fibrinolytic
juice into uhe circulation in sufficient quantity to be
measurable by its direct action on the fibrinolytic mechanism.
The tissue juice of carcinoma of the prostate, being
both, thromboplastic and fibrinolytic, could be responsible for
several syndromes, all of than rare. The first would be that
usually provoked by local surgery of sudden flooding of the
22k -
circulation with prostatic thromboplastin, leading to ;-ACUt©
hypofibrinogennemia and to primary or secondary fibrinolysis.
All this is of short duration and is followed by death of
the patient or relatively complete recovery. It would be
easy on such occasions to redas any associated fibrinolysis
both because of the short duration of the episode and because
of technical difficulties when dealing with acute hypo-
fibxinogenaemia.
The second syndrome would occur where thrombcplastic
tissue juices reach the blood stream as a small chronic spill¬
over, usually unprovoked by interference. This would lead
to a lowered fibrinogen level with secondary fibrinolysis
which presumably would mop up the end product of intravascular
clotting or would itself be the result of the mopping up.
Hie amount of tissue juice would be too small to be effective
by a direct action on the fibx-inolytic mechanism.
The third syndrome would result from the escape of
tissue juice which by its quantity or its quality would act
directly on the fibrinolytic mechanism and could be demonstrated
to be different from the physiological fibrinolysis by, for
example, its physical properties. This need not be associated
with fibrinogen depletion. It is possible that the second
and the third syndromes would represent equilibria between
the noxious agent and the body defences. The capacity of the
liver to regenerate fibrinogen is particularly important In
this context and observations on the biological half life of
such fibrinogen would be interesting (see Hammond and Verel, 1959).
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Perhaps these suggestions are too complicated.
It may be that the same prostatic juice is both throabqplastic
and fibrinolytic at one and the same time in vivo, for this
would not even demand a relationship between coagulation and
lysis. This seems to cut across the concept of physiological
interrelationships.
Ey such hypotheses all the peculiarities of the
patients described relating to fibrinogen depletion and
fibrinolysis are explained away. It would appear to be
necessary to examine more patients similarly affected, both
in an emergency and in the chronic phase, in order to test the
hypothesis. The explanation which has been given is
applicable in its entirety only to tissue which is simultaneously
thromboplastlc and fibrinolytic. We have demonstrated this
to be the case in carcinoma of the prostate, but it would be
interesting to know if the combined thromboplastin and
fibrinolytic activity is equally apposite to other lesions
developing elsewhere in such places as have only rarely been
associated so far with fibrinolysis and hypofibrlnogenaemia.
There is much in published work to suggest that this would be
so.
0 o o o o
Results have been presented showing an increase of
lytic activity with age, and there is a close parallel between
this and the increase of latent prostatic carcinoma with age
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as published by Franks (i95^-)• he found a progressively
increasing incidence of histological carcinoma in his series
of autopsies on men from the age of 4-0 until the id.nth decade,
when he found latent carcinoma in almost all the prostates
examined. Frank' s work created the problem which made a
choice of controls for carcinoma of the prostate so difficult,
even although one did not expect a carcinoma which was only
latent to influence the results. It was the reason why the
controls were divided into those where there was known benign
prostatic hypertrophy, those where there was known malignancy
elsewhere than in the prostate, and those admitted to hospital
for reasons other than malignancy. It was decided not to use
women as controls for a prostate series because it seemed
desirable to narrow down the controls as far as possible.
Variable factors due to sex differences would add an unknown
which might prove difficult to analyse.
The three control groups and the carcinoma of prostate
series were remarkably alike in their display of increasing
lysis with age, and when all are taken together the results
hold even greater authority. Clearly the increased lysis is
not a feature of clinical carcinoma of prostate, nor of
recognised malignancy elsewhere in the body, but is a phenomenon
common to all men in hospital taken as a group. In this
respect the control series has not acted as a control. To
test the observation further it would now be profitable to
examine a female series, the significant observation in this
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context being; the presence or absence of a slope of
increasing lysis with age. It should be relatively easily
assessed.
The range of lytic activity shown by the various age
groups never approached the levels associated by many with
clinical bleeding;. From the age of 40 to 00 the mean lysis
time of the 50 per cent clot shortened progressively until
it was approximately halved (figure 7). Even at the age of
80 the mean time in hours was greatly in excess of anything
associated with abnormally fast fibrinolysis. These
observations appear to contribute a point of fact to the
study of the process of ageing in men, to which fibrinolysis
has so far contributed very little.
No large published series of patients examined for
fibrinolysis and covering a wide range of eges has been
discovered. Albrechtsen (1957) stated that no correlation
could be established between the stable activator concentration
and age or sex. Fearnley and Lackner (1955) found no
difference in fibrinolysis related to age between 20 and 40
years. Sawyer, Fletcher, Alkjaersig and. Sherry (l%0) stated
that they found no correlation of fibrinolysis with age in the
population they studied but did not give details. Buckell
and Elliott (1959a) found a higher level of fibrinolytic
activity in the younger age group of a series of men, all of
whom were under 50 years old.
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Some other changes -with age hare been observed in
the blood, one of them being the increasing concentration of
antihaeiaqphilic factor reported by Coqperberg and Teitelbaum
(1960). These authors felt that their finding was a
manifestation of hypercoagulability predisposing to thrombosis.
Such a claim appears at first sight to be in contradiction to
the finding of increasing fibrinolysis but the complexity of
the problem of hypercoagulability and fibrinolysis is apparent
and it is not considered that the opinion of Cocperberg and
Teitelbaum is necessarily in conflict with our own. It
does seem uncertain, however, whether an increased concentration
of antihemophilic factor can be regarded as ipso facto evidence
of hypercoagulability.
0000000
It seems appropriate to end this discussion by a
critical appraisal of the results which have been presented,
lest it could be claimed that they are a false product of the
method used to create them. Other results might have been
possible using different methods.
The dilution method for demonstrating plasma
fibrinolysis has had its critics. Yon Kaulla and bchultz
(1958) declared that the dilution method was not always correct.
They found that diluted plasma was less sensitive than
undiluted plasma to the fibrinolysis induced by pyrogens.
Sherry, Lindemeyer, Fletcher and Alkjaersig (1959) found that
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the Fearalcy clot lysis technique was cumbersome and less
sensitive than the plasma euglobulin metliod and found the
several dilutions of plasma required to be a further
disadvantage.
The method used here has also been found to be
cumbersane and time cd nsuming, but this does not condemn it.
A serious criticism which can be levelled against the method
is the unpredictable times at which the clots lyse. Nothing
short of an hourly or two-hourly day and night vigil for a
matter of months on end would have allowed the assays reported
here to be observed in the optimum way and it is not surprising
that Lackner and Goosen (1959) devised a camera to photograph
the clots in a modified version of the test. The extremes
of shape of the curves shown in figures 3, 4 and 5 show the
need for caution if single plasma dilutions are to be used
for presenting results, but as the test was carried out here
the lysis time of the 50 per cent clot seems to be superior
to all others and the clear result obtained in this work from
the analysis of a large series does itself defend the use of
the method.
It is interesting to note that Feamley and Tweed
(1955) found that lysis was sometimes apparent in thrombin-
elotted plasma in a 1:4 dilution when it was not apparent in
greater dilutions. They attributed this to an inhibiting
effect of thrombin and proceeded to demonstrate this by an
appropriate experiment. Later in the same table the reverse
situation occurred using plasma from other subjects, and only
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the dilute clots lysed. Fearoley and Tweed attributed this
to the diluting out of a serum plasmin inhibitor. They may
well have been correct, but two such variations of pattern
apparent in the same table, taken together with our own
findings, do ■show that there are difficulties associated with
the test which makes it difficult to interpret and present.
It is not possible to entertain the belief that the test is
analytic of any one fibrinolytic component.
Here perhaps lies the strength of the method. It
represents,within limits, the final common pathway of all
influences concerned with fibrinolysis. Only the rising pB
is obviously unphysiological, but this does not seem to
affect actively lysing plasma to any obvious extent. If it
is wished to demonstrate an effective fibrinolytic influence
in a group of people, the principle of the dilution method
appears ideal, although in practice it may have disadvantages.
It would seem that the observation of increasing lysis in men
with the passage of years is complete in itself and needs no
qualification.
Without special study it is impossible to venture on
the problem of which fibrinolytic component makes the lysis
time shorter with increasing age. It could be an increase
in activator or a diminution of plasrain inhibitor. Bo
comment is made about the possible function of the increased
fibrinolysis. Its relevance to the problem of vascular
thrombosis is obvious.
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The method used lades the refinement and accuracy
require, to show slight variations of lytic activity except
in most rigidly controlled trials. there the variation
expected is slight it would seem preferable to use the same
subjects repetitively as Feaxnley himself has done from
time to time. On the other hand tvhen one is using only-
one assay from each of many patients a more refined method
might create its own problems in interpretation due to the
very wide variation which appears to exist in physiological
fibrinolysis and the superiority of such a method might
thereby be diminished.
>
Whereas the clear finding of an age difference was
obtained from analysis of lysis times which were within the
normal range, no clear finding arose from study of the
abnormally short lysis times. Although a relatively large
series of carcinoma of the prostate has been presented here,
support for the importance of fibrinolysis in this condition
has not been obtained. The problem at this stage is really
whether an alternative method of assay might have given a
significant incidence of abnormal results. This is not
felt to be likely. Observation of the exact time when lysis
of clots occurred after a short incubation was very much more
accurate than when lysis was delayed. It was only in the
latter case that night hours passed without any observations
being made. It is felt to be probable that other methods of
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fibrinolysis assay, such as the euglobulin lysis time or
liberation of radioactive iodine from clots, would have




A review has been presented of the extensive
literature concerning the aseptic dissolution of blood clot,
or fibrinolysis. Study of such work draws attention to a
widespread uncertainty about the physiological role of
fibrinolysis. It can be seen also how frequently the
assumption has been made, without proof, that fibrinolytic
activity has been the primary cause of bleeding episodes
when the evidence goes no further than to demonstrate active
fibrinolysis during bleeding.
differing patterns of results have been obtained
from assays of fibrinolysis in 206 patients, using a technique
requiring serial dilutions of chilled plasma with
subsequent incubation. Analysis has shown that the most
comparable figures are obtained from the lysis times of clots
prepared from 50 per cent plasma in buffer. With a view to
assisting the interpretation of results a study has been made
of the effect on the test of environmental factors and drugs.
68 cases of carcinoma of the prostate comprise the
main series in this work, the diagnosis being confirmed
histologically in kU of these. The more important case
histories have been given in detail.
A control series of 130 male patients in hospital
has been divided into three sub-groups for analysis, these
being of benign prostatic hyperplasia, miscellaneous malignant
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conditions and miscellaneous non-malignant conditions.
All groups,including the main series, taken separately and
together, show the same statistically significant increase
of fibrinolysis with age. The lysis time of the $0 per
cent clot is approximately halved between the ages of 40
and 80.
There is no statistically significant difference
in fibrinolytic activity between the main series of carcinoma
of prostate and the control group. Nor has any certain
effect on fibrinolysis been observed associated with
metastatic spread, oestrogen therapy or bilateral orchidectomy
in appropriate cases of carcinoma of prostate in the main
series.
It has been shown here that rapid fibrinolysis
in vivo need not be accompanied by fibrinogen depletion or
bleeding. In addition, a case of serious bleeding in carcinoma
of the prostate reported here in detail has shown fibrinogen
depletion without demonstrable fibrinolysis at the time of
the crisis.
These observations have been used to support the
hypothesis that the abnormal bleeding which sometimes occurs
in carcinoma of the prostate is not primarily due to
fibrinolysis but is due to a consumption of coagulation factors,
including fibrinogen, in the course of pathological intravascular
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clotting. The clotting factor may arise from prostatic
' & : T
tissue, laboratory work having shown the presence of thrombo-
plastic as -well as a more generally recognised fibrinolytic
activity in both benign and malignant prostatic tissue.
When rapid fibrinolysis has been found in this
series it has almost always been attributed to the variations
of a physiological system, but no claim is made that
pathological fibrinolysis cannot occur in association -with
carcinoma, of the prostate. In one case the fibrinolysin
•was sufficiently heat stable as to suggest that it might
have been a pathological fibrinolysin.
APPENDIX ONE
- 23b -
The oa.se of E.S. (case 1)
On February 13th, 1956, a man aged 71 presented
with haematuria -which had developed over the previous week.
He gave a history of unremitting backache over the previous
six months and of scalding and frequency of micturition.
The liver was palpable 1-|- inches (3» 8 cm. ) below the eostal
margin in the mid-clavicular line. He had a large fixed
prostate gland which was thought to be probably malignant.
By the time of his admission to hospital on March 6th the
haematuria had stopped spontaneously.
Investigations
A few of the hnematological investigations have
already been presented in table XI. Radiographs of the
pelvis did not sho ary evidence of bory metastases, but an
intravenous pyelogram revealed a moderately severe left
hydronephrosis and a lobulated filling defect on the bladder
base.
As an initial therapeutic procedure bilateral
orchidectony was per, armed, end a biopsy of the prostate was
also taken, using the perineal approach. This ultimately
confirmed the presence of an anaplastic carcinoma of the
prostate. After the biopsy had been removed all the
traumatized tissue began to bleed freely, and the patient
developed peripheral circulatory failure. Post-operatively
the peidneal wound continued to bleed, and his condition
deteriorated. Ho improvement was observed as a result of
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the emergency transfusion of three bottles of stored blood
over four hours: indeed, he began to develop spontaneous
subcutaneous bruising around the shoulder-girdle and arras.
At this stage it was reported that the original specimen of
venous blood removed for emergency cross-matching had still
failed to clot. The syndrome was fully investigated by the
following, laboratory tests.
1. Failure of "blood to clot. The specimen of blood
removed immediately after the operation had not been in
contact with an anticoagulant, and yet it appeared to remain
i
completely fluid apart from a very minute clot which comprised
little more than a few fibrin strands lying loose within the
specimen. This tiny clot did not increase in size thereafter.
Indeed, it became less visible during the succeeding five
hours. This apparent failure of clot formation as observed
in the blood transfusion laboratory suggested the diagnosis
of fibrinogen depletion. The following tests confirmed the
presumptive diagnosis.
2. Thrombin and whole blood. Since thrombin is a
specific indicator of the presence of fibrinogen, given the
absence of inhibitors, 0.2 ml. of commercial thrombin (haw,
50 N.I.H. units per ml. of normal saline) was added, to the same
volume of oxalated whole blood. When assessed some 60 seconds
later a very poor clot had formed. It was small in size,
occupied a mere fraction of the total volume, and was
ineffective in enmeshing red cells. By contrast, normal
blood produced a large firm clot occupying the whole volume
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and enmeshing almost all the red cells. When the original
specimen sent for cross-watching was substituted for the
oxalated specimen no clot at all was seen. Presumably such
fibrinogen as had been present had already clotted.
Treatment of the bleeding
Dried fibrinogen fractionated from pooled human
plasma was injected intravenously as fast as possible.
Four grams were dissolved in 200 ml. of pyrogen-free
distilled water and given over 20 minutes. At the time,
the patient was dangerously shocked, with blood running
freely from the wound, and he had a weak pulse of 130 a
minute. All serious bleeding ceased within half an hour,
and within one hour of the fibrinogen transfusion all oczing
had stopped, with dramatic clinical improvement. No :further
fibrinogen therapy was necessary. The wound subsequently
healed well.
Investigations for fibrinolysis
The simplest emergency method for demonstrating
fibrinolysis is by the observation of a whole blood clot kept
at body temperature. This is always impossible when, as
here, the fibrinogen level is so lor; that virtually no clot
is formed. Further, the absence of patient's fibrinogen
demands a test for fibrinolysis which uses fibrinogen from
another source. lb such technique was used, here during, the
night of the emergency. Blood removed 12 hours after the
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emergency was examined as follows.
Quantitative test for fibrinolysis (Biggs and i acfarlaae,
1933b): Serial estimation of the amount of clot remaining
after incubation (measured by "tyrosine" released) showed, no
evidence of commencing fibrinolysis up to four hours. The
blood was not kept chilled before the test. A similar test
performed on a specimen removed from the patient 90 hours
after the emergency was not significantly different.
Examination for lvsis of' normal clot by patient's plasma: No
lysis was visible to the naked eye following the immersion of
a washed fibrin clot (formed by the addition of 0.2 ml. thrombin
to 0.1 ml. normal plasma) into undiluted patient's plasma,
followed by incubation at 37°C for 2k hours.
Subsequent course
The patient was discharged from hospital three weeks
after the surgical episode from which he so nearly died.
His wound had healed and the plasma fibrinogen had remained
well within the normal range. The total serum acid phosphatase
level had fallen progressively to 7 G-utman units per 100 ml.
The blood urea was within the normal range. Etilboestrol
had been started ten days after the operation and he was
discharged home to take 10 rag. three times daily. Details
of laboratory findings can be found in table XI,
Second admission
Six months later he was re-admitted on 8,10.56.
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suffering from acute retention of urine. I. .mediately after
his arrival in hospital he managed to pass urine spontaneously.
Subsequent cystoscopy showed inaxy small stones and phosphatic
debris in the bladder. This required three sessions with a
Bigelow's bladder evacuator to remove all the stones. At
none of these occasions was there any clinical or
haematological deterioration. Plasma fibrinogen level
remained normal. Stilboestrol was continued as before.
Third admission
"ithin a month he was re-admitted on 25.1 "1.56. again
suffering from urinary retention. The cause was apparently
the impaction of calcarious matter in his urethra. A
cystoscope was passed twice on this occasion and a considerable
amount of debris was removed from the bladder. In addition
to maintaining the urine at an acid pH, stilboestrol was
continued and he was discharged heme on 10.12.56. It is
worth noting that about this time he complained of swelling
of his right leg below the knee. It became "blue" shortly
afterwards. No cause for this was found and the leg recovered.
It gave no further trouble until the end.
For the subsequent eighteen months the patient
continued to attend the out-patient department at intervals.
There was general satisfaction all round at his progress. At
the end of this time he gave a story which was interpreted as
the passing per urethram of a calculus which had been causing
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ureteric colic. X-ray showed two large bladder calculi
for which hospital treatment was advised.
Fourth admission
On 25.8.58. he was re-admitted for removal of
bladder calculi. In the absence of any obvious haenatological
contraindication, supra-pubic cystostony was performed and two
large stones were removed. There was no unexpected bleeding
at any time and healing was uneventful. The fibrinogen level




On 12.2.59. he was admitted as an emergency case.
He had suffered since his previous discharge from epigastric
pain passing through to the back, and coming on two hours
after food. The pain was relieved by alkalis. Two nights
before admission he had begun to cough up blight red blood
and believed that he must have lost two pints altogether
since then. There load been two similar but less severe
periods of haemoptysis during the preceding week. He also
commented that he had begun to bruise at the slightest touch
for the previous two or three months. X-ray of the chest
allowed a density in the left lower lobe, possibly consolidation,
and also many boby metastases. Cn this admission hypo-
fibrinogenaeraia was demonstrated for the first time since
the acute episode of 1956, but it was accompanied by a
thrombocytopenia of 40,000/c.mm. , this for the first time
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and a fast rate of clot lysis. Four grains of fibrinogen,
fractionated from human plasma, were given with some good effect.
The haemoptysis diminished to a minimal blood streaking, but
the fibrinogen level relapsed to pre-treatment level within
two days. 4-0 units of long-acting corticotrophin were given
by injection every day in the hope of reducing the fibrinolysis.
The patient's general state improved slightly and he was
discharged on 3*3*59. feeling better, but not fit.
On 21.3*59. he died at home. The patient had been
feeling quite well and was standing up to dust his pillow when
he turned back and fell dead. His family doctor said tliat
the patient had had further swelling in the right calf with
some pain. There was pitting oedema of both legs, particularly
on the right side. He thought the local diagnosis was of deep
phlebothrombosis.
No autopsy was possible. It was suspected that





The lysis times and plasma fibrinogen levels
according to age, in the three control groups
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TABLE- XXXII (cont. )
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TABLE XXXIII
The lysis times and plasma fibrinogen levels according
to age in the main series of carcinoma of prostate.
lysis time in hours P50
Histological evidence No histological Diagnosis by Plasma
No. of patients Decade of age of prostatic carcinoma evidence but clinical story fibrinogen
diagnosis beyond and palpation g./l00 ml.
reasonable doubt of prostate




+ 98 # 0.48
+ 23 0.45
+ <4 55 41 0.47
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7 80 - 89 + 48 O.58
4 0.49




+ 44 24 0.44
44 before figure signifies
out-patient examination
4* after figure signifies the
presence of known metastases
+ = buffer containing calcium
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